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Drosophila neurotrophins (DNTs) - Spätzle (Spz), DNT1 and DNT2 - and 3 members of the 
Toll protein family – Toll, Toll-6 and Toll-7, of which Toll is Spz’s receptor – have been 
shown to promote neuronal survival and motoneuron targeting in embryos. Yet, it remains to 
be understood (1) whether the DNTs influence cell number and central nervous system (CNS) 
development after embryonic stages to result in the behaving larva, and in turn (2) whether 
these events influence larval CNS repair after injury. Here, I investigated the functions of 
DNTs and Tolls in the formation and repair of the larval CNS, focusing mostly on Spz. I used 
GAL4 reporters, MiMIC-GFP protein traps and antibodies to the DNTs and Tolls to describe 
their larval CNS distributions. Interestingly, Spz was restricted to the mechanosensory 
domain in the ventral nerve cord (VNC). I generated a new loss of function allele for spz and 
showed that spz mutations affect glial numbers in the larval abdominal VNC. Using stabbing 
injury in the larval CNS, I showed that loss of spz antagonised wound repair. To conclude, my 
data show the involvement of Spz in larval CNS development, and that Spz has a prominent 
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Understanding how the brain works remains an extensive research pursuit in this early 21st 
century (Alivisatos et al., 2012). In this pursuit, one of the fundamental questions which arise 
is how the metazoan nervous system orchestrates its cellular parts to achieve functionality. 
The metazoan nervous system is central to generating behaviour (Ferreira et al., 2014a), a set 
of adaptable and complex movements which are mediated through muscle contractions, even 
including the generation of communication such as gestures, speech and writing. Metazoan 
nervous system ranges in complexity. A simple type of nervous system is a diffuse nerve net 
in prebilaterians. The diffuse nerve net is exemplified in the sedentary polyps of the phylum 
Cnidaria, and it comprises of two fundamental neurons: sensory neurons and motoneurons 
(Angerer et al., 2011; Arendt et al., 2008; Ferreira et al., 2014a). In contrast, the central 
nervous system (CNS) found in bilaterians are complex and delimited. The interneurons, 
which associated between the sensory neurons and motoneurons, are introduced in the 
bilaterians (Angerer et al., 2011; Arendt et al., 2008; Ferreira et al., 2014a). When the CNS is 
defined anatomically as “nervous tissue that comprises distinct agglomerations of functionally 
specialized neurons (nuclei) interconnected by axon tracts (neuropile)” (Arendt et al., 2008), 
and as nervous tissue which “may be subdivided into separate parts (ganglia)” (Arendt et al., 
2008), the CNS then takes various forms in shape and size across phyla of deuterostomes and 
protostomes. The deuterostomes mentioned here include the vertebrates, while the 




The concept of the nervous system being central to creating behaviours is the basis for many 
histological studies on the structure of the nervous system (Ferreira et al., 2014a). When the 
architecture of the nervous system emerges, the obvious phenomena are the accompanying 
growth in organ volume and an increase in cell number. Neuronal and glial cells of the 
nervous system have their numbers adjusted through trophic interactions to organise the 
development of a properly functioning nervous system (Gomes et al., 2001; Hidalgo et al., 
2011). Neuronal cells also adjust the growth of their dendritic connections such that the 
circuits they form are suitably matched to the functions they perform (Tripodi et al., 2008). 
Such coordination endows the nervous system with plasticity (i.e. the ability to undergo 
change). Plasticity confers structural robustness to the nervous system, that is to say that the 
challenges of maintaining cell identity and tissue functions in a developing, growing and 
changing organisation of the nervous system are met, at least partly, by counteracting 
structural compensations (Gomes et al., 2001; Hidalgo et al., 2011; Marder and Prinz, 2003; 
Tripodi et al., 2008). Structural robustness, in turn, allows the reproducible functioning of the 
nervous system across individuals and throughout life such as in learning and memory. 
Furthermore, plasticity enables cells to undertake responses to injury by promoting repair 
(Hidalgo and Ffrench-Constant, 2003; Hidalgo et al., 2011). 
 
1.1 Neurotrophism in Drosophila 
 
1.1.1 Definition of Neurotrophic Factors and Neurotrophins 
 
Neurotrophic factors (NTFs) are a subset of growth factors which act in the nervous system, 
where they regulate survival, development and function, while neurotrophins (NTs) are one of 
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the major classes of NTFs (Blum and Konnerth, 2005; Boyd and Gordon, 2003; Deister and 
Schmidt, 2006; Huang and Reichardt, 2001; Lewin and Barde, 1996; Lu et al., 2005).  
 
1.1.2 Neurotrophic Factors in Drosophila 
 
The effort placed into the identification and functional demonstration of neurotrophic factors 
in Drosophila melanogaster (D. melanogaster) has revealed that the human and fruit fly 
nervous systems share the same building blocks in the course of their development to organise 
the emergence of the nervous system circuitry (Newquist et al., 2013; Palgi et al., 2009; Zhu 
et al., 2008). The corollary of this revelation is that structural robustness had extended 
reproducible formation and functioning of the nervous system over evolutionary time and that 
the Drosophila nervous system is also plastic like that in the mammalian (Hidalgo et al., 
2011). These findings place an importance on the fitting use of Drosophila as a choice model 
organism to understand the workings of the brain and to investigate regeneration of the 
damaged or diseased nervous system.  
 
1.1.2.1 Neurotrophins in Drosophila 
 
In vertebrates, the neurotrophins (NTs) are a major class of secretory, dimeric proteins which 
share common structural features and which make up one of the protein families that link 
nervous system structure and function (Blum and Konnerth, 2005; Hidalgo et al., 2011; 
Lewin and Barde, 1996; Lu et al., 2005). Neurotrophins regulate many aspects of nervous 
system development and function including axon guidance, cell proliferation, cell 
differentiation, cell survival, axonal and dendritic elaborations, membrane trafficking, synapse 
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formation and synaptic plasticity (Gurthrie, 2007; Reichardt, 2006). It is therefore 
unsurprising that abnormal neurotrophin function is linked to brain diseases such as 
neurodegeneration (e.g. Alzheimer’s disease), psychiatric disorders (e.g. depression) and 
impaired memories (Allen and Dawbarn, 2006; Martinowich et al., 2007; Reichardt, 2006).  
 
Mammalian NTs carry out their functions in conjunction with their Trk, p75 and Sortilin 
receptors (Bartkowska et al., 2010; Devesa and Ferrer-Montiel, 2014; Jansen et al., 2007; Lu 
et al., 2005; Marchetti et al., 2015; Nykjaer et al., 2005; Reichardt, 2006). However, no 
canonical neurotrophin receptor homologues of Trk, p75 or Sortilin have been found in 
Drosophila (Manning et al., 2002). Instead, the Drosophila neurotrophins (DNTs) found 
within the Spätzle protein family bind to paralogues of the Toll family. The Drosophila 
neurotrophin Spätzle (Spz) is a well-known activating ligand of the receptor Toll (Hu et al., 
2004; Weber et al., 2003). The functional conservation between the DNTs and the 
mammalian NTs has been demonstrated in vivo in Drosophila by the maintenance of neuronal 
survival and motor-axon targeting during embryonic development (Zhu et al., 2008). The 
DNTs are also required for synaptogenesis in the larval neuromuscular junction (NMJ) 
(Sutcliffe et al., 2013). Toll has neurotrophic, axon-targeting and synaptogenesis functions in 
the embryos too (Halfon et al., 1995; Inaki et al., 2010; Rose et al., 1997; Zhu et al., 2008). 
The loss of Toll results in muscle defects in the larvae (Halfon et al., 1995; Halfon and 
Keshishian, 1998). However, it remains to be understood how the DNTs influence the 
adjustment of cell numbers and the wiring of the nervous system after embryonic stages to 




It is known that the central nervous system (CNS) in humans exhibits poor regenerative 
ability following traumatic injury and chemotoxicity, or as a result of ongoing 
neurodegenerative processes (Carlson, 2007; Horner and Gage, 2000). When reiterating the 
fact that the neurotrophin family regulate many aspects of nervous system development and 
function, this characteristic naturally confers promising potential upon the neurotrophins to 
assist regenerative processes (Ferraro et al., 2004; Horner and Gage, 2000). To date, there 
have been no in vivo functional studies of DNTs in Drosophila CNS regeneration.  
 
1.1.2.2 MANF and CDNF in Drosophila 
 
Independent from the NTs, the second class of vertebrate neurotrophic factors consists of the 
Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) and the Cerebral Dopamine 
Neurotrophic Factor (CDNF) (Lindholm and Saarma, 2010). In Drosophila, the single protein 
homologous to vertebrate MANF/CDNF is Drosophila MANF (DmMANF) (Palgi et al., 
2009). MANF and CDNF protect vertebrate midbrain dopaminergic (DA) neurons and 
DmMANF preserves the functional role of protecting DA neurons in Drosophila (Lindholm 
and Saarma, 2010). DmMANF is produced by glial cells, and this situation is comparable to 
mammalian astrocytes nearby DA neurons (Palgi et al., 2009). Towards the end of 
embryogenesis, DmMANF is needed for the maturation and maintenance of DA neurites as 
well as the maintenance of dopamine levels (Palgi et al., 2009). Without DmMANF, 
maturation of the nervous system is affected severely by specific and signification reduction 
of DA neurites (Palgi et al., 2009). Hatched mutant embryos die in the first instar larval stages 
or immediately after the first molt (Palgi et al., 2009). Given that the specific loss of 
dopamine in human adults is the hallmark of Parkinson’s disease (PD), the study of 
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DmMANF in Drosophila models for neurodegeneration has great potential for the 
understanding of PD (Coulom and Birman, 2004; Palgi et al., 2012; Palgi et al., 2009; 
Whitworth et al., 2006). 
 
1.1.2.3 Netrins in Drosophila 
 
The DNTs found within the Spätzle protein family are expressed in the embryonic CNS 
midline, an intermediate target of interneurons (Zhu et al., 2008). Netrins are classical axon 
guidance cues and they overlap their expression patterns with the DNTs in the midline target 
of interneurons, with Netrin-B in particular, but not Netrin-A, serving as an en passant 
neurotrophic factor (Newquist et al., 2013).  
 
1.1.2.4 GDNF Family Signalling in Drosophila 
 
The mammalian glial cell-line derived neurotrophic factor (GDNF) family ligands (GFLs) are 
growth factors related to the Transforming Growth Factor Beta (TGFβ) protein superfamily 
(Airaksinen and Saarma, 2002). The GFLs consist of GDNF, artemin, neurturin and persephin 
(Airaksinen and Saarma, 2002; Baloh et al., 2000). GFLs play a crucial role in the 
development and maintenance of distinct neuronal populations in the vertebrate central and 
peripheral nervous system (PNS) (Kallijarvi et al., 2012). Dimeric GFLs bind cognate GDNF 
family receptor alpha (GFRα) receptors to activate Ret receptor tyrosine kinase signalling 




While no GDNF homologue has been identified in Drosophila yet, a Ret homologue is 
conserved in Drosophila and is expressed in the nervous tissue where downstream Ret 
signalling could be conserved (Abrescia et al., 2005; Aron et al., 2010; Hahn and Bishop, 
2001; Kallijarvi et al., 2012; Sugaya et al., 1994). 
 
1.1.3 Gliatrophic Factors in Drosophila 
 
In the adult Drosophila brain, glial proliferation can be induced by neuronal programmed cell 
death (PCD), and conversely suppressed by inhibition of neuronal PCD (Kato et al., 2009). 
Therefore, studying the development, maintenance and survival of glia to understand the 
wiring of nervous system circuitry is as relevant as studying the neuronal counterpart.  
 
Growth factors which regulate the survival of glia are called gliatrophic factors. In Drosophila, 
there is only one Epidermal Growth Factor Receptor (EGFR) which binds multiple ligands, 
including Spitz and Vein, homologues of Transforming Growth Factor Alpha (TGFα) and 
Neuregulin, respectively (Hidalgo et al., 2011; Hidalgo et al., 2001). A subset of midline glia 
expressing EGFR during embryonic development depends on Spitz to be secreted by 
neighbouring neurons for its survival (Bergmann et al., 2002). Pioneers neurons produce Vein 
to maintain survival of neighbouring EGFR-expressing longitudinal glia (Hidalgo et al., 
2001). There is also only one homologue in Drosophila for both Platelet-Derived Growth 
Factor Receptor (PDGF) and Vascular Endothelial Growth Factor (VEGF) called PVR, and 
this receptor is also required by the midline glia for survival through PVF ligand secretion 




Using Spitz/TGFα and Vein/Neuregulin as the growth factors to compare and contrast with 
NGF, Spitz/TGFα, Vein/Neuregulin and NGF are similar to each other in how they are 
secreted to maintain cell population survival in the nervous system. They overlap through 
exerting their functions through specific protein receptor families in the neighbouring cell or 
target field. However, the growth factors Spitz/TGFα and Vein/Neuregulin differ from NGF 
in the target cell type they maintain in the nervous system.  
 
1.1.4 Review of the Identification of DNTs in the Spätzle Protein Family 
 
The mammalian NT family consists of the Nerve Growth Factor (NGF), Brain-Derived 
Neurotrophic Factor (BDNF), Neurotrophin-3 (NT3) and Neurotrophin-4/5 (NT4/5) (Lewin 
and Barde, 1996). From teleost bony fish, Neurotrophin-6 (NT6) and Neurotrophin-7 (NT7) 
have been isolated (Gotz et al., 1994; Nilsson et al., 1998). Mature NTs are derived after the 
synthesis and modification of precursors called proneurotrophins (proNTs) (Edwards et al., 
1998; Lewin & Barde, 1996). Both mature NTs and proNTs carry out functions through their 
Trk, p75 and Sortilin receptors in an assortment of receptor complexes, including as simple 
homodimeric structures or as multimeric co-receptor partners (Jansen et al., 2007; Lu et al., 
2005; Nykjaer et al., 2005; Reichardt, 2006) (Bartkowska et al., 2010; Devesa and Ferrer-
Montiel, 2014; Marchetti et al., 2015).  
 
Structurally, members of the NT family adopt a three-dimensional (3D) fold so-called the 
cystine-knot (CysKnot), an elongated anti-parallel β-strand with 3 disulphide bridges among 
intra-cysteine residues (DeLotto and DeLotto, 1998; Hoffmann et al., 2008; Mizuguchi et al., 
1998; Weber et al., 2007). The NTs share common structural features including the formation 
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of homo- and hetero- dimers (Lewin and Barde, 1996; McDonald and Hendrickson, 1993). 
Spz, having a CysKnot and capable of dimerising, belongs with NTs in the CysKnot 
superfamily of proteins (DeLotto and DeLotto, 1998; Gangloff et al., 2008; Hoffmann et al., 
2008; Hu et al., 2004; Mizuguchi et al., 1998; Parthier et al., 2014; Stelter et al., 2013; Weber 
et al., 2007; Weber et al., 2005; Weber et al., 2003). Of the 4 classical NTs, Spz is most 
similar to NGF according to these criteria: amino acid sequence alignment of the CysKnot, 
consistency between predicted comparative structural modelling and experimented 
biochemical treatment of dimeric Spz, and matching crystallographic structure of the CysKnot 
(DeLotto and DeLotto, 1998; Gangloff et al., 2008; Hoffmann et al., 2008; Mizuguchi et al., 
1998; Weber et al., 2007; Weber et al., 2003). NGF is most well-understood for its trophic 
effect in the development of early PNS (Cohen and Levi-Montalcini, 1956; Davies, 1996; 
Levi-Montalcini and Cohen, 1960; Lewin and Barde, 1996). For clarity, a neurotrophic effect 
is defined as the mediation of axon outgrowth as well as long-term dependence between 
neurons and the target cells they innervate such that the neurons can survive (Gurthrie, 2007). 
Biologically, Spz promotes motor axon targeting (Zhu et al., 2008). Put together, Spz is a 
structural and functional homologue of mammalian NTs.  
 
DNT1 and DNT2 are Spz paralogues Spz2 and Spz5, respectively (Parker et al., 2001; Zhu et 
al., 2008). DNT1 was identified as related to BDNF using amino acid sequence alignment and 
comparative protein structure tools (Zhu et al., 2008). In particular, DNT1 retains all the 
residues relevant to forming the human CysKnot (Zhu et al., 2008). Akin to Spz, DNT1 also 
has the dimerising features of canonical NTs (Zhu et al., 2008). Another protein structurally 
close to DNT1, Spz and the human NTs is DNT2, but the other Spz paralogues – Spz3, Spz4 
and particularly Spz6 – are divergent (Parker et al., 2001; Zhu et al., 2008). DNT2 also 
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dimerises (McIlroy et al., 2013). According to structure-based alignment, among the Spz 
paralogues, DNT1 and DNT2 are the closest to the NT superfamily, followed by Spz (Zhu et 
al., 2008). DNT1 and DNT2, like Spz, are required for axon targeting, as disrupting their 
functions causes motor axon terminals to sprout and misroute (Zhu et al., 2008). DNT1 and 
DNT2 maintain neuronal survival too, as exemplified by loss of function mutants having an 
increase in neurons undergoing programmed cell death (PCD) in the embryonic CNS, while 
neurons can be rescued from naturally occurring cell death (NOCD) upon overexpression of 
DNT1 and DNT2 in vivo (Zhu et al., 2008). In short, at least DNT1, DNT2 and Spz form a 
Drosophila NT family on the basis of structural and functional criteria to the mammalian NTs 
(Zhu et al., 2008).  
 
So far, the similarities of DNTs to mammalian NTs described above have been based on 
structural and functionally homology. In particular, the functional comparison was based on 
NGF’s first discovered role, that is, the growth and survival effect of NTs. Beginning with M. 
Shorey’s work to observe embryonic chick nerve development in the absence of the organs to 
which nerves normally innervate (Shorey, 1909), and up to the experiments establishing 
purified NGF’s role as a trophic factor (Cohen and Levi-Montalcini, 1956; Levi-Montalcini 
and Cohen, 1960), a succession of key ideas: (i) that the size of the target field, to which 
nerves innervate, influences the size of the surviving neuronal population (Hamburger, 1939); 
(ii) that the target provides the necessary conditions for neurite outgrowth and maintenance of 
the nerves (Hamburger and Levi-Montalcini, 1949); and (iii) that the survival is mediated 
through a target-derived soluble protein which exerts a trophic effect (Cohen et al., 1954). 
Such ideas paved the way to develop the concept of the “neurotrophic hypothesis” whereby 
“the survival of developing neurons depends on the supply of a neurotrophic factor that is 
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synthesized in limiting amount in their target fields” (Davies, 1996; Gilbert, 2000; Guthrie, 
2007). Again, there are parallels to be drawn between the in vivo functions of DNTs with the 
neurotrophic hypothesis. Firstly, transcripts of spz, dnt1 and dnt2 are produced in relevant 
areas: the embryonic CNS midline, an en-passant target of interneurons, and the muscles, the 
target field of motor neurons (Zhu et al., 2008). At least DNT1 has been shown to operate in a 
target-dependent manner (Zhu et al., 2008). The use of RNAi knockdown restricted to the 
midline induces neuronal death in the CNS while conversely, the overexpression of active 
DNT1 at the midline rescues neuronal survival. Secondly, the appropriate support by DNTs is 
dependent on concentration. Having too little of DNTs by way of loss of function mutants or 
RNAi knockdowns, as well as having too much by gain of function, will both cause 
misrouting in motor axon terminals (Zhu et al., 2008). Therefore, beyond structural and 
functional homology, the physiology of DNTs is also consistent with the neurotrophic 
hypothesis which focuses on the non-autonomous growth and survival effects of NTs.  
 
The regulation of appropriate cell number comes through the balance of cell proliferation, cell 
survival and cell death (Hidalgo and Ffrench-Constant, 2003). The mammalian NTs, through 
their receptors, also adjust cell numbers through cell proliferation and cell death (Gupta et al., 
2013; Huang and Reichardt, 2003; Lu et al., 2005; Nykjaer et al., 2005). For example, high 
affinity binding of proNTs to p75 induces apoptosis (Lee et al., 2001; Lu et al., 2005; Nykjaer 
et al., 2005). The importance of regulating appropriate cell number is highlighted in cases 
when upregulation of BDNF/TrkB signaling leads to abnormal cellular proliferative changes 
and pathological conditions such as cancer (Gupta et al., 2013). In Drosophila, developing 
tissues eliminate compromised cells which present health risks to the animal through a 
proposed Spz-dependent apoptotic pathway (Meyer et al., 2014).  
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On top of adjusting cell number, NTs also regulate functions such as synaptogenesis and 
synaptic plasticity, with the latter encompassing long-term potentiation (LTP), long-term 
depression (LTD) and structural changes to synapses (Lu et al., 2005; Martinowich et al., 
2007; Poo, 2001). Since the discovery of the DNT family, the study of Spz and their 
paralogues (including Spz3, Spz4 and Spz6) within the context of development and nervous 
system have been centred around synaptogenesis and synaptic transmission in the larval NMJ 
(Ballard et al., 2014; Sutcliffe et al., 2013) and the removal of unfit cells by apoptosis in the 
larval wing disc (Meyer et al., 2014).  
 
1.1.5 DNT Signalling 
 
1.1.5.1 Molecular Mechanism of Spz Activation 
 
After protein translation, an inactive Spz pre-pro-protein consists of an N-terminus signal 
peptide, a regulatory prodomain and a C-terminus CysKnot domain (DeLotto and DeLotto, 
1998; Schneider et al., 1994; Weber et al., 2003). The N-terminus signal peptide has a signal 
sequence (Morisato and Anderson, 1994), which is needed to instruct the delivery of proteins 
through correct cytoplasmic routes to be secreted outside the cytosol. The regulatory 
prodomain has sequences essential for efficient folding and secretion of dimeric Spz (Weber 
et al., 2007). Spz’s dimerising feature is due to a disulphide bond between inter-CysKnot 
subunits (DeLotto and DeLotto, 1998; Gangloff et al., 2008; Hoffmann et al., 2008; Hu et al., 
2004; Mizuguchi et al., 1998; Parthier et al., 2014; Stelter et al., 2013; Weber et al., 2007; 




Spz is a secreted protein (Morisato and Anderson, 1994). Before being secreted, Spz pre-pro-
protein is processed internally to remove the signal peptide and the resulting Spz pro-protein 
(proSpz), consisting of the regulatory prodomain and C-terminus CysKnot, is secreted into the 
extracellular space as a native and unstructured 80kDa homodimer (DeLotto and DeLotto, 
1998; Schneider et al., 1994; Weber et al., 2003). The 12kDa CysKnot domain consists of 
106 amino acids and is hence also known as C106 (DeLotto and DeLotto, 1998; Morisato and 
Anderson, 1994). C106 itself is the activing and mature fragment of Spz (DeLotto and 
DeLotto, 1998; Schneider et al., 1994). It binds Toll ectodomain with high specificity and 
high affinity in a 2:2 stoichiometry to activate Toll-receptor signalling pathway (Weber et al., 
2003). In contrast, the prodomain is natively largely unstructured but has an amphipathic 
helix which masks a hydrophobic region of Spz (Arnot et al., 2010; Weber et al., 2003). In 
pro-protein form, Spz acts to prevent itself interacting with Toll’s binding region (Arnot et al., 
2010; Weber et al., 2003). Upon proteolytic cleavage of dimeric proSpz, the prodomain and 
C106 remain associated non-covalently to stabilise C106 (Hoffmann et al., 2008; Weber et 
al., 2007). However, upon the cleaved-complex binding allosterically to Toll, the prodomain 
gets released, leaving the binding between active C106 and Toll to initiate signalling 
(Gangloff et al., 2008; Weber et al., 2007). The released prodomain has been proposed to act 
as a negative regulator for both the protease cleaving proSpz and the Spz-processing reaction.  
 
1.1.5.2 Spz in Dorsal-Ventral Patterning and Immunity 
 
Spz has two well-known functions. Together with its receptor Toll, they are first discovered 
for their roles in generating dorsal-ventral (DV) polarity in the development of the Drosophila 
embryo (Anderson and Nusslein-Volhard, 1984; Morisato and Anderson, 1994; Schneider et 
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al., 1994; Stein and Nusslein-Volhard, 1992). When third instar larvae and adult are immune-
challenged by fungal and Gram-positive bacteria, both spz and Toll expression are up-
regulated for immune responses (Buchon et al., 2009; Jang et al., 2006; Kambris et al., 2006; 
Lemaitre et al., 1996; Tauszig et al., 2000). 
 
To carry out DV patterning and immunity functions, the Spz pro-protein (proSpz) has to be 
within the extracellular space for proteolytic cleavage by clip-domain serine proteases (Hecht 
and Anderson, 1992; Jang et al., 2006; Misra et al., 1998). For DV patterning, Easter (Ea) is 
the responsible protease which cleaves proSpz to release C106 (Anderson and Nusslein-
Volhard, 1984; DeLotto and DeLotto, 1998; Morisato and Anderson, 1994). As for Toll-
dependent antimicrobial responses, Spätzle Processing Enzyme (SPE) instead is the required 
terminal enzyme (Jang et al., 2006; Kambris et al., 2006). SPE processes proSpz identically 
to Ea and their functional homology is demonstrated by activated SPE rescuing DV polarity 
in embryos lacking easter (Jang et al., 2006). However, just as DV patterning and immune 
responses are different functions from each other, the origins and activation cascades of the 
zymogens Ea and SPE are also different (Figure 1.1). 
 
In specifying DV polarity, Spz and its upstream processing enzymes, including Ea, are 
maternally-derived and deposited into the perivitelline space during the syncytial blastoderm 
stage (Anderson and Nusslein-Volhard, 1984; Chasan et al., 1992). The zymogens of the 
activating cascade of Spz, in sequence, are: (i) Gastrulation Defective (GD), (ii) Snake (Snk), 
and (iv) Ea (Anderson and Nusslein-Volhard, 1984; Morisato and Anderson, 1995). Active 
GD cleaves zymogen Snk. In turn, active Snk cleaves Ea. The activation of Ea by Snk is the 
key ventrally-restricted event in the embryonic patterning of DV polarity (Cho et al., 2012).   
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Figure 1.1 The spätzle-Toll pathway in embryonic dorsal-ventral patterning and immunity.




























Active Ea then cleaves proSpz and the binding of mature Spz to Toll initiates ventralising 
signal (Morisato and Anderson, 1995).  
 
SPE is a zygotic product of immune tissues such as the lymph gland, fat body (functional 
analogy of human liver) and mature hemocytes (analogous to phagocytes) (Mulinari et al., 
2006). Zygotic proSpz is present in hemocytes which circulates the hemolymph (Irving et al., 
2005; Lemaitre et al., 1996; Weber et al., 2003). Circulating pattern recognition receptors 
(PRRs), such as peptidoglycan recognition protein SA (PGRP-SA) and Gram-negative 
binding protein 1 (GNBP1), initiate a protease cascade which eventually cleaves and activates 
SPE, in turn cleaving proSpz to activate Toll-signalling in the fat body for immune responses 
(Jang et al., 2006; Kambris et al., 2006; Michel et al., 2001). The activation of SPE-Spz-Toll 
signalling also leads to transcriptional positive feedback of SPE to ensure adequate response 
to microbial infection (Jang et al., 2006; Kambris et al., 2006). Surprisingly, the spz gene, 
encoding for the substrate of SPE, is not the target of Toll signalling in the fat body (Irving et 
al., 2005).  
 
Within the cytoplasm, activation of Toll ultimately leads to the phosphorylation of Cactus 
(IƙB), which causes the disruption of the complex between Cactus and transcription factor 
Dorsal, a NFƙB homolog, followed by the release and nuclear translocation of Dorsal required 
for DV patterning (Morisato and Anderson, 1995). In immune response, the NFƙB homolog is 
Dorsal-related immunity factor (Dif), and Toll activation degrades Cactus of the Dif/Cactus 
complex, leading to Dif nuclear translocation and transcription of immunity-related genes (Ip 




Put together, the activation of Spz for competent Toll signalling can be achieved by different 
spatiotemporal expression of two distinct serine proteases, and that the same ligand-receptor 
pair can be utilised for different physiological processes (Jang et al., 2006; Jang et al., 2008; 
Mulinari et al., 2006).  
 
1.1.5.3 Similarities between Spz, Coagulogen and BDNF  
 
The mechanism of Spz cleavage by active Ea and SPE in the perivitelline fluid and 
hemolypmh, respectively, bears resemblances to two systems: the clotting cascade in the 
hemolymph of horseshoe crab (Limulus), and the expression of protein-synthesis-dependent, 
late-phase, long-term LTP (L-LTP) in the mouse hippocampal synaptic cleft.  
 
Of the clotting cascade, coagulogen belongs to the CysKnot superfamily and its CysKnot 
resembles those of Spz and NGF (Bergner et al., 1996). Coagulogen is actually closest in 
structural identity to Spz4 than it is to Spz, but current phylogenetic tools do not resolve 
coagulogen as sufficiently different from Spz and NTs (Zhu et al., 2008). Although a Toll 
homology in horseshoe crab (tToll) does exist to mediate immunity, it is yet unknown if 
coagulogen may serve as a ligand for tToll and if coagulogen have neurotrophic functions in 
horseshoe crab (Inamori et al., 2004; Zhu et al., 2008). Unlike Spz and NGF, coagulogen 
does not dimerise (Bergner et al., 1996; DeLotto and DeLotto, 1998; Mizuguchi et al., 1998). 
Instead, coagulogen is proteolytic processed by a proclotting enzyme into insoluble coagulin 
which aggregates with each other into a gel (Bergner et al., 1996; Iwanaga, 1993). The 
proclotting enzyme bears similarity to Ea and SPE in that they all need to be activated through 
a protease cascade (Bergner et al., 1996; Iwanaga, 1993).  
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Spz and BDNF belong to the NT superfamily. BDNF in the adult brain regulates synaptic 
plasticity with important implications for depression and memory (Lu et al., 2005; 
Martinowich et al., 2007; Poo, 2001). BDNF is secreted constitutively in its pro-form 
(proBDNF) from post-synaptic hippocampal neurons (Lu et al., 2005; Mowla et al., 1999). 
Without cleavage to release the prodomain, proBDNF facilitate LTD through receptor p75 
signalling (Lu et al., 2005; Rosch et al., 2005; Woo et al., 2005). Upon high stimulus 
stimulation, tissue plasminogen activator (tPA) is released from the pre-synaptic neuron (Lu 
et al., 2005; Pang et al., 2004). In the synaptic cleft, tPA meets and cleaves inactive zymogen 
plasminogen into active serine protease plasmin (Lu et al., 2005; Pang et al., 2004). Plasmin, 
in turn, cleaves extracellular proBDNF into mature BDNF (mBDNF), a key protein product 
for the expression of L-LTP through receptor TrkB signalling as well as the increase in spine 
density which is analogous to synaptic structure formation (Lu et al., 2005; Pang et al., 2004).  
 
In short, Spz, NGF and coagulogen share similarities in CysKnot structure, with Spz and 
coagulogen serving roles in immunity. Spz and coagulogen are both processed by 
extracellular proteases. Recently, NGF has been demonstrated to have a Spz-like immunity 
role against Staphylococcus aureus infection in vertebrates through receptor TrkA (Hepburn 
et al., 2014). Given the active roles Spz/Toll and NGF/TrkA signalling play in the immune 
and nervous systems, it is therefore intriguing to speculate if coagulogen and tToll exert 
neurotrophic effects in the horseshoe crab too. Between Spz and BDNF, they share similar 
traits in the manner of their secretion as pro-forms and in the cleavage of their pro-forms by 
active serine proteases, albeit for the separate physiological functions of development, 




Comparing secretion of Spz in the Drosophila and mammalian systems adds further parallels 
between the two and alongside structural and functional homology. However, secretion of 
NTs is influenced by the cell type, the environment and whether or not the function will be 
carried out in an autocrine or paracrine manner. NGF is well-understood for its role as a 
target-derived trophic factor during development of early peripheral nervous system (Cohen 
and Levi-Montalcini, 1956; Davies, 1996; Levi-Montalcini and Cohen, 1960; Lewin and 
Barde, 1996). In this case, NGF is well-known to be cleaved by furin through the constitutive 
secretory pathway within the target tissue to be secreted for the survival of sufficient numbers 
of connecting neurons (Lu et al., 2005; Mowla et al., 1999). In spite of NGF’s discovery as a 
neurotrophic factor, NGF mediates apoptosis too (Lu et al., 2005; Nykjaer et al., 2005). As an 
example, when the tissue environment is perturbed, as in the case of adult brain injury, 
proNGF is secreted and binds p75 in vivo to trigger lesion-induced death of adult 
corticospinal neurons (Harrington et al., 2004). For the expression of hippocampal L-LTP, 
proBDNF is secreted by the post-synaptic neuron and is processed extracellularly by plasmin 
into mBDNF, which acts in an autocrine manner on TrkB on the post-synaptic side (Lu et al., 
2005; Pang et al., 2004). For LTD, proBDNF binds p75 (Rosch et al., 2005). These do not 
rule out proBDNF being processed intracellularly. Indeed, mBDNF is found intracellularly 
and differs from mNGF in that mBDNF is better retained by the regulated secretory pathway 
within hippocampal neurons (Mowla et al., 1999). The release of both mBDNF and isolated 
BDNF pro-domain from hippocampal neurons requires high frequency activity (Anastasia et 
al., 2013; Nagappan et al., 2009). However, for Schwann cells, the principal glia of the PNS, 
both proBDNF and mBDNF are released into the extracellular space without stimulation, 
suggesting that differential intracellular sorting of pro- and mature NTs occurs in different cell 
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types (Lu et al., 2005; Mowla et al., 1999). At present time, our knowledge of sorting the 
DNTs pertains to the extracellular secretion of proSpz.  
 
1.1.5.4 Mutations in dnt Genes  
 
At the time of identifying DNTs within the Spz protein family, the mutants used to study Spz, 
DNT1 and DNT2 were spz2, dnt141, dnt155 and dnt2e03444 (Zhu et al., 2008).  
 
1.1.5.4.1 Point Mutations in spz 
 
Spz2 is a point mutant allele which arose from the carcinogenic mutagen ethyl 
methanesulfonate (EMS) (Tearle and Nusslein-Volhard, 1987). The use of EMS brings about 
mutagenesis in a stochastic manner throughout the genome such that it is very likely spz 
would not be the only gene affected by the mutagenic treatment. Within the spz locus anyhow, 
the point mutation is a nucleotide substitution of a thymine base at position 400 into an 
adenine which results in an amino acid replacement of tyrosine-134 into asparagine (Y134N) 
(Weber et al., 2007). The amino acid residue 134 is located in the pro-domain 31 amino acids 
preceding Ea’s proteolytic processing site (Weber et al., 2007). The effect of the spz2 
mutation is twofold: secretion of proSpz is ineffective and any secreted proSpz exists either as 
monomers (with an absent disulphide bond) or as multimers (with multiple disulphide-linked 
aggregates) (Weber et al., 2007). The importance of the prodomain is highlighted also in NGF 
as critical for the secretion and proper folding of mNGF (Rattenholl et al., 2001; Suter et al., 
1991). However, the prodomain does not interfere with Toll signalling so any phenotype 
which arise from spz2 would be restrictive to defective processing of dimeric Spz pro-protein 
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and would not in principle encompass Toll and associated downstream signalling (Weber et 
al., 2007). Nonetheless, the spz2 allele remains interesting for the reason that there is a 
common single nucleotide polymorphism (SNP) which converts valine to methionine at 
codon 66 within the prodomain of the human bdnf gene (bdnfVal66Met) (Egan et al., 2003).  
 
Human subjects heterozygous for the variant BDNF (bdnfVal66/bdnfMet), the most predominant 
expression profile, were associated with poorer episodic memory and abnormal hippocampal 
activation (Egan et al., 2003; Hariri et al., 2003). In the Golgi apparatus, Sortilin interacts 
with the prodomain of BDNF in the specific region containing codon 66 and mediates the 
efficient intracellular targeting of proBDNF to the regulatory secretory pathways (Chen et al., 
2005). The Met66 substitution alters the binding interaction between proBDNF and Sortilin in 
the Golgi apparatus such that the intracellular trafficking of proBDNF is inefficiently sorted 
into secretory granules in cortical neurons (Chen et al., 2005; Chen et al., 2004). 
ProBDNFVal66 is distributed more uniformly in the hippocampal cell bodies and dendrites 
while proBDNFMet66 aggregates in the perinuclear region (Egan et al., 2003). The inefficient 
trafficking and sorting of proBDNF ultimately results in less proBDNF secreted from cortical 
and hippocampal neurons upon stimulating activity (Chen et al., 2004; Egan et al., 2003). So 
there are parallels between spz2 and bdnfVal66Met in the way the prodomain mutation affect its 
secretion. Proteolytic processing of proBDNF is unaffected (Chen et al., 2004), but in the 
mice subventricular zone (SVZ) and dentate gyrus (DG), the two brain areas important for 
adult neurogenesis (Ming and Song, 2011), TrkB activation is decreased (presumably due to 
less proBDNF secretion), LTP is affected and there are less survival of newborn neural 
progenitor cells (Bath et al., 2012; Bath et al., 2008). Single- and double-copy bdnfMet66 
knock-in mice have smaller hippocampal volume (Chen et al., 2006). Because BDNF 
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regulates neuronal differentiation and synaptic plasticity, the impact on hippocampal volume 
is attributed to altered neuronal morphology, and indeed, bdnfMet66 knock-in mice display 
decreased dendritic arbor complexity (according to Sholl analysis) and smaller dendritic field 
occupancy by DG neurons (Chen et al., 2006). 
 
The prodomain itself is an interesting entity because its biological function, if any, is 
unknown, even though the isolated prodomain is a natural cleavage by-product of the proNTs 
into mature NTs. So far, the prodomain in proSpz form is known molecularly to prevent 
proSpz from interacting with Toll to limit bioavailability and to stabilise C106 (Arnot et al., 
2010; Hoffmann et al., 2008; Weber et al., 2007; Weber et al., 2003). Weber et al. (2007) 
hypothesised that the prodomain of Spz remains associated to CysKnot and would not be 
released until after Toll binding to limit the diffusion of the CysKnot and thereby ensure a 
maximal impactful ventralising signal. Following receptor engagement, the prodomain would 
be released for subsequent lateral inhibition by acting as a negative regulator at the level of 
Easter processing, active Easter or the Spz processing reaction (Weber et al., 2007). It is easy 
to wonder if the isolated prodomain of Spz also acts as a negative regulator of SPE in 
immunity after Toll-dependent upregulation of SPE. When the prodomain of BDNF is 
released, it is monomeric (Anastasia et al., 2013). The function of the isolated Val66 
prodomain remains to be elucidated, but the Met66 prodomain in the extracellular space is an 
active ligand which promotes growth cone retraction in hippocampal neurons via p75 and 
SorCS2, a sortilin-related sorting receptor (Anastasia et al., 2013).  
 
There are two other EMS-derived point mutants of spz available: spz3 and spz4 (Tearle and 
Nusslein-Volhard, 1987). Both alleles are point mutants in the CysKnot domain (Weber et al., 
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2007). In spz3, glutamine-207 is replaced by arginine (Q207R), while in spz4, a conserved 
cysteine residue of Spz, NGF, BDNF and NT-3 is replaced by serine (C232S) (Weber et al., 
2007). The Q207R mutation of spz3 is thought to cause conformational changes in C106 such 
that Spz’s interaction with Toll is abolished. With spz4, the CysKnot structure could be 
compromised by changes in protein packing or by an absence of a canonical intra-disulphide 
bond (Mizuguchi et al., 1998; Weber et al., 2007).  
 
1.1.5.4.2 Mutations in dnt1 and dnt2 Genes 
 
Dnt141 and dnt155 were generated by homologous recombination for the studies in Zhu et al. 
(2008), and were verified to be genetic null alleles by PCR, Southern blot and reverse 
transcriptase PCR. The nulls dnt141 and dnt155 are ideal standard loss of function mutants.  
 
Dnt2e03444 was the only available mutant allele at the time of study by Zhu et al. (2008), and it 
is the dnt2 allele with a large 5.9 kb transposon insert in its intronic region, after the exon 
encoding the signal peptide (Dos Santos et al., 2015). The downside of using dnt2e03444 is the 
possibility of the insert being spliced out and excluded from the mature RNA for protein 
translation. This could effectively create functional DNT2 protein.  
 
1.1.5.5 Toll Receptors of DNTs 
 
The Toll receptor superfamily, comprising the Drosophila Tolls and the vertebrate Toll-like 
receptors (TLRs), is collectively known for innate immunity functions (Leulier and Lemaitre, 
2008; Ooi et al., 2002; Tauszig et al., 2000). There are 9 Toll receptor paralogues in 
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Drosophila: Toll, Toll2/18wheeler, Toll3/MstProx, Toll4, Toll5/Tehao, Toll6, Toll7, 
Toll8/Tollo and Toll9 (Leulier and Lemaitre, 2008). Spz is the ligand for Toll (Weber et al., 
2003), and is proposed to bind more than one Toll receptor to activate NFƙB-dependent 
apoptosis, prominently Toll2, Toll3, Toll8 and Toll9, to remove unfit cells such that they do 
not become part of future tissue materials (Meyer et al., 2014b). Spz3 paralogue is reported to 
be a likely ligand for Tollo genetically (Ballard et al., 2014). All the mentioned receptors 
proposed for Spz requires biochemical confirmation.  
 
1.2 Drosophila as a Model Organism and Technical Approach 
 
1.2.1 Larval CNS Anatomy 
 
The larval CNS is comprised of: (1) the brain in two hemispheres, each with an optic lobe, 
and connected by the central brain commissures; and (2) the VNC, with thoracic and 
abdominal parts (Hartenstein, 1993). The VNC is homologous to the human spinal cord. The 
thoracic VNC is made up of 3 segments, T1 to T3, while the abdominal VNC is made up of 8 
or 9 segments, A1 to A8/9 (Ito et al., 1995). An open-access figure on the schematics of 
neurons in the Drosophila CNS is provided in Figure 1.2 (Sanchez-Soriano et al., 2005). 
 
Synaptic contacts are restricted to the neuropile, a cell-body free area. The neuropile also 
contains the ascending, descending and commissural axon fiber tracts (Ito et al., 1995). 
Neuronal and glia cell bodies, and neuroblasts, are restricted to the cortex, a synapse-free area 
(Hartenstein, 1993; Ito et al., 1995). The VNC circuitry consists of interneurons and efferent 
neurons which send out monopolar projections into the neuropile, where they form   





arborisations and synapses (Sanchez-Soriano et al., 2005). The neurites of the CNS 
interneurons and efferent neurons are joined by projections from the peripheral afferent, 
sensory neurons (Landgraf et al., 2003). Efferent neurons also project from theneuropile 
through segmentally repeated nerves into the periphery, where motoneurons meet muscle and 
form neuromuscular junctions (NMJs) (Landgraf et al., 2003). Sensory neurons (such as 
mechanosensory chordotonal neurons) project through ventral nerve roots to innervate the 
sensory output region in the ventral VNC while motoneurons project through dorsal nerve 
roots from the motor input area in the dorsal VNC (Landgraf et al., 2003; Zlatic et al., 2009). 
All the motoneurons form dendrites in the dorsal neuropile, including aCC and RP2 
motoneurons (Landgraf et al., 2003). 
 
Glial cells in the VNC are classified into surface, cortex and neuropile-associated glia (Ito et 
al., 1995). Interface glia (IG) are a subset of neuropile-associated glia at the cortex-neuropile 
boundary (Ito et al., 1995). The surface of the CNS is covered by the perineurium, which 
consists of the acellular extracellular matrix (ECM), called the neural lamella, and the surface-
associated glial cells underneath (Ito et al., 1995). Anti-Ebony, anti-GS2 and anti-Repo 
antibodies are all glial differentiation markers, and all three can detect IG. IG can also be 
visualised using alrm-GAL4. All glia nuclei, except those of midline glia, can be marked by 
anti-Repo.  
 
1.2.1.1 Mutations Affecting VNC Length 
 
Towards the end of embryogenesis, the VNC condenses, while in the larval stages, there is 
growth in the VNC. During larval development, the neural lamella adjust to the growing 
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nervous system and perineural glial cells secrete proteases to remodel the neural lamella 
(Meyer et al., 2014a).  
 
Earlier, PVR was mentioned to be a gliatrophic factor (Learte et al., 2008). Disrupting pvr 
inhibits hemocyte migration, which in turn means deposition of extracellular matrix (ECM) 
around embryonic tissues is lost and VNC fails to condense (Olofsson and Page, 2005).  
 
RK2 is a glial specific homeodomain protein which is expressed in all embryonic glial cells, 
with the exception of midline glia and glia cells sibling to external sensory neurons (Campbell 
et al., 1994). Embryos mutant for rk2 are embryonic lethal and their nerve cord fails to 
condense properly (Campbell et al., 1994).  
 
Core 1 galactosyltransferases (C1GalTA) elongate their substrates by adding galactose, and it 
is expressed in the embryonic amnioserosa and CNS (Lin et al., 2008). Mutant C1GalTA 
animals exhibited elongated larval VNC and misshaped brain hemispheres (Lin et al., 2008). 
C1GalTA is required to glycosylate laminin, a component of the ECM (Lin et al., 2008).  
 
Impaired enzyme activity of glucuronyltransferase P (GlcAT-P) also results in elongated 
larval VNC (Pandey et al., 2011). With repo-GAL4 in the background of mutant GlcAT-P, 
VNC elongation enhanced (Pandey et al., 2011). Overexpressing GlcAT-P in hemocytes in 
the background of mutant GlcAT-P rescues VNC length (Pandey et al., 2011).  
 
In short, mutations which intricately affect the extracellular matrix, glia and hemocytes 




1.2.1.2 Mutations Affecting Cell Numbers in the Larval VNC 
 
Neuroblasts are Drosophila neural progenitor cells which are capable of self-renewing, 
differentiating or entering quiescence (Lai and Doe, 2014; Maurange and Gould, 2005; 
Maurange and Lanet, 2014). With the neuroblasts, Drosophila undergo two distinct phases of 
neurogenesis, embryonic and postembryonic, which are separated by quiescence (Saini and 
Reichert, 2012). The embryonic neurogenesis is responsible for building the larval CNS, 
whereas embryonic and postembryonic neurogenesis are both responsible together for 
building the adult fly CNS. During the third larval instar, thoracic and abdominal VNC 
neuroblasts acquire competence to undergo apoptosis, but the only brain and thoracic 
neuroblasts re-enter the cell cycle while abdominal neuroblast undergo cell death (Maurange 
and Gould, 2005; Maurange and Lanet, 2014). Unregulated neuroblast division has been 
shown to result in tumorous overproliferation (Saini and Reichert, 2012; Southall et al., 
2008). Postmitotic neurons are also capable of dedifferentiating to neural progenitor cell-like 
state, as in lola mutants, in which the number of neurons decrease but the number of 
progenitors increase to form tumors (Southall et al., 2014). Mutations in cell fate determinants 
such as Brat, Numb and Prospero will affect neuronal number due to disruption in the 
neurogenic differentiation pathway (Saini and Reichert, 2012; Southall et al., 2014; Southall 
et al., 2008).  
 
With the exception of midline glia, all embryonic gliogenesis is promoted by glial cell 
missing (gcm) which suppressed neuronal fate and induced reverse polarity (repo) to confer 
stable glial identity through (Awasaki et al., 2008; Flici et al., 2014; Jones et al., 1995). In 
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general, glial number is tightly coordinated with signals from neurons (Hidalgo and Griffiths, 
2004; Hidalgo et al., 2011; Hidalgo et al., 2001; Kinrade et al., 2001).  
 
1.2.2 Injury in the Larval CNS 
 
Regeneration is a biological phenomenon which confers a metazoan the ability to physically 
and functionally restore its damaged or lost body parts. This regenerative ability occurs at 
many levels throughout the animal kingdom including humans (Carlson, 2007). While 
regeneration in humans is prominent in certain tissues and organs such as the skin and the 
liver, the central nervous system (CNS) exhibits poor regenerative ability following traumatic 
injury and chemotoxicity, or as a result of ongoing degenerative processes (Carlson, 2007; 
Horner and Gage, 2000). As such, injured and degenerating CNS is devastating and 
debilitating (Horner and Gage, 2000). It is acknowledged that the poor regenerative ability of 
the CNS comes down to the fact that CNS regeneration itself is a multistep process at the 
cellular level, and yet this process is challenged by diminishing intrinsic growth ability and a 
series of antagonistic events at the lesion site (Ferraro et al., 2004; Fitch and Silver, 2008; 
Horner and Gage, 2000; Liu et al., 2011). (a) An injured neuron must first survive, but 
secondary damage by the immune system exacerbates neuronal damage. (b) Then, surviving 
damaged axons must circumvent the inhibitory factors in the CNS environment to extend and 
to re-establish connections with their target cells; otherwise, misrouting can occur, leading to 
axonal degeneration or faulty connections. (c) Upon contact, axons need to be remyelinated in 
order to mediate reliable electrical conduction. (d) Finally, functional synapses must form for 
connectivity. In pursuing and developing strategies for promoting CNS regeneration, 
promising leads include drug-induced release of neurotrophic factors by glia or neurons, and 
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the possibility of therapeutic delivery of neurotrophic factors (Ahmed et al., 2009; Douglas et 
al., 2009; Jacques et al., 2012).  
 
Drosophila is an incredibly powerful model organism to investigate gene function in vivo and 
discover gene networks as well as neuronal circuits (Bier, 2005; Olsen and Wilson, 2008). 
Many gene functions and gene networks have a high degree of evolutionary conservation. 
Drosophila offers a wide variety of experimental tools and has repeatedly propelled 
mammalian research and the understanding of human diseases, including developmental and 
neurological disorders (Bellen et al., 2010; Bier, 2005; Jeibmann and Paulus, 2009).  
 
As the nervous system develops in volume and cell number, wiring connections are 
established. Injury models can help our understanding of how growth happens as the nervous 
system develops and wires. Injury paradigms link to understanding development by 
addressing how the nervous system deal with injury to restore a working organ with wiring 
re-established. Also, attempts at recapitulating development itself in adulthood can maximise 
the effectiveness of biological processes in regeneration (Harel and Strittmatter, 2006). An 
example of applying this form of scientific thinking into action uncovered the gene network 
consisting of cell cycle inhibitor Prospero (Pros) and cell cycle activators, Notch and 
Dorsal/NFκB, which together maintain an arrested, proliferative ability of glial cells in the 
Drosophila larvae (Kato et al., 2011). Glial cells proliferate in response to VNC injury in the 
larvae using the Pros-Notch-NFκB gene network (Kato et al., 2011). Glial cells which lose 
proliferative potential, such as those in adult flies 8 days after eclosion, do not respond to 




When a stabbing injury is applied dorsally to a normal larva’s abdominal VNC using a fine 
tungsten needle, a wound is generated which initially expands in area and subsequently 
shrinks, indicating gross anatomical repair to an extent (Kato and Hidalgo, 2013). When the 
intracellular domain of Notch (NotchICD) is overexpressed from glia, the larval VNC length 
extended due to an increase in glial numbers (Kato et al., 2011). Remarkably, upon injury of 
VNC in the background of NotchICD being overexpressed from glia, wound enlargement is 
prevented, injury-induced apoptosis is rescued, and the wound effectively closed as observed 
by time-lapse imaging of the area of lesion shrinking completely (Kato et al., 2011). This 
suggests either NotchICD in glia has a pro-survival function, or that the increase in glia 
numbers, in the background of NotchICD being overexpressed, led to an overproduction of a 
trophic factor. Spz could be expressed in larval glia (Sutcliffe, 2011), and so Spz could be 
overproduced to provide more trophic support.  
 
Spz binds Toll, which act upstream of NFƙB. Upon injury of the CNS, NFƙB is important for 
promoting glial cell division (Kato et al., 2011). Such links makes the DNTs, as secreted 
ligands with trophic activity, interesting candidates to study for potential roles in CNS repair. 
In particular, Spz would be most promising because its receptor, Toll, has an additional 
function of cellular adhesion, important for cell-cell interactions (Halfon et al., 1995; Keith 
and Gay, 1990). Also, Spz is thought to bind to other Toll receptors, including Toll-2, Toll6 
and Toll-8 (McIlroy, 2012; Meyer et al., 2014b), receptors which mediate heterophilic 
interactions between cells to promote oriented cell arrangements (Pare et al., 2014). Recently, 
a Spz-independent Toll/NFƙB pathway has been characterised for epidermal wound repair in 
Drosophila (Carvalho et al., 2014). This suggest that Spz is not the only activating ligand of 
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Toll (Carvalho et al., 2014). Nonetheless, this does not rule out the role Spz could possibly 
play for CNS repair.  
 
1.3 Rationale of the Project 
 
Spz, dnt1 and dnt2 are expressed in the embryonic CNS and muscle, where they are required 
for neuronal survival and targeting by motoneurons (Zhu et al., 2008). In the larvae, spz, dnt1 
and dnt2 are expressed in the body wall muscles, where they regulate NMJ synaptogenesis 
(Sutcliffe et al., 2013). Yet, two issues remain to be understood: (1) to what extent do the 
DNTs influence cell number in the formation of the nervous system circuitry after embryonic 
stages to result in a behaving larva; and (2) to what extent do the developmental functions of 
DNTs influence the capacity of the larval CNS to repair after injury.  
 
To contribute to an understanding towards the functional role of DNTs in the regulation of 
cell numbers within the larval CNS, this project needs to first address whether or not the 
DNTs remain biologically relevant after embryonic stages in the larval CNS (see Chapter 3).  
 
To study loss of function effects, there must be appropriate loss of function mutants. There are 
suitable null mutants for dnt1 for studying loss of function effects, but more appropriate loss 
of function mutants for spz and dnt2 could be generated (Section 1.1.5.4). For this purpose, 
this project aims to generate null mutants of dnt2 and spz via targeted deletions (see Chapter 
4). Since there is a naturally occurring SNP in the prodomain of BDNF, the spz2 allele is still 
interesting to study (Section 1.1.5.4.1). Therefore, the effects of spz2 in the larval CNS will be 
characterised (see Chapter 5).  
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Toll6 and Toll7 genetically rescue the viability of homozygous spz2 mutants (Dr A. Hidalgo, 
personal communication). Homozygous spz2 adult mutants have been reported to have very 
small optic lobes (N. Ruiz & Dr J. Wentzell, personal communication). By extending the 
viability experiment and looking into the effect Toll6 and Toll7 genetically exert on 
homozygous spz2 CNS size, Toll6 and Toll7 will be tested as potential receptors for Spz (see 
Chapter 5).  
 
The overexpression of NotchICD in glia prevents injury-induced apoptosis. The pro-survival 
effect could be exerted directly by NotchICD or indirectly through increasing glia numbers 
upon the overexpression of NotchICD. This project will test for an interaction between the 
DNTs and Notch in the background of pan-glial overexpression of NotchICD (see Chapter 5). 
The project will also use the stabbing injury method developed by Kato et al. (2011) to 
investigate the function of DNTs in gross CNS repair (see Chapter 6). 
 
1.4 Aims of the Project 
 
∑ To characterise the larval expression patterns of spz, dnt1 and dnt2 using the GAL4 
reporter system. 
∑ To determine the larval distribution patterns of Spz, DNT1, DNT2, Toll, Toll6 and 
Toll7 using purposely developed antibodies. 
∑ To generate spz and dnt2 null alleles as tools for functional analysis. 
∑ To characterise the spz2 allele by examining its effect on glial and neuronal structures. 
∑ To test whether Toll6 and Toll7 are potential receptors of Spz using genetics. 
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∑ To investigate the functions of spz, dnt1 and dnt2 in the larval CNS by examining their 
effects on glial, mitotic and apoptotic cell numbers.  
∑ To test whether there is an interaction between the DNTs and the Notch member of the 
gene network underlying glial cell proliferation upon VNC injury.  
∑ To investigate whether loss or gain of function in components of the DNT system 









2.1.1 Housing and Handling Drosophila 
 
Flies were bred on cornmeal agar medium made by the Central Services Team of the School 
of Biosciences in the University of Birmingham. Cornmeal agar medium was dispensed as 
12mL food aliquots into glass vials. Vials contained food at the bottom and were plugged 
with cotton wool. Female flies lay their eggs on the food surface where the larvae hatch. 
Larvae go through three instar stages, living and feeding in the food until wandering stage, 
that is, when third instar larvae undergo a behavioural change (Ashburner et al., 2005). 
Wandering larvae are larvae which leave the moist food medium to preferably climb up the 
dry walls of the vial where they will pupariate and subsequently eclose as flies (Ashburner et 
al., 2005; Godoy-Herrera et al., 1984; Roote and Prokop, 2013). Stock-keeping involved mass 
transferring flies to fresh food vials every 28 days. The fly stocks used in this project are 
listed in Table 2.1. Unless otherwise indicated, stocks were maintained in temperature-
controlled incubators at 18°C while experiments and crosses to make stocks were conducted 
at 25°C. Stocks and experiments were both kept under a 24-hour cycle of 12hrs dark and 
12hrs light in the temperature-controlled incubators to ensure a constant lighting condition 





Table 2.1 Fly stocks used in this project (part 1/4). 
The use of parenthesis surrounding balancers or markers in genotype labels indicates that a 
proportion of the stock can homozygosed and exists without having the stated balancers or 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 2.1 Fly stocks used in this project (part 4/4).  
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For the purposes of selecting sex, collecting virgin females and scoring genetic markers, flies 
were first immobilised on porous pads through which carbon dioxide dispensed. Immobilised 
flies on porous pads were then visualised under a dissecting scope. 
 
Unwanted flies were discarded into a morgue, which is a basic set-up of a jar containing 
industrial methylated spirit (IMS). Flies of desired phenotypes were transferred to fresh vials 
using a paint brush. Crosses to make stocks were established on Friday as day 0 to begin 
virgin female collection on day 10, Monday. These crosses were discarded after day 16 to 
prevent any recovery of second generation offspring. 
 
Figure 2.1 shows how sex was routinely identified among Drosophila. Male flies were 
distinguished by the presence of sex combs in the first tarsal segment on the first pair of legs, 
while the female flies do not have sex combs (Ahuja and Singh, 2008; Ng and Kopp, 2008). 
Also, the males tend to have fully pigmented tergites in abdominal segments A5 and A6 while 
the females do not have full pigmentation in the corresponding tergites (Kopp et al., 2000), so 
the males displayed uniformly dark dorsal cuticle plates at the posterior tip of the abdomen 
while the females displayed dark stripes dorsally. Males and females have dark and fair 
external genitalia, respectively (Bridges, 1936). After sex identification, females were 
securely recognised as virgins by meconium visible through the pleural cuticle of the 
abdominal sternum (Roote and Prokop, 2013). In other words, the first faecal waste product 
of the female was seen through the non-bristled areas on the ventral side of the abdomen as a 
dark spot (Weigmann et al., 2003), as shown in Figure 2.1. 
 
Mass transfer of flies to fresh food vials every 28 days was effective for stock-keeping   
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Figure 2.1 Identification of sex and determination of sexual maturity among Drosophila 
melanogaster. (A) Sex combs, (B) pigmentation pattern of abdominal tergites, and (C) 
pigmentation levels of external genitalia were features used to identify sex. (D) Meconium of 
females were used to distinguished that the females were virgins. Fly photographs were 
reproduced from FlyMove website with permission (Weigmann et al., 2003). Fly images 
were constructed from the Genotype Builder Photoshop file published by Roote and Prokop 
(2013).
meconium seen through
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purposes, but it could result in overcrowded cultures. To prevent overcrowding when making 
fly stocks, 10 virgin females were inseminated by 6 males in an en masse cross, and the cross 
was transferred to a new vial every two or three days. To prevent overcrowding when 
conducting experiments, between 10-30 virgin females were crossed to 6-20 male flies in one 
vial, and the cross was transferred to a new vial every three hours, such that the egg laying 
time (ELT) was 3 hours. Only larvae from crosses with 3hrs ELT were used for experiments 
while larvae from crosses maintained overnight were discarded. 
 
2.1.2 Standard Genetic Mating Protocols 
 
A balancer is a chromosome with inversion breakpoints and deleterious (homozygous lethal) 
mutations, such that the same balancer chromosome cannot exist in homozygosis, but is 
instead useful to maintain other deleterious mutations in stable stocks from being lost from 
the population. Balancers also prevent recombination on the same chromosome and they 
allow chromosomes to be followed in genetic mating schemes using genetic markers. Some 
balancers carry transgenes such as P{LacZ}, which is plasmid encoding the β-GALactosidase 
enzyme. The LacZ could be used for specific experiments, but no β-GALactosidase staining 
was performed in this project and so the mention of LacZ is limited to the fly stocks listed in 
Table 2.1.  
 
Figure 2.2 illustrates the common genetic markers and balancers used in this project. A 
‘minus’ symbol in superscript (-), when used in labelling genotype, generally stands for any 
allele variants which is not wild-type while a ‘plus’ script, or superscript, symbolises the wild-
type chromosome (+) and allele (+). Mini-white (w+m) is a gene construct derived from full-   
Figure 2.2 Common Drosophila genetic markers and balancers used in this project. The 
recessive visible alleles are y-, e- and w-. The dominant visible alleles are B-, Dr-, If-, Cy-, 
Ser-, Hu-, Sb- and Tb-. Mini-white (w+m) is a transgene which results in orange eyes when 
inserted into flies with w- background. Flies of genotype w-;;MKRS/TM6B,LacZ (stock no. 3, 
Table 2.1) have orange eyes because the plasmid encoding LacZ also carried the sequence 
construct for w+m. In addition, w-;;MKRS/TM6B,LacZ flies display stubble bristles on the 
notum and excess humeral bristles. Flies of genotype w-;If/CyO;MKRS/TM6B (stock no. 4, 
Table 2.1) are marked by white eyes having irregular facets, curly wings, stubble bristles on 
the notum and excess humeral bristles. Scale bar represents 0.5mm. Fly images were 
constructed from the Genotype Builder Photoshop file published by Roote and Prokop (2013).
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wild-type yellow y-/y- ebony e-/e-
white w-/w- mini-white w+m Irregular facets 
If+/If-
Curly Cy+/Cy-






Bar B+/B- Drop Dr+/Dr-












length wild-type white gene (w+), and when inserted into flies with w- background, the flies 
have orange eyes. DrMio is the dominant visible allele for the Drop gene which results in 
microphthalmia (reduced eyes) phenotype (Figure 2.2). The Kruppel allele, which arises in 
irregular facets in the eyes is KrIf, but it is more commonly known as If- (Figure 2.2). 
Chromosome 1 in this project was balanced by FM7, which carries the dominant visible and 
non-lethal allele for the Bar gene, B1 (Dos Santos et al., 2015; Lindsley and Zimm, 1992). 
Heterozygous B+/B1 alleles manifest in the Drosophila fly as bar-shaped eyes (Figure 2.2), 
while flies which are homozygous B1/B1 display narrowly bar-shaped eyes. Chromosome 2 
was balanced either by CyO or SM6A, which both carry the dominant visible allele for the 
Curly gene (Cy1) that manifest in the Drosophila fly as curly wings (Dos Santos et al., 2015; 
Lindsley and Zimm, 1992). MKRS and TM3 are chromosome 3 balancers, and they carry the 
dominant visible allele for Stubble (Sb1) which results in stubble bristles on the notum of the 
Drosophila fly (Dos Santos et al., 2015; Lindsley and Zimm, 1992). TM3 can also carry the 
dominant visible allele for the Serrate gene, Ser1 (Dos Santos et al., 2015; Lindsley and 
Zimm, 1992). Serrated wings appear to be clipped (Holtzman and Kaufman, 2013). TM6B is 
also a chromosome 3 balancer. In this project, the TM6B balancer used carries the dominant 
visible alleles for the Antennapedia (AntpHu or Hu) and Tubby (Tb1) genes, as well as the 
recessive visible alleles for claret (ca-) and ebony (e-) (Dos Santos et al., 2015; Lindsley and 
Zimm, 1992). Given that Tb1 manifest in the Drosophila larvae and pupae in the form of 
tubby bodies (Figure 2.2), TM6B was preferentially used over MKRS and TM3 for balancing 
chromosome 3. AntpHu results in excess humeral bristles in the Drosophila fly (Figure 2.2). 
The ca- and e- alleles give rise to phenotypes in the fly too. Flies have reduced red eye 




The exchange of balancers on chromosome 3 for the TM6B balancer was carried out  
according to protocol A (Figure 2.3). Alleles and transgenes on chromosome 3 were 
combined by recombination following protocol B (Figure 2.4). With alleles and transgenes on 
chromosomes 1 and 3 separately, they were combined according to protocol C (Figure 2.5). 
Genetic elements on chromosomes 2 and 3 separately were combined according to protocol D 
(Figure 2.6). 
 
Gene expression was driven using the standard GAL4/UAS system as illustrated in Figure 2.7 
(Brand and Perrimon, 1993). GAL4 is a yeast transcription factor and its expression in 
Drosophila is under the control of genomic enhancers. Targeted gene expression is dependent 
on activation of GAL4 binding sites called Upstream Activation Sequence (UAS). In the 
offspring of GAL4-expressing flies crossed to flies carrying the target gene behind the UAS, 
the target gene is activated in a cell- or tissue-specific pattern.  
 
Exelixis fly deficiency lines are stocks with chromosomal deletion. Df(3R)Exel6205/TM6B 
(stock no. 39, Table 2.1), Df(3L)Exel6101/TM6B (stock no. 40, Table 2.1) and 
Df(3L)Exel6092/TM6B (stock no. 41, Table 2.1) were the deficiency lines used for the spz, 
dnt1 and dnt2 genes, respectively.  
 
2.1.3 Genetic Protocol for Cleaning the spz2 Allele of ca1 Mutation  
 
The fly stock w+;;spz2ca1/TM6B (stock no. 19, Table 2.1) had its spz2 allele cleaned of the 
claret mutation (ca1) by recombination according to the genetic scheme in Figure 2.8. All 
genotypes were in w+ background to follow the claret allele which affects the red eye pigment   













1. discard F1 females and males 
with stubble bristles on notum
2. cross F1 virgin females and males 
with excess bristles on humerus
Figure 2.3 Genetic protocol for swapping balancers on chromosome 3. This protocol allowed
alleles or transgenes (illustrated as “G”) in the larval and pupal stage to be identified in
experiments by following the Tb- marker. 
Protocol B: recombination of two genetic elements on chromosome 3
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Figure 2.4 Genetic protocol for combining two genetic elements on chromosome 3 by
recombination. The two genetic elements in different fly stocks are illustrated by “G” and 
“H”. Multiple crosses of a single F2 male to 3 virgin females were established to set up 
multiple unique F3 lines because each F2 putative recombinant could arise from different 
chiasmata during recombination within the germline of F1 mothers. Each F3 lines were tested 
for the presence of recombined genetic elements. For example, alleles were tested by lethality, 
PCR or phenotype. GAL4-transgenes were tested by crossing to UAS-transgenes encoding 











0 ♀ ♂w-;;“G” w- ;;“H”x
single male matings
F
2 ♀ ♂w-;; MKRSTM6B,Tb-Hu-








1. discard F3 females and males
with stubble bristles on notum
2. cross F3 virgin females and males 
with excess bristles on humerus 
1. test lines for presence of both “G” and “H”
2. discard non-recombinant lines
3. keep 1-3 F4 recombinant lines
1. discard F1 males
2. cross F1 virgin females
1. discard F2 females
2. discard F2 males 
with excess bristles on humerus
3. cross F2  males
with stubble bristles on notum  
Protocol C: combination of two genetic elements separated on 1st and 3rd chromosomes
66
Figure 2.5 Genetic protocol for combining two genetic elements on chromosomes 1 and 3. 
The two genetic elements in different fly stocks are illustrated by “G” and “H” on 
chromosomes 1 and 3, respectively. Combining two genetic elements on separate 










G0 ♀ ♂FM7,B-;; TM3,Ser-Sb-
“G”;;+x
1. discard F1 males
2. discard F1 females with any of these phenotypes:
normally shaped eyes and stubble bristles on notum
3. keep F1 virgin females with all these phenotypes:
bar-shaped eyes and serrated wings
CONSIDER CHROMOSOME 3:
en masse
1. discard F1 females
2. discard F1 males with any of these phenotypes:
normally shaped eyes and serrated wings
3. keep F1 males with all these phenotypes:




CONSIDER CHROMOSOMES 1 AND 3:
1. discard F2 females and males 
with any of these phenotypes:
normally shaped eyes, 
narrowly bar-shaped eyes (B-/B-), and
stubble bristles on notum 
2. cross F2 virgin females and males 
with all these phenotypes:
bar-shaped eyes, 
serrated wings, and
normal bristles on notum
G



























Protocol D: combination of two genetic elements separated on 2nd and 3rd chromosomes
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Figure 2.6 Genetic protocol for combining two genetic elements on chromosomes 2 and 3. 
The two genetic elements in different fly stocks are illustrated by “G” and “H” on 
chromosomes 2 and 3, respectively. Combining two genetic elements on separate 















1. discard F1 females
2. discard F1 males with any of these phenotypes:
curly wings, normally shaped eyes, 
and stubble bristles on notum
3. keep F1 males with all these phenotypes:
straight wings, eyes with irregular facets 















1. discard F1 males
2. discard F1 females with any of these phenotypes:
straight wings, eyes with irregular facets, 
and excess bristles on humerus
3. keep F1 virgin females with all these phenotypes:
curly wings, normal-shaped eyes, 










CONSIDER CHROMOSOMES 2 AND 3:
F








1. discard F2 females and males 
with any of these phenotypes:
straight wings, eyes with irregular facets, 
stubble bristles on notum, and
normal bristle numbers on humerus
2. cross F2 virgin females and males 
with all these phenotypes:
curly wings, normally shaped eyes, 
normal bristles on notum, and
excess bristles on humerus
The GAL4/UAS system
Figure 2.7 Illustration of the GAL4/UAS system adopted from Brand & Perrimon (1993). 
Left hand side of G0 cross: The expression of yeast transcription factor GAL4 is driven 
from genomic enhancers. Right hand side of G0 cross: The target gene “G” is behind the 
Upstream Activation Sequence (UAS) and “G” is silent in the absence of GAL4. F1 cross: 
The expression of “G” is active whenever and wherever GAL4 is driven. Fly images 









































Figure 2.8 Genetic scheme for cleaning spz2 allele of ca1 mutation. All crosses used w+
background on chromosome 1 to follow alleles affecting eye pigment phenotype. Individual 
F2 males carrying wild-type ca
+ allele were crossed to 3 virgin females to establish multiple 
unique F3 lines because each F2 putative recombinant could arise from different chiasmata 
during recombination within the germline of F1 mothers. Each F3 lines were tested for the 
presence of recombined spz2 to ca+ by lethality. 
1. discard F1 males 
2. discard F1 females 
with excess bristles on humerus
3. cross F1 females 
with normal bristle numbers on humerus
1. discard F2 females 
2. discard F2 males 
with reduced red pigment in eyes
3. cross F2 males 
with normal red eyes 
1. discard F3 females and males 
with any of these phenotypes:
reduced red pigment in eyes,
ebony body, and
normal bristle numbers on humerus
2. cross F3 virgin females and males 
with all these phenotypes:
normal red eyes,
normal brown body and
excess bristles on humerus
test for presence of spz2
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level (Cheli et al., 2010; Harris et al., 2011; Holtzman and Kaufman, 2013). The G0 cross 
used w+;;spz2ca1/TM6B and Oregon-R to obtain wild-type ca+ for recombination to spz2 in the 
germline of F1 females. Recombination could arise from different chiasmata so the F2 cross 
used single males carrying ca+. 78 single male matings were established. Out of the 78 
matings, 15 of them had F3 offspring with ca+ balanced over TM6B. The 15 F3 lines were 
tested to determine whether or not the spätzle locus carried the spz2 or spz+ allele. The test by 
lethality was carried out according to the genetic scheme in Figure 2.9. If w+;;spz?ca1/TM6B 
was crossed to Df(3R)Exel6205/TM6B in the G0 generation, and the resulting F1 
spz?ca1/Df(3R)Exel6205 mothers laid F2 eggs which hatch, then the spätzle locus carried the 
spz+ allele. If the F2 eggs were not viable, then the spätzle locus carried the spz2 allele and the 
fly line had its spz2 allele cleaned of ca1 (genotype: w+;;spz2ca+/TM6B, stock no. 20 and 21, 
Table 2.1).  
 
2.1.4 Genetic Protocol for Generating dnt2 and spz Loss of Function Alleles 
 
The genetic protocols for generating dnt2 and spz loss of function alleles in this project 
followed the deletion strategy of using heat-shock driven flippase recombinase (hsFLP) with 
Exelixis transposons, which are P-element XP (P{XP}) and piggyBac (PBac) insertion lines 
containing flippase recombinase target (FRT) sites (Parks et al., 2004; Thibault et al., 2004).  
Insertions lines PBac{RB}dnt2e03444 (stock no. 6, Table 2.1) and P{XP}d05170 (stock no. 7, 
Table 2.1) were paired for dnt2 locus deletion, while P{XP}spzd00069 (stock no. 8, Table 2.1) 
was paired with PBac{RB}e00046 (stock no. 9, Table 2.1) for spz locus deletion. Figure 2.10 
and Figure 2.11 provide the schematic of the genetic crosses used for generating new dnt2 and 
spz alleles, respectively. At G0, males carrying the lower coordinate transposons   
Testing for the presence of spätzle loss of function allele 
Figure 2.9 Testing for the presence of spätzle loss of function allele by lethality at F2
 
generation. If the F2 generation is viable, the spätzle locus carries the wild-type allele (spz
+). 
If the F2 generation is instead not viable, the spätzle locus carries the loss of function allele 
(spz-).
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check lethality of F2 generation
G






1. discard F1 males
2. discard F1 females
with excess bristles on humerus
3. cross F1 virgin females










Figure 2.10 Genetic scheme used for generating a dnt2 loss of function allele. By the F2
generation, crosses would place two FRT-bearing transposon insertions in trans (e03444 and
d05170) and in the presence of a heat-shock driven flippase recombinase (hsFLP). Activation 
of flippase recombinase in F2 would result in the F3 generation of a hybrid element 
(e03444/d05170) with a genomic deletion between insertions e03444 and d05170. Multiple 
crosses of a single F3 male to 3 virgin females were established to isogenise chromosome 1 
and to test for hybrid dnt2e03444/d05170 by PCR. 
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Generation of dnt2 loss of function allele
G0 ♀ ♂xhsFLP;; DrMioTM3,Sb1 ;;dnt2e03444
w-
single male matings
1. heat shock F2 larval progeny
2. discard F2 males
2. discard F2 females with stubble bristles on notum
3. cross F2 virgin females with normal bristles on notum
1. discard F1 females
2. discard F1 males with reduced eyes
3. cross F1 males with stubble bristles on notum
1. discard F5 females and males 
with stubble bristles on notum
2. cross F5 virgin females and males






































1. discard F3 females
2. cross F3 males 
1. discard F4 females
2. discard F4 males 
with excess bristles on humerus




Figure 2.11 Genetic scheme used for generating a spz loss of function allele. By the F2
generation, crosses would place two FRT-bearing transposon insertions in trans (d00069 and
e04446) and in the presence of a heat-shock driven flippase recombinase (hsFLP). Activation 
of flippase recombinase in F2 would result in the F3 generation of a hybrid element 
(d00069/e04446) with a genomic deletion between insertions d00069 and e04446. Multiple 
crosses of a single F3 male to 3 virgin females were established to isogenise chromosome 1 
and to test for hybrid spzd00069/e04446 by PCR. 
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Generation of spz loss of function allele
G0 ♀ ♂xhsFLP;; DrMioTM3,Sb1 ;;spzd00069
w-
single male matings
1. heat shock F2 larval progeny
2. discard F2 males
2. discard F2 females with stubble bristles on notum
3. cross F2 virgin females with normal bristles on notum
1. discard F1 females
2. discard F1 males with reduced eyes
3. cross F1 males with stubble bristles on notum
1. discard F5 females and males 
with stubble bristles on notum
2. cross F5 virgin females and males





































1. discard F3 females
2. cross F3 males 
1. discard F4 females
2. discard F4 males 
with excess bristles on humerus






(PBac{RB}dnt2e03444 and P{XP}spzd00069) were mated with virgin females carrying hsFLP 
transgene. F1 male progenies, which carrying both the lower coordinate transposon and hsFLP, 
were then mated to virgin females carrying the higher coordinate insertions (P{XP}d05170 
and PBac{RB}e00046). After 2 days, F1 parents and F2 germ-line progenies were subjected to 
a 1 hour, 37°C heat shock. The next day, the parents were removed while the progenies were 
subjected to daily 1 hour, 37°C heat shocks for 4 consecutive days. F2 progenies were raised 
to adulthood to collect virgin female flies. These F2 females were crossed to male flies 
containing marked balancer chromosomes (w-;;MKRS/TM6B, stock no. 3, Table 2.1). 
Resulting F3 white-eyed (w-) progeny males were collected and individually crossed to virgin 
female flies of genotype w-;;MKRS/TM6B. Due to the F4 female population inheriting hsFLP, 
F4 males were crossed to virgin female balancers (w-;;MKRS/TM6B) to isogenise 
chromosome 1 and to retrieve a suitable stock in the next F5 generation. A total of 21 and 17 
w- isolate fly lines were established for generating new dnt2 (dnt2e03444/d05170) and spz 
(spzd00069/e04446) alleles, respectively, including w-;;spzMA05/TM6B (stock no. 24, Table 2.1), w-
;;spzMA10/TM6B (stock no. 25, Table 2.1) and w-;;spzMA12/TM6B (stock no. 26, Table 2.1).  
 
2.1.5 Survival Index Assay 
 
In order to test the viability of alleles over TM6B, crosses were set up in vials between virgin 
females and males of relevant genotypes. Vials were incubated at 25°C unless otherwise 
stated. The crosses were transferred to new vials with fresh food daily. As soon as flies began 
to eclose, normally 10 days after setting up the cross and incubating at 25°C, the vials were 
emptied of flies every day at 9am and 5pm until there was no further eclosion. The numbers 
of Tb+ and Tb- pupal cases (Figure 2.2) were counted from the first cross and subsequent   
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transfers to calculate survival index (SI), a measure of allele viability over TM6B: 
𝑆𝑆 = 2 ×
𝑛𝑛𝑛𝑛𝑛𝑛 𝑜𝑜 𝑇𝑛+
𝑛𝑛𝑛𝑛𝑛𝑛 𝑜𝑜 𝑇𝑛− 
For wild-type alleles over TM6B segregating in Mendelian fashion, the expected value of SI is 
1 (Figure 2.12):  






When SI is significantly less than 1, there are fewer non-tubby homozygotes than would be 
expected for wild-type, indicating that the allele reduced viability of larvae reaching pupal 
stages and is therefore semi-lethal. If SI is more than 1, there are more homozygotes than 
would be expected for wild-type segregration. SI is 0 when there are no homozygotes, 
indicating that an allele is fully lethal. 
 
2.1.6 Visualising RP2 Neurons 
 
To visualise wild-type RP2 neurons in third instar larval CNS, w;;RN2-FLP (stock no. 64, 
Table 2.1) flies were first crossed to w;UAS-myr-RFP, tub-FRT-CD2-FRT-GAL4, UAS-
FLP/CyO,wg-LacZ; (stock no. 66, Table 2.1). Yeast flippase recombinase (FLP) was under 
the RN2 regulatory element control. In F1 generation, when FLP induced recombination 
between FRT sites (which were separated by the CD2 linker), myr-RFP was expressed under 
the control of tub-GAL4. The inclusion of UAS-FLP allowed irregular GAL4 expression to be 
stabilised such that GAL4 was always expressed. F1 third instar larvae were selected for myr-
RFP expression under the Leica MZ FLIII stereo-fluorescence microscope to be dissected. To 
visualise RP2 neurons in loss of function background, spz2,RN2-FLP/TM6B,LacZ (stock no. 
65, Table 2.1) flies were crossed to UAS-myr-RFP, tub-FRT-CD2-FRT-GAL4, UAS-FLP/   
Chromosomal segregation according to Mendelian inheritance
en masse
G




























Figure 2.12 Segregation of balanced wild-type chromosomes according to Mendelian 
inheritance. When heterozygous alleles over TM6B are crossed in G0 and the F1 progeny 
counted, a third of F1 are expected to be homozygous and two-thirds heterozygous 
according to Mendelian segregation. TM6B/TM6B homozygotes are embryonic lethal, and 
thus, not viable and never pupate. 
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CyO;spz2ca1/TM6B (stock no. 67, Table 2.1) and UAS-myr-RFP, tub-FRT-CD2-FRT-GAL4, 
UAS-FLP/CyO;Df(3R)Exel6205/TM6B (stock no. 68, Table 2.1). This part of the project was 
contributed equally by M. P. Nallasivan up until the point of analysis (Section 2.5.3).  
 
2.2 Molecular Biology 
 
2.2.1 Genomic DNA Extraction 
 
Whenever possible, genomic DNA from homozygous males of each isolate fly line was 
purified. Otherwise, heterozygous males were used. Of the 21 w- isolate fly lines for the FLP-
FRT deletion of dnt2, 14 were homozygous viable while the remaining 7 were homozygous 
lethal. All 17 isolates for FLP-FRT deletion of spz were homozygous lethal. Genomic DNA 
was prepared from 15 male flies using Gentra® Puregene® DNA Purification System Kit 
(Qiagen®). The procedures of cell lysis, RNase A treatment, protein precipitation, nucleic acid 
precipitation and DNA hydration followed the manufacturer’s protocol for D. melanogaster 
(Qiagen, 2010).  
 
2.2.2 Conventional PCR 
 
Different polymerase chain reaction (PCR) strategies were used for confirming deletion by 
hsFLP-FRT strategy (Section 2.1.4), including the deletions resulting in fly lines w-
;;spzMA05/TM6B (stock no. 24, Table 2.1), w-;;spzMA10/TM6B (stock no. 25, Table 2.1) and w-
;;spzMA12/TM6B (stock no. 26, Table 2.1). Figure 2.13B provides a schematic and description 
for the different PCR strategies, while Table 2.2 and Table 2.3 list the expected PCR fragment   
Figure 2.13 Precise-end point hsFLP-FRT deletion adapted from Parks et al. (2004). (A) 
Using hsFLP-FRT recombination to generate w- deficiencies by deletions to lose the w+m 
marker. (B) Successful hsFLP-FRT recombination will result in a genomic deletion which 
leaves behind a resulting hybrid element at the recombination site. The residual transposon 
element (Tn1/Tn2) can be detected by PCR in three ways: (i) hybrid PCR, (ii) two-sided 
PCR, and (iii) genomic PCR. Element-specific forward (Tn1 fwd) and reverse (Tn2 rev) 
primers can detect the hybrid element of two transposons in hybrid PCR, while the hybrid 
element’s residual ends can be detected using paired element-specific and genomic-specific 
primers in two-sided PCR (GP fwd with Tn1 rev, and Tn2 fwd with GP rev). Further 
confirmation can be supported by genomic PCR using genome-specific primers on their own 



























Molecular concept for hsFLP-FRT deletion
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sizes using various primer pair combinations. Transposon primers for both ‘hybrid’ and ‘two-
sided’ PCR were already previously published (Parks et al., 2004), whereas genomic primers 
were custom made in-house using NetPrimer (PREMIER Biosoft) and Primer-BLAST 
(National Centre for Biotechnology Information). All primers were manufactured by Eurofins 
MWG Operon. For products longer than 2kb, PCR was carried out using Phusion® High-
Fidelity DNA Polymerase (New England Biolabs). For products less than 2kb, PCR was 
carried out using Taq DNA Polymerase (Invitrogen). 
 
2.2.3 Inverse PCR 
 
Inverse PCR permit the recovery of sequences flanking transposon elements. Briefly, the 
protocol entailed genomic DNA extraction (Section 2.2.1) from P{XP}d05170 flies, digestion, 
ligation, PCR and sequencing. Digestion was carried out using restriction enzyme Sau3AI 
(Promega) at 37°C for 1 hour (hr), then at 65°C for 20 minutes (mins). Ligation was carried 
out using T4 DNA Ligase (New England BioLabs) at 18°C overnight. To confirm transposon 
insertion in P{XP}d05170, two rounds of PCR was set up using primers designed by Exelixis 
(Table 2.4). The PCR product was purified by preparative gel electrophoresis and column-
spin purification to be sent for sequencing (Genomics Lab at University of Birmingham). 
Sequencing primers were designed by Exelixis (Table 2.4). The resulting nucleotide sequence 
output was retrieved using Chromas Lite (Technelysium) and the transposon insertion 



















Internal deleteGP fwd deleteGP rev No band 195bp 
Hybrid Tn1 fwd Tn2 rev 1.7kb No band 
LHS two-sided  GP fwd Tn1 rev 408bp * see legend 
RHS two-sided Tn2 fwd GP rev 619bp 




















LHS two-sided  GP fwd Tn1 rev 408bp No band 















RHS two-sided Tn2 fwd GP rev 619bp No band 
Genomic GP fwd GP rev 12.5kb 5.2kb 
Primer Sequences 
Name Sequence (5’ to 3’) 
deleteGP fwd GAA GAT CTC GAG CTG TGG GCG GCT ACT GT 
deleteGP rev CGG AAT TCA TGC AAA TCG ACG GCG AAT GA 
Tn1 fwd TGC ATT TGC CTT TCG CCT TAT 
Tn1 rev AAT GAT TCG CAG TGG AAG GCT 
Tn2 fwd CCT CGA TAT ACA GAC CGA TAA AAC 
Tn2 rev TTT ACT CCA GTC ACA GCT TTG 
GP fwd CAT TAC CAA CTA ACG CAC ATT 
GP rev AAT TCC CAA TAT ACC TGT GCT 
 
Table 2.2 Primers for screening putative dnt2 loss of function allelic stocks.  
The left- and right-hand sides of the two-sided PCR must both give bands of expected sizes 
(408bp and 619bp) from an isolate fly line to determine that the hybrid element is present. 





















LHS two-sided  GP fwd Tn1 rev 354bp * see legend 
RHS two-sided Tn2 fwd GP rev 670bp 

















LHS two-sided  GP fwd Tn1 rev 354bp No band 

















RHS two-sided Tn2 fwd GP rev 670bp No band 
Primer Sequences 
Name Sequence (5’ to 3’) 
Tn1 rev CCT CGA TAT ACA GAC CGA TAA AAC 
Tn2 fwd AAT GAT TCG CAG TGG AAG GCT 
GP fwd GCC TTA TAG TCT GCC ACT GTT 
GP rev ACA TGG CGA TTA CTT GCA GTG 
 
Table 2.3 Primers for screening putative spz loss of function allelic stocks.  
The left- and right-hand sides of the two-sided PCR must both give bands of expected sizes 
(354bp and 670bp) from an isolate fly line to determine that the hybrid element is present. 




Recovery of sequences flanking 5’ end of P{XP}d05170 insertion 
Primer Name PCR Round Sequence (5’ to 3’) 
51A 1 AAT GAT TCG CAG TGG AAG GCT 
51B 1 CAC CCA AGG CTC TGC TCC CAC AAT 
52A 2 TAC CAG TGG GAG TAC ACA AAC 
52B 2 TTT ACT CCA GTC ACA GCT TTG 
XP-5SEQ sequencing ACA CAA CCT TTC CTC TCA ACA 
 
Table 2.4 Primers for the recovery of sequences flanking 5’ end of P{XP} elements.  






Wandering larvae were dissected for their CNS in cold phosphate buffered saline (PBS). 
Embryonic brains were dissected by Dr M. Losada and the dissected, unfixed brains were a 
gift to this project. For all immunostaining purposes, unless otherwise indicated, the following 
steps were observed: CNS were fixed in 4% formaldehyde solution with PEM buffer (0.1M 
PIPES; 2mM EGTA; 1mM MgSO4) for 50 mins at room temperature (RT). After washing 
and permeabilising with 0.3% Triton X-100 in PBS (PBTx) for 30 mins at RT, CNS were 
blocked using 10% normal goat serum (Vector Laboratories) with 0.3% PBTx for at least 1 hr 
at RT or overnight at 4°C. Blocking was succeeded by the following sequence: incubation in 
primary antibody solution, washes, incubation in secondary antibody solution, and washes 
again. This sequence after blocking was repeated for any second immunolabelling required. 
Finally, immunostained CNS were mounted on microscope slides using mounting media of 
glycerol and dH2O in a 4:1 composition, before being covered with 18mm by 18mm 
borosilicate glass coverslips of thickness 0.08mm (VWR). In the case of immunostaining 
CNS with anti-nc82 (DSHB), the fixing and permeabilising steps were modified: CNS were 
fixed in 4% paraformaldehyde with PBS for 3 hrs on wet ice, and then permeabilised by 0.3% 
PBTx for 1 hr at RT. With anti-Toll7-AAQ staining, the wash buffer 0.3% PBTx was 
replaced by 0.3% Tween-20 in PBS (PBTw). 
 
Table 2.5 and Table 2.6 list the primary and secondary antibodies used in the course of this 
project, respectively. Stocks of the primary and secondary antibodies were usually diluted in 
10% normal goat serum with 0.3% PBTx for use in immunohistochemistry. In the case of 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 2.6 Secondary antibodies used for immunohistochemistry.  
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Anti-Ebony is a gift reagent from S. Carroll and it was used at dilution 1:250, the same 
dilution used by Kato et al. (2011) for anti-Ebony staining in larval brain tissue. The signal 
and specificity of anti-Toll-d300 (Santa Cruz Biotechnology), as well as those of custom-
designed antibodies against the DNTs and Toll7 (Davids Biotechnologie), were first 
characterised in this project. The usefulness of anti-Toll-d300 and the custom-designed 
antibodies will be assessed in Chapter 3. Dilution series to optimise immunostaining signal 
and controls to establish specificity were not usually carried out in this project since the 
Hidalgo lab has extensive experience in using antibodies for immunostaining in the 
Drosophila CNS. Hence, the specificity of commonly used antibodies sourced from Clontech, 




2.4.1 Image Acquisition  
 
All images of Drosophila adult eyes were collected on a Zeiss Stemi 2000-C 
stereomicroscope equipped with an AxioCam ICc3 camera, which was controlled with the 
Zen lite 2012 software.  
 
Phase contrast images of whole larval CNS were acquired from the Zeiss Axioplan 2 
equipped with a 10x/0.3 Plan-Neofluar objective lens and an AxioCam HRc camera, which 
was controlled with Zen lite 2012 software. Alternatively, phase contrast images were viewed 
from the Zeiss Axio Observer equipped with a 10x/0.3 Plan-Neofluar objective lens and then 
acquired using Zen 2010 software. 
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Fluorescent, confocal images of larval CNS were taken from two systems: (1) the Leica TCS 
SP2 AOBS spectral confocal scanner mounted on a Leica DM IRE2 inverted fluorescent 
microscope; and (2) the Zeiss LSM710 spectral confocal scanner mounted on the Zeiss Axio 
Observer. The Leica was equipped with a 20x/0.7 Plan-Apochromat multi-immersion 
objective lens and a 40x/0.75 Plan-Apochromat oil lens. The Zeiss was fitted with a 25x/0.8 
Plan-Apochromat oil objective lens and a 40x/1.3 Plan-Neofluar oil lens. Alexa Fluor® 488 
was excited with the 488nm line from the 100mW argon (Ar) and 75mW argon-krypton 
(ArKr) lasers on the Leica system, and from the 25mW Ar laser on the Zeiss system. Alexa 
Fluor 647® was excited with the 633nm line from the 10mW helium-neon (HeNe) laser on 
the Leica and the 5mW HeNe on the Zeiss. Endogenous myristoylated tandem dimer Tomato 
(myr-tdTomato) and myr-RFP were excited with the 543nm line from the 1mW HeNe laser 
on the Zeiss. 
 
2.4.2 Time-Lapse Recordings of Stabbed Samples 
 
Two sets of Z-stack time-lapse recordings over the course of 10 to 15 hrs were carried out 
using the Leica confocal microscope with the 20x objective lens. Samples were maintained at 
25ºC in a temperature controlled chamber (Life Imaging Services). One set of Z-stack time-
lapse recording over the duration of 12 hrs was imaged by the Zeiss confocal using the 25x 
lens. Samples were maintained at 25ºC using the Zeiss heated stage controlled by the Zeiss 
TempModule. Endogenous green fluorescent protein (GFP) was excited using the 488nm line 




2.4.3 Image Processing and Analysis 
 
Every image was processed and analysed using ImageJ (version 1.44p or 1.49i) and Adobe 
Photoshop CS6 (64 bit). Images of RFP-positive RP2 neurons (Section 2.1.6) were processed 
in ImageJ according to Ou et al. (2008) for Sholl analysis. The pixels showing the cell soma 
and axon were removed manually from each focal point. Any background spot was removed 
by running the built-in Median Filter function at radius 1 pixel. After each focal plane was 
converted to a binary image by applying the Auto Threshold function, dendrites were then 
ready to be analysed by Sholl analysis using the plug-in written by Ferreira et al. (2014b) 
(Section 2.5.3) . Time-lapse images (Section 2.4.2) were processed by ImageJ plugins 
Turboreg and Stackreg to correct sample movement. 
 
2.5 Phenotypic Analysis 
 
2.5.1 Cuticle Preparations of Unhatched Embryos 
 
The protocol for cuticle preparations of unhatched embryos was adopted from Stern and 
Sucena (2000). Females were allowed to lay their eggs in cages on grape juice agar plates for 
24 hours. After 24 hours, the females were removed and the laid eggs left alone to develop on 
the grape juice agar plates for a further 24 hours. The eggs were then washed with tap water 
through an egg sieve. The egg sieve was placed in a small dish containing 50% bleach (12% 
sodium hypochlorite) until the eggs developed from dull white to having shiny appearance, 
indicating full dechorionation of embryos. The dechorionated embryos were then dried by 
blotting the egg sieve on dry paper towel. Using a wet paintbrush, the embryos were 
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transferred from the egg sieve into a 1.5mL microcentrifuge tube containing 500μL heptane 
and 500μL methanol. The microcentrifuge tube was shaken using a vortex mixer for 30 
seconds to cause the vitelline membrane to pop. The heptane and methanol mixture was 
removed and replaced with 1mL of methanol for washing. Devitellised embryos were washed 
twice with methanol and then twice with 0.1% PBTx. Embryos were then transferred to a 
clean microscope slide. Excess liquid was absorbed by a piece of filter paper while avoiding 
the embryos. A drop of diluted lactic acid (75%) was placed on the embryos and a clean 
coverslip placed over the preparation. The preparation was cooked in an oven at 60°C for 
27.5-28 hours. Cuticles were viewed by using low-power objectives (10x) with the condenser 
set in phase-contrast position for higher-powered objective (Ph3) as a substitute for dark-field 
illumination on the Zeiss Axioplan 2.  
 
2.5.2 Measurements of CNS Size 
 
Wandering larvae were dissected and CNS fixed for 30 minutes. CNS were then washed with 
0.3% PBTx for 30 minutes, and finally suspended in 80% glycerol. Microscope slides were 
layered twice with cellotape and a small rectangle, around the centre of the slide, cut out with 
a razor. This rectangular area was where CNS were mounted and covered with a coverslip 
without being squashed. Mounting technique and quality was very consistent under the 
author’s hands. Images were acquired immediately, or a day later at latest, to avoid tissue 
shrinkage. Measurements of CNS size were done in ImageJ by drawing region of interests 
(ROIs) separately for the brain area, VNC area and VNC length. Area and length 




2.5.3 Sholl Analysis of RP2 Dendrites 
 
Processed images of RFP-positive RP2 dendrites were used for Sholl analysis (Section 2.4.3). 
Before running the plugin, the centre of analysis was defined as the point where the axon 
intersected with the cell soma, and the centre was selected using the Point Selection Tool. 
Table 2.7 details the essential parameters used when running Sholl Analysis v3.4.3 plug-in for 
analysis of RFP-positive RP2 dendrites. The output of each Sholl Analysis for each neuron 
supplied a list of the x- and y-coordinates, with x-values being distance from cell soma and y-
values being the number of intersections at each distance sampled. Each RP2 neuron was 
categorised into one of three groups: thoracic RP2, A1-3 RP2 or A6-7 RP2. In each genotype 
in each category, the associated y-values were summed up at each distance sampled before 
obtaining the mean number of intersections for statistical comparisons. 
 
2.5.4 DeadEasy for Automatic Counting of Cells 
 
DeadEasy Larval Glia (Forero et al., 2012) is the software which was purposely written in 
Java as an ImageJ plugin to count automatically the number of all larval glia stained with anti- 
Repo and later acquired as confocal microscopy images. In the publication by both Forero et 
al. (2012) and Kato et al. (2011), confocal serial sections of anti-Repo staining were obtained 
with the BioRad Radiance 2000 upright confocal microscope as images of pixel size 
0.5665μm and step size 1 μm. DeadEasy Larval Glia identifies stained cells first through each 
confocal slice in 2-dimensional shape (circular or elliptical), and then throughout the stack in 
3-dimensions based on mimimum and maximum volume as well as pixel intensity. The 
software creates a stack of processed images in which the identified objects reproduce those   
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Definition of Shells 
Parameter Input Use 
Starting radius 5.0μm (thoracic 
and A1-3 RP2 
neurons) 
2.5 μm (A6-7 
RP2 neurons) 
This input defines the radius of the first 
concentric spherical shell, and thus the first 
discrete measurement from the centre of 
analysis. 
Ending radius NaNμm “NaN” stands for “Not a Number”. This input 
instructs the program to sample the entire Z-
stack image. 
Radius step size 5.0μm (thoracic 
and A1-3 RP2 
neurons) 
2.5 μm (A6-7 
RP2 neurons) 
This input defines the radius of the second and 
subsequent concentric spherical shells. By 
having the step size the same as the starting 
radius, the discrete sampling is incremented 
equally. 
Descriptors and Curve Fitting 
Parameter Input Use 
Enclosing radius 
cutoff 
1 This input instructs the program to use one 
intersection in defining the last and widest 
shell. 
Primary branches 1 An RP2 neuron has one axon only leaving the 
cell body and thus the number of primary 
branches is 1.  
Sholl Methods 
Parameter Input Use 
Linear Tick the box This input instructs the program to supply a 
graph of number of intersections by shells 
versus radius length for each neuron. This 
graph will be supplied with a list of x- and y-
coordinates which can be saved manually.  
Polynomial Best fitting 
degree 
The linear profile will include the line of best 
fit in the graph of number of intersections 
versus radius length for each neuron. 
Output Options 
Parameter Input Use 
Create intersections 
mask 
Tick the box This input instructs the program to supply a 
maximum intensity projection of the neuron 
analysed, in which the measured dendrites is 
painted according to its linear Sholl profile 
using a rainbow color map.  
Save results in 
image directory 
Tick the box This input allows Sholl plots, associated 
coordinates and Sholl intersection mask to be 
saved directly and automatically. 
 
Table 2.7 Parameters used when running Sholl Analysis v3.4.3 (Ferreira et al., 2014b) to 
analyse dendrites of RP2 neurons.   
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of the Repo-positive glia in the raw images (Figure 2.14), enabling comparisons and 
validation. Validation by Forero et al. (2012) was carried out through counting the number of 
false positive objects and false negative cells using 10 different confocal image stacks. False 
positive objects are those which DeadEasy Larval Glia identified incorrectly as Repo-positive 
glia while false negative cells are those which incorrectly escape identification as Repo-
positive glia. A total of 947 real cells were counted after verifying each cell between the raw 
and DeadEasy-processed images. DeadEasy Larval Glia identified 907 cells with an accuracy 
of 0.11% false positive and 4.33% false negative (Forero et al., 2012). In this project, 
confocal serial sections were obtained with the Zeiss LSM 710 microscope due to the 
breakdown of the BioRad Radiance 2000 upright confocal microscope. The pixel size was 
0.664μm and the step size 1 μm. Validation through counting the number of false positive 
objects and the false negative cells was carried out from 21 different confocal image stacks in 
ImageJ using Cell Counter. The accuracy of DeadEasy Larval Glia when switching from the 
BioRad to the Zeiss system was 0.3% false positive and 3.9% false negative.  
 
Before running DeadEasy Larval Glia, ROIs must be selected (Figure 2.15). Peripheral nerves 
exiting the VNC were excluded from the ROI. For the abdominal VNC, the ROI was defined 
according to Kato et al. (2011) as the area starting from the posterior of a pair of Repo- 
positive ventral interface glia (vIG) in the last thoracic segment (T3) to the posterior tip of the 
ventral nerve cord (Figure 2.15). The thoracic ROI was defined by the adjacent area anterior 
to the abdomen and which encompasses three pairs of interface glia in unique C-shaped 




Figure 2.14 DeadEasy Larval Glia processes raw images of anti-Repo staining. (A) 
Maximum projections of 10 confocal slices to show the ventral interface glia of the third 
thoracic segment (T3 vIG). (B) Maximum projections of whole Z-stack of the same sample as 
in (A). DeadEasy results are in pseudocolor magenta. White solid line: ROI boundary drawn 
for DeadEasy to process. Scale bar represents 50μm. 
DeadEasy Larval  Glia
T3
vIG





Figure 2.15 Defining abdominal and thoracic VNC areas as ROIs in anti-Repo staining. The 
ventral interface glia (vIG) of the last thoracic segment (T3) must first be identified in 
longitudinal view through the Z-stack of confocal serial sections. The abdominal ROI 
according to anti-Repo staining is defined as the posterior end of the VNC beginning from 
the T3 vIG. The thoracic ROI according to the same staining is defined as the anterior region
to T3 vIG and includes three pairs of interface glia in unique C-shaped arrangements.



















2.5.5 Stabbing Injury to the Larval VNC 
 
Stabbing was done in sterile conditions according to the injury paradigm which was set up by 
Kato et al. (2011) and described with more details Kato and Hidalgo (2013) in the Journal of 
Visualized Experiments. CNS were dissected from staged 96h AEL old larva in Shields and 
Sang M3 insect culture medium (Sigma) and transferred to fresh culture medium where they 
were pooled until the dissecting period of a maximum of 20 mins was over. Once dissection 
was finished, each pooled CNS had their abdominal VNCs stabbed from the dorsal side 
(Figure 2.16). The instrument of choice was a fine tungsten needle of 0.5mm diameter at the 
base and 1μm diameter at the tip (Roboz Surgical Instrument Co.).  
 
For time-lapse imaging of stabbed genotype G9, in which endogenous GFP labels all the 
neuropile axons, stabbed samples were transferred and placed dorsal side down in a 35mm 
glass-based dish (Iwaki), previously coated with 0.01% poly-L-lysine (Sigma) and containing 
1mL Shields and Sang M3 insect medium supplemented with 7.5% fetal bovine serum 
(Sigma) as well as1% penicillin-streptomycin (Sigma). The sample with the highest shape 
integrity upon being attached to the dish was used for time-lapse imaging. The glass-based 
dish was lid-covered throughout imaging to prevent evaporation.  
 
For immunohistochemistry, stabbed samples were transferred and cultured separately for 20 
to 24 hrs at 25ºC in a 24-well plate (Corning) containing 500μL culture medium with 7.5% 
fetal bovine serum and 1% penicillin-streptomycin mix. Control samples were dissected, 
pooled and cultured similarly to stabbed samples, but without applying the needle for injury. 
Following culture, the samples were checked under the Leica MZ8 stereomicroscope for   
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Figure 2.16 Applying a stabbing injury to the larval VNC. Dissected CNS in Shields and 
Sang M3 insect medium was pierced through the abdomen from the dorsal side by a fine 











either the retainment of normal shape and size or the attainment of abnormal gross 
morphology characterised by a cauliflower-like appearance. Samples with normal integrity 
were selected to be fixed for anti-GS2 immunolabelling while abnormal samples were 
discarded due to severe tissue degradation. 
 
2.5.6 Measurement of Neuropile Wound Size 
 
Wound area was visualised either by GFP in genotype G9 or by anti-GS2 staining. The area 
was measured according to Kato et al. (2011) on longitudinal Z-stack images of the neuropile 
acquired using confocal microscopy. The largest outline of the wound throughout the stack of 
images (that is, the neuropile) was set as the ROI in ImageJ, and the area measured in μm2. 
 
2.6 Statistical Methods 
 
All data were collated and analysed using Excel 2010 (Microsoft). All statistical tests were 
carried out using SPSS Statistics 21 (IBM). In all cases, the null hypothesis was that there was 
no difference between test samples and controls. In all results, whenever the p-value was less 
than 0.05 (p<0.05), the null hypothesis of the test was rejected. The * symbol in statistical 
results indicates p<0.05, ** meaning p<0.01 and *** p<0.001. Comparisons which are not 
statistically significant are denoted by ‘ns’. 
 
The data for survival index assays were categorical (Section 2.1.5), and all categorical data 
were tested using Pearson’s chi-square test (χ2). Whenever multiple comparisons among 
different genotypes were made, a Bonferroni correction was applied to the χ2 test by 
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multiplying the p-value with the number of comparisons. When categorical data such as 
survival index were plotted in bar charts, error bars were not applicable.  
 
Continuous data were obtained from experiments involving area measurements (Section 
2.5.2; Section 0), cell counting (Section 2.5.4) and Sholl analysis (Section 2.5.3). The data 
sets were tested for normality using kurtosis and skewness, as well as the Kolmogorov-
Smirnov and Shapiro-Wilk tests. Data were treated as normally distributed when absolute 
kurtosis and absolute skewness was less than 1.96 of the standard error kurtosis and skewness, 
respectively. According to the Kolmogorov-Smirnov and Shapiro-Wilk tests of normality, 
data were normally distributed when p-value was greater than 0.05 (p>0.05).  
 
If data were not normally distributed, medians would be considered. For two samples, the 
medians would be compared using the Mann-Whitney U test. For three or more samples, the 
medians would be tested using the Kruskal-Wallis one-way ANOVA, with post hoc multiple 
comparisons performed using the Dunn method.  
 
Normally distributed data from different samples were tested for the homogeneity of 
variances. Variances of the data from different samples were considered equal if Levene’s 
Test resulted in p>0.05. For two samples having equal variances, the means were compared 
using the independent samples t-test for equality of means. For three or more samples having 
equal variances, the means were compared using the one-way ANOVA, after which post hoc 
multiple comparisons were applied using the Dunnett or Bonferroni method. The Dunnett 
method compares all the means of test samples to the control mean, while the Bonferroni 
compares all means to each other. For normally distributed data of different samples having 
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unequal variances (Levene’s Test, p<0.05), Welch ANOVA was applied instead. In turn, the 
post hoc multiple comparison was performed using the Games-Howell method, which 
compares all means to each other. 
 
When continuous data such as area and length were plotted in bar charts, error bars 
representing standard deviation (SD) were used instead of standard error (SE). All statistical 









This chapter is about determining whether or not the DNTs remain biologically relevant in the 
larval CNS after embryonic stages.  
 
3.1.1 Known Expression Patterns of DNTs, Toll, Toll6 and Toll7 in Larval CNS 
 
Previously in the Hidalgo lab, expression patterns of dnt genes in embryos were described 
from localised mRNA expression using the in situ hybridisation technique (Zhu et al., 2008). 
In the larva, transcripts for dnt1, dnt2 and spz were expressed in the body-wall musculature 
(Sutcliffe et al., 2013). Dnt1 transcripts were detected in the larval optic lobe and diffusely 
throughout the central brain and thoracic cortex (Sutcliffe, 2011; Zhu et al., 2008). Dnt2 
transcripts were restricted the larval eye-antenna disc (Sutcliffe, 2011). Spz transcripts were 
detected in the larval optic lobe, diffusely throughout the central brain and VNC, and in 
higher levels in cells within the central brain and VNC (Sutcliffe, 2011). 
 
Toll6 and Toll7 transcripts were shown to be expressed in the larval optic lobes, central brain 
and VNC (McIlroy, 2012). GAL4 reporter lines for Toll, Toll6 and Toll7 showed GFP 
expression in the CNS (McIlroy, 2012; Sutcliffe, 2011). Although Toll is the well-known 
receptor of Spz, and spz transcripts were found in the larval CNS (Sutcliffe, 2011), whether or 
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not Toll is expressed in the larval CNS has yet to be discovered, primarily because the 
research focus has mainly centred around the role of Toll in embryonic dorsal-ventral 
patterning and in immunity. 
 
3.1.2 GAL4 Reporters for dnt Genes 
 
There are four available GAL reporters for dnt1 which were generated by Dr B. Zhu of the 
Hidalgo lab (Figure 3.1A). The regulatory sequence upstream of dnt1 used for Dnt1-I’s 
construct was derived from the 2.3kb genomic region between dnt1 and its adjacent gene tie 
(Figure 3.1A). At 4.8kb, dnt1-II’s construct was the longest and was an extension of dnt1-I’s 
construct length, encompassing the first exon of dnt1, up to and including the first intron of 
dnt1 (Figure 3.1A). Dnt1-III’s 2.5kb construct was cloned from the first exon and first intron 
of the dnt1 gene (Figure 3.1A). The fourth dnt1-GAL4 construct used the first intron only 
(Figure 3.1A). Put together, the four dnt1-GAL4 transgenic constructs had covered all the 
non-coding genomic regions between the dnt1 and tie genes, both fully and at divided lengths, 
for which their suitability as drivers to express dnt1 patterns were tested.  
 
Dr S. Alahmed generated a dnt2-GAL4 transgenic based on cloning approximately 2.5-6.0kb 
of the region upstream of the dnt2 coding region (Dr S. Alahmed, personal 
communication).The spz-GAL4 construct was generated in the lab by cloning approximately 





3.1.3 Mi{MIC}-EGFP Protein Traps for spz and Toll6  
 
Gene expression patterns can also be visualised with protein traps (Venken et al., 2011a). 
Protein traps depend on the presence of transposons, such as Minos, in the gene of interest 
(Venken et al., 2011a). The Minos-mediated integration cassette (Mi{MIC}) incorporates an 
enhanced green fluorescent protein (EGFP) tag into genes (Venken et al., 2011b), and there 
are Mi{MIC} lines containing EGFP tags available for spz (Figure 3.13A) and Toll6 genes 
(Figure 3.27A).  
 
3.1.4 Antibodies for DNTs, Toll and Toll7 
 
The Hidalgo lab generated antibodies to the DNTs, Toll6 and Toll7 using peptides that were 
designed by the collaborators, Dr J. Aurikko and Prof N. Gay, and by Davids Biotechnologie. 
Commercially available antibodies against Toll are available (Table 2.5). 
 
Two different antibodies were raised against DNT1. They were raised against the peptides, 
RRPQ and VRY. The RRPQ peptide is a 21-mer amino acid sequence (RRPQHSEARLDLD 
LAPSETHS) within the DNT1 C-terminus tail (Figure 3.4A). This portion of the C-terminus 
exists in four out of seven DNT1 isoforms annotated in FlyBase. The VRY peptide is an 18-
mer amino acid sequence (VRYARPQKAKSASGEWKY) within the DNT1 CysKnot domain 
(Figure 3.5A). 
 
Three peptides were designed for the purpose of raising antibodies against DNT2. These 
peptides are DNT2-ALN, DNT2-GYN and DNT2-KRL. Their amino acid sequences are 
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situated in the CysKnot domain (Figure 3.8B). The ALN peptide is a 23-mer long amino acid 
sequence (ALNSRGNWMFVVNEQNTARQMVK). The GYN peptide is 18-mer long 
(GYNSRCEQKFVQKRLIAL) and its last 6 amino acid seqeuence overlaps with the KRL 
peptie, which is a 12-mer amino acid sequence (KRLIALQGNGQN).  
 
Two antibodies were raised against amino acid sequences within the CysKnot domain of the 
Spz protein (Figure 3.14A). The amino acid sequence of Spz-GLR, which is 14-mer long, is 
GLRADDTWQLIVNN, while Spz-ASK’s 9-mer sequence is ASIKSDGEL. 
 
3.1.5 Specific Aims 
 
The specific aims of this chapter are: 
∑ To characterise reporter patterns of dnt1-, dnt2- and spz-GAL4 in the larval VNC. 
∑ To characterise larval VNC EGFP patterns of Mi{MIC} insertions into the spz and 
Toll6 gene. 
∑ To characterise immunostaining patterns of anti-DNT1, anti-DNT2 and anti-Spz 
antibodies in the larval VNC. 
∑ To characterise immunostaining patterns on anti-Toll and anti-Toll7 antibodies in the 
larval VNC. 
 
3.1.6 Methods in Brief 
 
Dnt-GAL4 lines were crossed to UAS-GAP-GFP, UAS-mCD8-GFP and 10xUAS-myr-
tdTomato. GAP-GFP is a fusion of the myristoylation sequence from GAP43 gene to GFP, 
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and it is membrane-targeted. The mCD8-GFP is a protein fusion between the murine 
lymphocyte receptor CD8 and EGFP, and it is also membrane targeted. Myristoylated tandem 
dimer Tomato (tdTomato) fluorescent protein is membrane targeted too.  
 
Elav-GAL4 were crossed to UAS-DNT1-CK3’+ for pan-neuronal overexpression of activated 
DNT1 in the form of CysKnot with 3’ tail (genotype: elav>DNT1-CK3’+). Pdf-GAL4 were 
crossed to UAS-DNT2-CK-6A (genotype: pdf>DNT2-CK-6A) to overexpress the CysKnot 
form of DNT2 in laternal neurons (LN) in the brain. Repo-GAL4 crossed to UAS-actSpz(2) 
overexpress activated Spz in all glia, except midline glia (repo>actSpz(2)). The genotype 
spzHMS01178 is a fly stock used to knockdown spz (stock no. 29, Table 2.1).  
 
The antibodies used in this chapter are listed in Table 2.5 and Table 2.6. Antibodies against 
Toll6 failed to be optimised for immunohistochemistry and will not be discussed here.  
 
Z-stack confocal images of larval CNS were acquired in longitudinal view. Images in 
transverse view were reconstructed from acquired Z-stacks in ImageJ. Pixel width and height 




3.2.1 Expression Pattern of dnt1 in the Larval CNS 
 




Dnt1-I-GAL4 and dnt1-III-GAL4 transgenic flies were crossed to UAS-GAP-GFP, and the 
larval CNS stained with anti-GFP antibody. Between dnt1-I- and dnt1-III-GAL4, the 
expression patterns of GAP-GFP in the larval VNC were similar (Figure 3.1B and C). GAP-
GFP was found in the neurohemal organs (NHOs) in the abdomin (n=7, Figure 3.1B; n=7, 
Figure 3.1C). The neurohemal organ was identified as part of the abdomen because the stalk-
like structure at the segment border of neuromeres bifurcates and thoracic neurohemal organ 
do not exhibit bifucation (Ito et al., 1995).The GAP-GFP was also found in a pair of axons 
running along the midline (or close to the midline) between the anterior subesophageal 
ganglion (SEG/SubGgl) and the peripheral nerves of the posterior caudal neuromere, A8/9 
(n=7, Figure 3.1B). The cytoplasm of three cell soma pairs in the anterior half of the abdomen, 
relatively ventral in the nerve cord, carried abundant GFP signal (n=7, Figure 3.1B; n=7, 
Figure 3.1C). Anterior to the nerve cord, GFP was detected in the ring gland and, below the 
ring gland, in a pair of cell bodies together with their projections (n=1, Figure 3.1C).  
 
The crossings of dnt1-I- and dnt1-III-GAL4 to UAS-GAP-GFP were done in parallel with Dr 
S. Alahmed of the Hidalgo Lab. When using GAL4 lines other than dnt1-GAL4, Dr S. 
Alahmed observed similar GAP-GFP patterns to those shown in B and C (personal 
communication). Her GAP-GFP was seen in the pair of axons running close to the midline 
along the VNC and in the three pairs of ventral cell bodies (personal communication). The 
said GAP-GFP pattern had turned up in a sufficient number of occasions such that the 
legitimacy of the UAS-GAP-GFP transgenic stock was doubted and eventually checked 
(Hidalgo Lab, personal communication). Despite the absence of GAL4, Dr S. Alahmed 
detected endogenous GFP in UAS-GAP-GFP using anti-GFP antibodies (n=2, Figure 3.2A; 
raw data provided by Dr S. Alahmed). Furthermore, the anti-GFP pattern (Figure 3.2A) was   
Figure 3.1 Expression of GAP-GFP in the larval CNS as revealed by dnt1-GAL4. (A) Four 
genomic sequences cloned as possible promoters of dnt1 and spanning from dnt1’s coding 
region to Tie. Dnt1 and Tie genes are illustrated here in 5’ to 3’ orientation, although both 
genes are in the minus strand and Tie lies upstream of dnt1. (B) Expression of GAP-GFP 
driven by dnt1-I-GAL4 in the larval VNC (n=7). (C) Expression of GAP-GFP driven by dnt1-
III-GAL4 in the larval VNC (left: n=7) and BLs (right: n=1). Signal of endogenous GFP in 
(B) and (C) was amplified by labelling with anti-GFP and Alexa Fluor® 488 antibodies. 
White arrows: Bifurcation of NHO. Yellow arrowheads: Ventral cell bodies. Cyan 





























Figure 3.2 Checking of UAS-GAP-GFP and UAS-mCD8-GFP. Anti-GFP and Alexa Fluor® 
488 labelling in (A) UAS-GAP-GFP alone without GAL4 (maximum projections of larval 
CNS; n=2, raw images provided by Dr S. Alahmed), (B) UAS-mCD8-GFP alone without 
GAL4 (maximum projections of larval VNC; n=2), and (C) yw without GAL4 and UAS 
(maximum projections of larval VNC; n=2). Yellow arrowheads: Ventral cell bodies. Cyan 
arrowhead: GFP in RG. Scale bars in (A) to (C) represent 50μm.








similar to those in UAS-GAP-GFP under the control of dnt1-I- and dnt1-III-GAL4 (Figure 
3.2B and C). In effect, expression pattern data collected from fly crosses which used UAS-
GAP-GFP were invalid. However, any expression pattern data from crosses with UAS-mCD8-
GFP remained valid because the presence of GAL4 was proven to be required for the 
expression of mCD8-GFP (n=2, Figure 3.2B). Lack of GAL4 proteins did not yield reporter 
signal in UAS-mCD8-GFP (Figure 3.2B), and the background signal in UAS-mCD8-GFP was 
similar to the baseline level in yw, a genotype without GAL4 and UAS transgenes (n=2, Figure 
3.2C). 
 
Dnt1-GAL4 flies were crossed to UAS-mCD8-GFP, and the larval CNS stained with anti-GFP 
antibody. Dnt1-I-GAL4 drove mCD8-GFP expression in two regions: in a punctate fashion 
along the longitudinal axis of the neuropile at the dorsal edge, and in a narrow tract along the 
longitudinal axis of the ventral neuropile (n=19, Figure 3.3A). The punctate mCD8-GFP 
expression was strongest under dnt1-I-GAL4 (n=19, Figure 3.3A) and was variable in strength 
from weakly, with dnt1-II (n=20, Figure 3.3B) and dnt1-III-GAL4 (n=5, Figure 3.3C), to 
virtually non-existing with dnt1-IV-GAL4 (n=10, Figure 3.3D). Across the four dnt1-GAL4 
lines, the narrow tract pattern of mCD8-GFP was more consistent and more prominent than 
the punctate expression (Figure 3.3A-D). The prominent longitudinal tracts also have lateral 
GFP-positive axons in most segments of the nerve cord (Figure 3.3, top panel). These lateral 
GFP axons appear to connect the tracts in the neuropile with the edge of the nerve cord, 
particularly at the intersection with peripheral nerves (Figure 3.3, bottom panel). Collectively, 
the four dnt1-GAL4 transgenes, irrespective of their promoter length, reported similar EGFP 
patterns in the larval CNS, which means the regulatory region for dnt1 is most likely to be 
within the first intron of dnt1 (Figure 3.1A).  
Figure 3.3 Expression of mCD8-GFP under GAL4 driven by (A) dnt1-I- (n=19), (B) 
dnt1-II- (n=20), (C) dnt1-III- (n=5) and (D) dnt1-IV-GAL4 (n=10). Signal of endogenous 
mCD8-GFP was amplified by labelling with anti-GFP and Alexa Fluor® 488 antibodies. Top 
panel: Maximum projections of VNC in longitudinal view. Bottom panel: Maximum 
projections of thoracic segment T3 in reconstructed transverse view.  White arrowheads: 
Punctate GFP. Yellow arrowheads: Corresponding punctate GFP in longitudinal and 
transverse views. Cyan arrowheads: Corresponding tract in longitudinal and transverse 

















3.2.1.2 Immunostainings of Anti-DNT1 Antibodies 
 
Staining yw CNS with anti-DNT1-RRPQ antibody (Figure 3.4A) revealed signal in two pairs 
of cell bodies in the central brain area, in lateral cells in the VNC and in most areas of the 
neuropile (n=5, Figure 3.4B). These signal were also detected in the transheterozygous null 
genotype dnt141/Df(3L)Exel6101 (n=3, Figure 3.4B), indicating anti-DNT1-RRPQ is not a 
specific antibody.  
 
In yw CNS, anti-DNT1-VRY (Figure 3.5) stained the ring gland, the outer proliferation centre 
(OPC), the inner proliferation centre (IPC) and a pair of cell bodies in the anterior edge of the 
brain lobes (n=6, Figure 3.6B). There are punctate signals in the yw central brain and VNC 
neuropile (Figure 3.6B). The puncta are contiguous along the longitudinal axis in the thoracic 
neuropile, relatively ventral. These described patterns in the yw were reproduced in 
dnt141/Df(3L)Exel6101 (n=6, Figure 3.6B). In elav>DNT1-CK-3’+ CNS, signal came up in 
the ring gland and brain lobes too (n=4, Figure 3.6B). Most particularly, ectopic signal in 
multiple cell bodies in the lateral and ventral cortex were detected (Figure 3.6B). 
 
3.2.2 Expression Pattern of dnt2 in the Larval CNS 
 
3.2.2.1 Patterns of dnt2-GAL4 
 
Dnt2-GAL4 flies were crossed to 10xUAS-myr-tdTomato, and the larval CNS stained with 
anti-DsRed antibody. The 10xUAS-myr-tdTomato reporter might drive stronger expression 
than UAS-mCD8-GFP. At best, the myr-tdTomato expression under dnt2-GAL4 control was  
Figure 3.4 Staining of larval CNS with anti-DNT1-RRPQ antibodies. (A) DNT1 protein 
illustrated in the direction of N-terminus to C-terminus. SP: signal peptide. CK: CysKnot 
domain. RRPQ is a 21-mer amino acid sequence in the C-terminus tail. (B) Detection of 
DNT1 protein using anti-DNT1-RRPQ in yw control larvae (n=5) and dnt141/Df(3L)Exel6101 
transheterozygous null mutant larvae (n=3). Images were acquired using the 488nm laser 
with identical laser power and PMT settings, then processed using ImageJ and Photoshop. 
White arrowheads: Note signal in cell bodies in BLs. Yellow arrowheads: Note signal in 
cell bodies in VNCs. Scale bars in (B) represent 50μm.
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Figure 3.5 Raising polyclonal antibodies against DNT1 using the VRY peptide. (A) DNT1 
protein illustrated in the direction of N-terminus to C-terminus. SP: signal peptide. CK: 
CysKnot. VRY is an 18-mer amino acid sequence in the CysKnot domain. (B) Model of 
DNT1 protein by J. Aurikko and N. Gay. The quaternary structure is made of two DNT1 
monomers, one in green and one in red. In the red monomeric structure, the ball and stick 
model represents the VRY peptide in context of the DNT1 protein. 
A DNT1 protein




Figure 3.6 Detection of DNT1 protein using anti-DNT1-VRY antibodies. Maximum 
projections of: (A) medial BLs in longitudinal view, (B) medial VNCs in longitudinal view, 
(C) ventral VNCs in longitudinal view, (D) anterior abdomens in medial and longitudinal 
views, and (E) anterior abdomen in reconstructed transverse view. Genotypes: yw (n=6), 
dnt141/Df(3L)Exel6101 (n=6) and elav>DNT1-CK-3’ (n=4). Images were acquired using the 
488nm laser with identical laser power and PMT settings, then processed using ImageJ and
Photoshop. White arrowheads: Note signal in cell bodies. Yellow arrowheads: Note 


































detected only in the ring gland (n=1, Figure 3.7). 
 
3.2.2.2 Immunostainings of Anti-DNT2 Antibodies 
 
Dr A. Hidalgo, Dr J. Wentzell and the author started out immunohistochemistry work using 
anti-DNT2s in embryonic, adult and larval CNS, respectively. Immunostaining in embryos 
turned up with signal from all three anti-DNT2 antibodies (Figure 3.8), of which the most 
meaningful result came from staining with anti-DNT2-GYN. Anti-DNT2-GYN revealed 
revealed signal in the CNS, muscle, epidermal stripes and trachea (Dr A. Hidalgo & Dr J. 
Wentzell, personal communication). In the larval CNS, wisplike tracheal ganglionic branch 
(GB) was observed in the brain lobes and VNC (n=3, Figure 3.9C). No signal was observed in 
the adult brain by Dr J. Wentzell (personal communication). For the remaining two antibodies, 
anti-DNT2-ALN and anti-DNT2-KRL, immunohistochemical attempts had been made in the 
adult brain. Anti-DNT2-ALN did not yield signal while anti-DNT2-KRL revealed brain 
signal (Dr J. Wentzell, personal communication). Anti-DNT2-ALN staining revealed signal in 
the embryonic CNS, muscle and fat body. In the larval neuropile of yw central brain and VNC, 
anti-DNT2-KRL revealed strong puncta (n=3, Figure 3.10A’ and B’). There were also signal 
surrounding the surface edges of the CNS. The puncta and CNS surface signals were 
reproduced in the VNC neuropile of dnt237/Df(3L)Exel6092, indicating that anti-DNT2-KRL 
is not specific (n=1, Figure 3.10B’’). In genotype pdf>DNT2-CK-6A, ectopic symmetrical 
pair of cells furthest from the brain lobe commissure were detected (n=9, Figure 3.10A’’), 
indicating that anti-DNT2-KRL can detect endogenous DNT2. 
 
Next, yw CNS was stained with anti-DNT2-KRL and commercial anti-Fasciclin-II (anti-FasII)   
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Figure 3.7 Expression of myr-tdTomato under dnt2-GAL4. Signal of endogenous myr-
tdTomato was amplified by labelling with anti-dsRed and Alexa Fluor 647® antibodies 











Figure 3.8 Raising polyclonal antibodies against DNT2 using ALN, GYN and KRL peptides. 
(A) DNT2 protein illustrated in the direction of N-terminus to C-terminus. SP: signal peptide. 
ALN, GYN and KRL are 23-, 18- and 12-mer amino acid sequences in the CysKnot domain,
respectively. (B) Model of DNT2 protein by J. Aurikko and N. Gay. The quaternary structure 
is made of two DNT2 monomers, one in green and one in red. In the red monomeric structure, 
the ball and stick model represents the polypeptides from sequences of the ALN peptide to






Figure 3.9 Staining of larval CNS with anti-DNT2-GYN antibodies. (A) Maximum 
projections of dorsal CNS in longitudinal view. (B) Maximum projections of medial CNS in 
longitudinal view. (B’ inset) Maximum projections of abdominal VNC in reconstructed 
transverse view. Genotype: yw (n=3). White arrowheads: Tracheal signal. Yellow 
arrowheads: Corresponding tracheal ganglionic branching in the VNC. Cyan dashed path: 
Trace of a tracheal branch. Scale bars in (A) and (B) represent 50μm. Scale bars along x- and 











Figure 3.10 Detection of DNT2 protein using anti-DNT2-KRL antibodies. Maximum 
projections of: (A) medial BLs in longitudinal view, and (B) medial VNC in longitudinal 
view. Genotypes: yw (n=3), dnt237/Df(3L)Exel6092 (n=1) and pdf>DNT2-CK (n=9). Images 
were acquired using the 488nm laser with identical laser power and PMT settings, then 
processed using ImageJ and Photoshop. White asterisk: Ectopic signal. Yellow asterisks: 
Corresponding cell clusters. Magenta asterisks: Corresponding punctate clusters. Scale bars














to characterise and map the antibody pattern (Landgraf et al., 2003). DNT2 protein was 
distributed along the dorsal-lateral (DL) and dorsal-median (DM) neurons (n=2, Figure 3.11A 
and B). The puncta longitudinally along the DL is adjacently ventral to the DL tracts in the 
first two abdominal segments (Figure 3.11C). Most of the puncta are deposited along the 
centre axis of the neuropile in the transverse section (Figure 3.11C). The medial puncta 
clustered with the DM as well as the dorsal split of the ventral median fascicles (VMd) 
(Figure 3.11C).  
 
3.2.3 Expression Pattern of spz in the Larval CNS 
 
3.2.3.1 Patterns of spz-GAL4 
 
The 10xUAS-myr-dTomato reporter signal under the control of spzGAL4 (n=2) was stronger 
than UAS-mCD8-GFP (n=2), as exemplified by the signal intensity in the surface perineurium 
layer (Figure 3.12A). The perineurium layer was revealed all over the surface of the CNS 
except where the optic stalk enters the brain lobes (Figure 3.12B’’’). Also, the neuropile 
signal in the central brain and thorax appeared sparser than that in the abdomen (Figure 
3.12B’). The transverse view revealed that the denser neuropile signal in the abdomen than in 
both the thorax and central brain visually correlated with the increase of labelled cell bodies 
(Figure 3.12B’’).  
 
3.2.3.2 Patterns of spzMi08633 
 
There are two Mi{MIC} insertions into spz, one into the first intron and another into the 3’   
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Figure 3.11 Staining of anti-DNT2-KRL with anti-FasII. Maximum projections of: (A) 
thoracic VNCs in longitudinal view, (B) abdominal VNCs in longitudinal view, and (C) 
abdominal VNCs in reconstructed transverse view. Genotype: yw (n=2). D, d=dorsal;


































Figure 3.12 Expression of mCD8-GFP and myr-tdTomato under spz-GAL4. (A) Maximum 
projections of whole stack larval CNS. Genotypes: spz>mCD8-GFP (n=2) and spz>myr-
tdTomato (n=2). Signal of endogenous GFP and myr-tdTomato were amplified by labelling 
with anti-GFP+Alexa Fluor 488® and anti-dsRed+Alexa Fluor 647® antibodies, 
respectively. (B) Maximum projections of spz>myr-tdTomato in (B’) medial longitudinal, 
(B’’) reconstructed transverse, and (B’’’) ventral longitudinal views. In (B’’), the volume 
occupied by the squashed brain lobes reflects the distance between the coverslip and 
microscope slide, accounting for the deformed look of the brain lobes in comparison to the 
VNC (T1-T3, A1-A8/9). Scale bars in (A), (B’) and (B’’’) represent 50μm. Scale bars along 








untranslated region (UTR) (Figure 3.13A). EGFP was found in some cell bodies in the brain 
lobes and VNC, particularly obvious in the dorsal planes (n=2, Figure 3.13B). The strongest 
GFP signal was in the VNC neuropile in a tract-like manner while EGFP appeared to be 
absent from the optic lobe region (Figure 3.13B). The EGFP tract was located contiguously in 
the ventral neuropile (Figure 3.13B). The tract is connected to the peripheral nerves, 
suggested by the presence of EGFP in lateral nerves relatively ventral in the lateral thoracic 
cortex and relatively more dorsal in the lateral abdominal cortex (Figure 3.13B and C). 
 
3.2.3.3 Immunostainings of Anti-Spz Antibodies 
 
No specific signal was obtained from anti-Spz-ASIK staining (n=1, Figure 3.14 and Figure 
3.15). With anti-Spz-GRL (Figure 3.14), a pair of cells in the brain lobes as well as tracts 
within the neuropile of the VNC and SEG were detected (n=3, Figure 3.16A). The prominent 
tract signal derived from anti-Spz-GRL persisted in the genotype spzMA05/Df(3R)Exel6205 
(n=1, Figure 3.16B). It also persisted in knockdowns of spz (genotype: elav>spzHMS01178 and 
repo>spzHMS01178 (n=1, Figure 3.16C; n=1, Figure 3.16D). There was an absence of any 
obvious ectopic signal in larval overexpression of activated Spz (actSpz(2)) using repo-GAL4 
(n=2, Figure 3.16E).  
 
3.2.3.4 Combination of GAL4 Reporter, Mi{MIC}-EGFP and Antibody Patterns 
 
Using spz>myr-tdTomato, most of the reporter signal in the neuropile overlapped with 
BP102-positive areas (n=6, Figure 3.17). There was a lack of signal in a specific area of the 








Figure 3.13 Detection of GFP signal in spzMi08633. (A) Illustration of the spz gene and 
transcript adapted from FlyBase. Spz is oriented in minus orientation along the 5’ to 3’ 
chromosomal strand. The Mi{MIC} insertion of spzMi08633 took place into the first intron of the 
coding region of spz in minus direction to the gene. Mi{MIC} of spzMi02318 was into the 3’ 
UTR in plus orientation. FlyBase reports that the Spz transcript exists in eight isoforms with 
four exons having their length conserved across all eight isoforms and the remaining exons 
differing in splicing locations. Grey pentagon=variable length in UTR. Filled grey rectangle= 
fixed length in UTR. Filled orange rectangle=length of exon conserved across the eight 
isoforms. Unfilled orange rectangle=exonic regions which are subjected to alternative 
splicing. GFP pattern in maximum projections of (B) longitudinal view, and (C) 
reconstructed transverse view. Signal of endogenous GFP was amplified by labelling with 
anti-GFP and Alexa Fluor 488® antibodies (n=2). T=thoracic segment, A=abdominal 
segment. White arrowheads: GFP signal in cell bodes. Yellow arrowheads: GFP signal 


















from GLR peptide to ASIK
Figure 3.14 Raising polyclonal antibodies against Spz using ASIK and GLR peptides. (A) 
Spz protein illustrated in the direction of N-terminus to C-terminus. SP: signal peptide. 
GLR and ASIK are 14- and 9-mer amino acid sequences in the CysKnot domain,
respectively. (B) Model of Spz protein by J. Aurikko and N. Gay. The quaternary structure 
is made of two Spz monomers, one in green and one in red. In the red monomeric structure, 




Figure 3.15 Staining of larval CNS with anti-Spz-ASIK antibodies. Maximum projections of 




Figure 3.16 Detection of Spz protein using anti-Spz-GLR antibodies. (A) Anti-Spz-GLR 
staining in yw (n=3). Maximum projections of (A’) medial BLs in longitudinal view, (A’’) 
medial VNC in longitudinal view, and (A’’’) abdominal segments A1 and A2 in reconstructed
transverse view. Anti-Spz-GLR staining in (B) spzMA05/Df(3R)Exel6205 (n=1, confocal 
image), (C) elav>spzHMS01178 (n=1, confocal image), (D) repo>spzHMS01178 (n=1, confocal 
image) and (E) repo>actSpz (n=2, non-confocal image). Confocal images were acquired 
using the 488nm laser with identical laser power and PMT settings, then processed using 
ImageJ and Photoshop. White arrowheads: signal in cell bodies. Scale bars in (A’) and 
(A’’) represent 50μm. Scale bars Scale bars along x- and y-axes in (A’’) represent 25μm and 


















Figure 3.17 Characterising spz>myr-tdTomato with anti-BP102 staining. Signal of 
endogenous myr-tdTomato was amplified by labelling with anti-DsRed and Alexa Fluor 
647® antibodies (n=6). Maximum projections of (A) medial thoracic VNC in longitudinal 
view, (B) thoracic segment T3 in reconstructed transverse view, (C) medial abdominal VNC 
in longitudinal view, and (D) abdominal segment A1 in reconstructed transverse view. White
arrowheads: BP102-negative areas in the ventral neuropile, which corresponds to the central 
input areas of the mechanosensory axon terminals. Scale bars in (A) and (B) represent 20μm. 
















GLR pattern in the neuropile complemented anti-BP102 staining (n=2, Figure 3.18). Anti-
Spz-GLR also complemented the neuropile signal in spz>myr-tdTomato (n=2, Figure 3.19). 
EGFP of spzMI08633 fit into the areas unoccupied by myr-tdTomato in spz>myr-tdTomato (n=3, 
Figure 3.20).  
 
In the thorax of spz>myr-tdTomato, the myr-tdTomato fascicles run alongside the dorsal-
lateral (DL) and centre-intermediate (CI) neurons (n=4, Figure 3.21). No myr-tdTomato cells 
appeared to be FasII+ cells (Figure 3.21). In the abdomen, the area lacking myr-tdTomato 
signal in the ventral neuropile is below the centre axis (Figure 3.21B and D) Anti-Spz-GLR 
could cluster with CI neurons in the thorax (n=4, Figure 3.22B) but this was not obvious in 
the abdomen (Figure 3.22D). It is clear from the abdominal sections that the Spz protein 
distribution was below the centre axis of the neuropile, and in between the ventral lateral (VL) 
and ventral-median (VM) fascicles (Figure 3.22D).  
 
Anti-Spz-GLR signal was distributed in synaptic rich zones which were labelled with anti-
nc82, the antibody targeting Bruchpilot, an active zone protein (n=2, Figure 3.23). In 
alrm>mCD8-GFP, in which the interface glia (IG) was labelled, anti-Spz-GLR signal 
appeared to be distributed directly above the ventral IG (vIG) cells in both the thorax and 
abdomen (Figure 3.24B and D). Anti-Spz-GLR signal also met where vIG processes project 
into the neuropile (Figure 3.24B and D).  
 
Anti-GS2 staining of genotype spz>myr-Tomato, the interface between the dorsal neuropile 
and perineurium was clearly distinguished (n=3, Figure 3.25B and D). Additionally, it was   
Figure 3.18 Characterising anti-Spz-GLR pattern with anti-BP102 staining. Maximum 
projections of (A) medial thoracic VNC in longitudinal view, (B) thoracic segment T3 in 
reconstructed transverse view, (C) medial abdominal VNC in longitudinal view, and (D) 
abdominal segment A1 in reconstructed transverse view. Genotype: yw (n=2). White
arrowheads: BP102-negative areas in the ventral neuropile, which corresponds to the 
central input areas of the mechanosensory axon terminals. Scale bars in (A) and (B) represent 
















Figure 3.19 Characterising spz>myr-tdTomato with anti-Spz-GLR staining. Maximum 
projections of (A) medial thoracic VNC in longitudinal view, (B) thoracic segment T3 in 
reconstructed transverse view, (C) medial abdominal VNC in longitudinal view, and (D) 
abdominal segment A1 in reconstructed transverse view. Genotype: spz>myr-tdTomato (n=2).
White arrowheads: Areas in the ventral neuropile in which endogenous myr-tdTomato 
signal was absent. Scale bars in (A) and (B) represent 20μm. Scale bars along x- and y-axes 















Figure 3.20 Characterising spz>myr-tdTomato with spzMi08633. Signal of endogenous GFP was 
amplified by labelling with anti-GFP and Alexa Fluor 488® antibodies (n=3). Maximum 
projections of (A) medial thoracic VNC in longitudinal view, (B) thoracic segment T3 in 
reconstructed transverse view, (C) medial abdominal VNC in longitudinal view, and (D) 
abdominal segment A1 in reconstructed transverse view. White arrowheads: Areas in the 
ventral neuropile in which endogenous myr-tdTomato signal was absent, and which also 
coincide with the GFP+ mechanosensory domain. Scale bars in (A) and (B) represent 20μm. 














Figure 3.21 Characterising spz>myr-tdTomato with anti-FasII staining. Signal of endogenous 
myr-tdTomato was amplified by labelling with anti-DsRed and Alexa Fluor 647® antibodies 
(n=4). Maximum projections of (A) medial thoracic VNC in longitudinal view, (B) 
thoracic segment T3 in reconstructed transverse view, (C) medial abdominal VNC in 
longitudinal view, and (D) abdominal segment A1 in reconstructed transverse view. D=dorsal;
C=centre; V=ventral; L=lateral; I=intermediate; M=median. Scale bars in (A) and (B) 

























Figure 3.22 Characterising anti-Spz-GLR pattern with anti-FasII staining. Maximum 
projections of (A) medial thoracic VNC in longitudinal view, (B) thoracic segment T3 in 
reconstructed transverse view, (C) medial abdominal VNC in longitudinal view, and (D) 
abdominal segment A1 in reconstructed transverse view. Genotype: yw (n=4). D=dorsal;
C=centre; V=ventral; L=lateral; I=intermediate; M=median. Scale bars in (A) and (B) 























Figure 3.23 Characterising anti-Spz-GLR pattern with anti-nc82 staining. This shows that the
anti-Spz-GLR signal in the mechanosensory domain is a synaptic area. Maximum projections 
of (A) medial thoracic VNC in longitudinal view, (B) thoracic segment T3 in reconstructed 
transverse view, (C) medial abdominal VNC in longitudinal view, and (D) abdominal 
segment A1 in reconstructed transverse view. Genotype: yw (n=2). Scale bars in (A) and (B) 
















Figure 3.24 Characterising alrm>mCD8-GFP with anti-Spz-GLR staining. This shows that 
the anti-Spz-GLR signal is in neurons, not glia, and deep in neuropile. Signal of endogenous 
GFP was amplified by labelling with anti-GFP and Alexa Fluor 488® antibodies (n=2). 
Maximum projections of (A) medial thoracic VNC in longitudinal view, (B) thoracic segment 
T3 in reconstructed transverse view, (C) medial abdominal VNC in longitudinal view, and 
(D) abdominal segment A1 in reconstructed transverse view. White arrowheads: Signal in 
ventral interface glia (vIG). Scale bars in (A) and (B) represent 20μm. Scale bars along x- and 

















Figure 3.25 Characterising spz>myr-tdTomato with anti-GS2 staining. This shows that the
myr-tdTomato signal is not expressed in glia, and is instead in neurons and within neuropile. 
Signal of endogenous myr-tdTomato was amplified by labelling with anti-DsRed and Alexa 
Fluor 647® antibodies (n=3). Maximum projections of (A) medial thoracic VNC in 
longitudinal view, (B) thoracic segment T3 in reconstructed transverse view, (C) medial 
abdominal VNC in longitudinal view, and (D) abdominal segment A1 in reconstructed 
transverse view. Scale bars in (A) and (B) represent 20μm. Scale bars along x- and 















clear that myr-Tomato was within the confines of the neuropile boundary marked by anti-GS2 
(Figure 3.25C). 
 
3.2.4 Expression Pattern of Toll, Toll6 and Toll7 in the Larval CNS 
 
Wandering larvae of G9, in which all axons are labelled with GFP, was stained with anti-Toll-
d300. In the brains lobes, anti-Toll-d300 revealed an unidentified cell cluster on the dorsal 
side, the outer proliferation centre (OPC) and the inner proliferation centre (IPC) (n=4, Figure 
3.26A). Within the thorax, there was signal in 3 pairs of single isolated processes. Staining in 
yw embryonic stage 17 brains revealed only a cluster consisting of four cells in each brain 
lobe (n=11, Figure 3.26B).  
 
Immunoreactivity against EGFP in Toll6Mi02127 revealed cortex cells in the VNC and signal in 
the central brain (n=5, Figure 3.27). The immunoreactivity against Toll7 using anti-Toll7-
AAQ revealed neuropile signal in the VNC, central brain, lamella/medulla and ring gland 




Three tools were used to visualise gene expression patterns in this chapter: (1) GAL4 reporter 
lines, (2) Mi{MIC}-EGFP lines, and (3) a set of antibodies against all the protein of interests, 




Figure 3.26 Staining of larval CNS with anti-Toll-d300 antibodies. (A) Anti-Toll-d300 
pattern in maximum projections of longitudinal view. Genotype: G9 (n=4, wandering stage). 
(B) Anti-Toll-d300 pattern in maximum projection of whole stack CNS in longitudinal view.
Genotype: yw (n=11, embryonic stage 17). Dissected embryonic brains were a gift of Dr M. 
Losada. White arrowheads: Signal in unidentified cell cluster. Yellow arrowhead: Signal in 
IPC. Cyan arrowheads: Signal in OPC. Green arrowheads: Signal in isolated unbranched 













Figure 3.27 Detection of GFP signal in Toll6Mi02127. (A) Illustration of the Toll6 gene and 
transcript adapted from FlyBase. Toll6 is oriented in plus orientation along the 5’ to 3’ 
chromosomal strand. The Mi{MIC} insertion of Toll6Mi02127 took place into the exon of Toll6 
in plus direction to the gene. Flybase reports that the Toll6 transcript exists in three isoforms 
with the 5’ UTR and exon lengths conserved across all three isoforms. Grey pentagon= 
variable length in 3’ UTR. Filled grey rectangle=fixed length in 5’ UTR. Filled orange 
rectangle=length of exon conserved across the three isoforms. (B) GFP pattern in maximum 
projections of longitudinal view. Signal of endogenous GFP was amplified by labelling with 

















Figure 3.28 Staining of larval CNS with anti-Toll7-AAQ antibodies. Maximum projections of 





3.3.1 Limitations of GAL4 Reporters 
 
The following GAL4-UAS crosses were set up: dnt1>mCD8-GFP, dnt2>myr-tdTomato, 
spz>myr-tdTomato. In each case, there was reporter signal.  
 
Under the regulatory sequences of dnt1, GFP were detected in the ventral neuropile as 
longitudinal tracts. This GFP tract pattern would not match the diffused dnt1 transcript signal 
in the thoracic cortex (Sutcliffe, 2011; Zhu et al., 2008). Other than background signal in the 
VNC, myr-tdTomato reporter was detected strongly in the ring gland under the regulatory 
control of dnt2. So far dnt2 transcripts have been reported to be restricted to the larval eye-
antenna disc attached outside of the CNS (Sutcliffe, 2011). Therefore, the results from dnt2-
GAL4 and dnt2 mRNA so far matched.  
 
There was abundant myr-tdTomato signal in the neuropile and surface CNS under the 
regulatory control of spz. This would match the spz transcript localisation in the central brain 
and VNC, except virtually no reporter signal was observed under spz-GAL4 in the larval optic 
lobe, where spz transcripts have been detected (Sutcliffe, 2011).  
 
The use of GAL4 reporters can either be as an enhancer construct line or as an enhancer trap 
line. Dnt1-, dnt2- and spz-GAL4 are examples of enhancer trap line. The full working 
knowledge of all the enhancer elements for dnt1, dnt2 and spz are yet fully known. The 
intergenic region betweent dnt1 and tie were fully cloned, but this was not the case for dnt2 
and spz. Regulatory elements for dnt2 and spz which might have been missed could be outside 
of the cloned region. Although this is not the case for dnt1, it is conceivable that there could 
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be regulatory elements elsewhere and also in the intronic regions of dnt1, of which dnt1 has at 
least three introns in four out of seven of its isoforms.  
 
Following transformation of the enhancer construct into the fly genome, the expression of 
GAL4 is subjected to a positional effect, whereby identical constructs have different levels of 
expression according to their genomic insertion sites. Different levels of expression could 
arise due to each genomic locus displaying its own transcriptional base-level as well as degree 
of chromosomal condensation. Effectively, the regulation of the gene of interest could be lost 
and no longer applicable to the regulation of the enhancer construct GAL4.  
 
GAL4 could be designed to be incorporated into the locus of the gene of interest, downstream 
of the enhancer element and upstream of the gene of interest, that is, to design an enhancer 
trap line, but this could with its own drawback that the inserted construct might disrupt 
expression of the gene of interest.  
 
3.3.2 Limitations on Mi{MIC}-EGFP Lines 
 
Despite the claim that Mi{MIC} insertions do not appear to disturb protein function much 
(Venken et al., 2011a), there is no empirical evidence for this. For example, in the case of the 
Mi{MIC} insertion in Toll6Mi02127, the insertion took place into an intronless gene. However, 
for the purpose of GFP expression from the endogenous loci of Toll6 and spz, the use of 




EGFP expressed in spzMi08633 is restricted to the central brain in the brain lobes, some cells on 
the dorsal side of the VNC and a pair or ventral tracts in the VNC neuropile (Figure 3.13). 
The fly line spzMi02318 has yet to be purchased and tested.  
 
The EGFP from the Toll6 locus in Toll6Mi02127 belonged to cortex cells in the VNC and signal 
in the central brain (Figure 3.27). By comparing the EGFP pattern of Toll6Mi02127 to DsRed 
signal under the control of D42-GAL4 motoneuron reporter, the author found EGFP and 
DsRed to colocalised in the aCC motorneurons on the dorsal-median side of the VNC 
(McIlroy et al., 2013).  
 
3.3.3 Summary on Anti-DNT1 Antibodies 
 
Anti-DNT1-RRPQ was not a specific antibody (Figure 3.4). Neither was anti-DNT1-VRY 
(Figure 3.6). Nonetheless, the anti-DNT1-VRY pattern resembled the dnt1-GAL4 pattern 
more than the anti-DNT1-RRPQ pattern. Additionally, anti-DNT1-VRY detected 
overexpressed DNT1-CK-3’+ protein in an over-expression genotype. Therefore, anti-DNT1-
VRY was more likely to reveal the endogenous pattern of DNT1 than anti-DNT1-RRPQ. 
 
Ideally, in the testing of antibody specificity, an optimised signal is obtained in a positive 
control while the optimised signal is lost in a negative control. In embryonic wild-type, anti-
DNT1-VRY reproduced the endogenous pattern of dnt1 transcripts in the ventral midline and 
muscle. These patterns were absent from anti-DNT1-VRY embryonic stainings in the 
homozygous null mutant dnt141 (McIlroy et al., 2013). It is not understood why dnt141/ 
Df(3L)Exel6101 larval CNS retained the optimised anti-DNT1-VRY staining, which was 
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acquired using identical laser power and PMT settings to the yw control. One possibility 
which has yet to be eliminated is whether or not the Df(3L)Exel6101 chromosome truly do not 
carry the dnt1 gene. This is because the genotype of Df(3L)Exel6101 has yet to be verified by 
PCR or inverse PCR in the Hidalgo lab. A similar situation presented itself with anti-DNT2-
KRL larval staining in genotype dnt237/Df(3L)Exel6092. Df(3L)Exel6092 has yet to be 
verified too.  
 
3.3.4 Summary on Anti-DNT2 Antibodies 
 
Anti-DNT2-GYN stained for the trachea in embryos and in larva. In the VNC, the tracheal 
ganglionic branch (GB) was identified by the anti-DNT2-GYN (Figure 3.9), because the 
signal pattern matched a well-characterised route in tracheal patterning in the Drosophila 
nervous system (Englund et al., 1999; Pereanu et al., 2007; Uv et al., 2003). The GB migrates 
into the VNC via peripheral nerves and then extends along the ventral neuropile. At the 
ventral midline, the GB turns and migrates dorsally. Upon reaching the dorsal side of the 
neuropile, GB then extends laterally or posteriorly or both. 
 
Anti-DNT2-ALN staining was not done on larval samples. The anti-DNT2-KRL antibody 
revealed signal in the neuropile of the central brain and VNC as well as in small cell clusters 
in the brain (Figure 3.10). Anti-DNT2-KRL signal also surrounded the surface of the CNS, 





The pattern revealed by anti-DNT2-GYN and anti-DNT2-KRL in the larval CNS were 
different from each other. However, given that anti-DNT2-KRL could detect ectopic signal in 
an overexpressing gain-of-function genotype (pdf>DNT2-CK-6A), this would suggest that it 
is the most likely antibody to reval the endogenous protein. Double staining of anti-DNT2-
KRL with anti-FasII revealed that DNT2 was distributed partly along mapped neurons and 
partly along other as yet unidentified neurons (Figure 3.11). 
 
The CysKnots of DNT1 and DNT2 were detected by anti-DNT1-VRY and anti-DNT2-KRL 
in a punctate manner in the neuropile. The punctate pattern was not observed in anti-Spz-GLR 
staining of Spz CysKnot.  
 
3.3.5 Summary on Anti-Spz Antibodies 
 
The spz>myr-tdTomato reporter showed cells which appear to send projections into most 
areas of the neuropile except for the innervation area of sensory chordotonal neurons (Figure 
3.12 and Figure 3.17). The lack of innervation in a specific area of the larval neuropile could 
make the spz-GAL4 an interesting transgenic for mapping nervous system circuitry. 
 
Similar to anti-DNT1-VRY and anti-DNT2-KRL, anti-Spz-GLR revealed signal in 
transheterozygous loss of function and knockdown mutants (Figure 3.16). However, anti-
DNT1-VRY and anti-DNT2-KRL were able to recognise overexpressed DNT1 and DNT2 
CysKnot epitopes, whereas anti-Spz-GLR did not reveal signal of overexpressed activated 
Spz (Figure 3.16). Despite this limitation, anti-Spz-GLR pattern instead matched the EGFP 
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pattern in spzMI08633 (Figure 3.19 and Figure 3.20). Therefore, anti-Spz-GLR probably 
represents the endogenous distribution of Spz.  
 
The anti-BP102 and anti-Spz-GLR patterns were complementary to each other (Figure 3.18). 
So were the spz>myr-tdTomato and anti-Spz-GLR patterns (Figure 3.19). Anti-Spz-GLR 
signal was found in synaptic rich area in the neuropile, and this reveals that anti-Spz-GLR 
detected a secreted protein (Figure 3.23). The myristoylated tdTomato reporter targets to the 
the membrane. Therefore, it remains possible that spz-GAL4 and anti-Spz-GLR are both 
compatible with the endogenous pattern of Spz. The Anti-Spz-GLR signal also met where 
vIG processes project into the neuropile (Figure 3.24), and this provides an interesting link to 
interactions between glia and mechanosensory neurons.  
 
3.3.6 Summary on Toll, Toll6 and Toll7 
 
Commercial anti-Toll-d300 staining in the CNS of the wandering larvae revealed the 
neuroepithelia at the inner and outer proliferation centres, a mass of unidentified cells on the 
dorsal side of the brain and a set of simple processes in the thoracic VNC (Figure 3.26). The 
set of simple process is akin to the pattern of the R15D11 GAL4 driver in Li et al. (2014). 
R15D11 revealed immature neuronal cells in arrest, which act as stockpile for future use in 
the adult (Li et al., 2014). The anti-Toll-d300 staining is not complementary with the anti-
Spz-GLR pattern. 
 
The anti-Toll-d300 staining in the embryonic stage 17 CNS was limited to a cluster of four 
cells in each brain lobe (Figure 3.26). This pattern differs from the published anti-Toll 
 
147 
staining of axon neuropile and midline glia in embryonic stage 15 CNS (Zhu et al., 2008). 
Other than the difference in development time, another reason which could account for the 
difference in staining pattern is that the published staining used a different anti-Toll antibody, 
which was a gift from Prof N. Gay. 
 
Anti-Toll7-AAQ staining in yw larval CNS revealed signal in the VNC, central brain, 
lamella/medulla and ring gland. The distribution of anti-Toll7-AAQ staining in the neuropile 
VNC and central, as well as the lamella/medulla, matched the expression pattern of Toll7 
transcripts, indicating that the protein pattern likely represent the distribution of the 
endogenous Toll7 receptor (McIlroy, 2012; McIlroy et al., 2013). Anti-Toll7-AAQ is specific 
because no signal could be detected in Toll7 null embryos or in deficiency embryos which 
lack the Toll7 gene (McIlroy et al., 2013). The anti-Toll-7 staining is compatible with the 
anti-Spz-GLR pattern. 
 
3.3.7 Assessing Antibody Quality 
 
The antibodies against the CysKnots of DNT1, DNT2 and Spz were not specific. Their use in 
immunohistochemistry on CNS tissue for the purpose of characterising endogenous 
distribution of proteins is not accurate. Whether or not these antibodies would be useful in in 
vitro assays, for example, to detect proteins in western blots, remains to be tested. 
 
The specificity of commercial anti-Toll-d300 will require further testing on negative controls. 
There is also another commercial anti-Toll antibody available from Santa Cruz Biotechnology. 









4.1.1 Existing dnt2 and spz Loss of Function Alleles 
 
There are existing suitable null stocks for dnt1 for studying loss of function effects, but none 
for dnt2 and spz. Dnt141 and dnt155 are null mutant alleles previously generated by 
homologous recombination, and it is homozygous viable (Zhu et al., 2008). Dnt2e03444 is a 
homozygous viable hypomorphic allele with a large 5.9kb transposon insert in its intronic 
region, after the exon encoding the signal peptide (Dos Santos et al., 2015). There is a 
possibility of the transposon insert being spliced out and excluded from the mature RNA for 
protein translation, effectively creating functional DNT2 protein. Spz2, spz3, and spz4 arose by 
the application of ethyl methanesulfonate (EMS) which resulted in point mutations in Spz 
(Tearle and Nusslein-Volhard, 1987; Weber et al., 2007). According to FlyBase, there is at 
least one secondary mutation annotated with each spz allele due to the unspecific mutagenic 
effect of EMS: “ca1” with spz2, “ru1st1ea14ca1” with spz3, and “ru1Diap1st1kniri-1rnroe-1ppe1” 
with spz4. Spz2ca1 is homozygous semi-lethal, while ru1st1ea14spz3ca1 and ru1Diap1st1kniri-
1rnroe-1ppe1spz4 are homozygous fully lethal (Zhu et al., 2008). Here, this chapter is about the 




4.1.2 Exelixis hsFLP-FRT Deletion 
 
The strategy adopted to generate null mutant alleles of dnt2 and spz is based on the 
Drosophila genome deletion strategy developed by Exelixis (Parks et al., 2004; Thibault et al., 
2004). The deletion works on the principle that transposons, which carry flippase recognition 
target (FRT) sites, the substrates of yeast flippase recombinase (FLP), are used to efficiently 
cause deletions with precise endpoints defined by the FRT sites (Golic and Golic, 1996). The 
Exelixis transposons available for precise Drosophila genome deletion are the P-element 
(P{XP}), piggyBac RB (PBac{RB}) and piggyBac WH (PBac{WH}) insertion lines (Parks et 
al., 2004). These 3 transposons differ among each other in terms of the following: (i) the 
number of FRT sites carried (either 1 or 2), (ii) the orientation of the FRT site(s) relative to 
the mini-white (w+m) construct within the transposon; and (iii) whether or not there is a UAS 
construct (Thibault et al., 2004). According to Parks et al. (2004), there is a selection criteria 
to meet in choosing the type of transposons (P{XP}/PBac{RB}/PBac{WH}) to flank the 
genomic region to be deleted, that is, the allowable pairs of Exelixis transposons must both 
have the FRT sites in the same orientation to each other for heat shock FLP (hsFLP) to act on. 
Successful genome deletion is accompanied by a leftover hybrid transposon (Figure 2.13A). 
Allowable pairwise combinations will ultimately result in either red- or white-eyed flies 
depending on whether or not the w+m was removed from the genome (Parks et al., 2004). 
Confirmation of successful genome deletion is provided by PCR (Figure 2.13B). Parks et al. 
(2004) estimated 5 white-eyed and 50 red-eyed fly lines to be screened by PCR to obtain 4 




4.1.3 Spz Loss of Function Alleles Affect Embryonic Dorsal-Ventral Polarity 
 
Spz is found in the perivitelline fluid space that surrounds a developing embryo (Morisato and 
Anderson, 1994; Schneider et al., 1994). The spz signal transduces across the cell membrane 
by binding and activating the Toll receptor, henceforth establishing the signalling which 
culminate in generating the dorsal-ventral (DV) polarity axis of the developing embryo 
(Morisato and Anderson, 1995; Weber et al., 2003). Females lacking spz activity produce 
dorsalised embryos that miss ventral and lateral structures in the cuticles (Anderson and 
Nusslein-Volhard, 1984; Morisato and Anderson, 1994). Therefore, to demonstrate if newly 
generated spz alleles are truly loss of function in nature, an assessment of embryonic DV 
polarity is necessary.  
 
4.1.4 Specific Aims 
 
The specific aims of this chapter are: 
∑ To generate a loss of function allele of dnt2 and spz by hsFLP-FRT deletion. 
∑ To classify any newly generated spz allele. 
∑ To characterise the viability of any newly generated dnt2 and spz allele.  
 
4.1.5 Methods in Brief 
 
The genetic protocols to generate a null mutant allele of dnt2 and spz were supplied in Figure 
2.10 and Figure 2.11, and these protocols were based on the genetic scheme designed by 
Parks et al. (2004) for hsFLP-FRT deletion of the Drosophila genome (Section 2.1.4). For 
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generation of a dnt2 loss of function mutant allele, the allowable pairwise combination of 
Exelixis transposons chosen was between PBac{RB}dnt2e03444 at the lower coordinate and 
P{XP}d05170 at the upper coordinate (Figure 4.1). For new spz allele, the combination 
consisted of the P{XP}spzd00069 and PBac{RB}e04446 at the lower and upper coordinate, 
respectively (Figure 4.2). Putative transposon hybrids dnt2e03444/d05170 and spzd00069/e04446 were 
tested by PCR (Section 2.2.2).  
 
To determine whether or not any newly generated spz allele results in loss of function, cuticle 
preparations of unhatched embryos were made to observe dorsal-ventral polarity (Section 
2.5.1).  
 
The viability of any newly generated dnt2 and spz allele were examined using survival index 
(Section 2.1.5).  Chi-square test (χ2) was used to compare the observed ratio of Tb+ and Tb- 
pupal cases to the expected Mendelian ratio, as well as the observed ratios of Tb+ and Tb- 
from two test crosses (Section 9.1). For χ2 test between two crosses, Bonferroni post hoc 




4.2.1 Generating a dnt2 Loss of Function Allele  
 
A total of 21 putative hybrid dnt2e03444/d05170 fly lines were established (Figure 2.10). Of these 
















Figure 4.1 Exelixis transposons for generating a dnt2 loss of function mutant allele (adapted 
from FlyBase, Parks et al. (2004) and Thibault et al. (2004). (A) The dnt2 gene, in minus 
orientation, is located along chromosomal arm 3L in cytogenetic location 63A1 from 
sequence 2,883,638 to 2,892,164. PBac{RB}dnt2e03444 and P{XP}d05170 were selected as the 
flanking pair of starting insertions to delete the genomic region between them. Such a 
deletion will remove the start codon of the coding sequence (CDS). PBac{RB}dnt2e03444 is the 
lower coordinate transposon between the two; it is inserted into the intronic region of dnt2 at 
sequence 2,887,990 while P{XP}d05170 is inserted into the genome outside of dnt2’s gene 
span at sequence 2,892,453. Flybase reports only one isoform for the dnt2 gene. (B) 
PBac{RB}dnt2e03444 and P{XP}d05170 are transposons inserted the fly genome in minus 
orientation. The cis recombination in P-element XP occurs earlier than the trans 
recombination between XP and piggyBac element RB (Parks et al., 2004). Their genomic 
orientation and position of the mini-white (w+m) gene allows for deletion to be initially 











Figure 4.2 Exelixis transposons for generating a spz loss of function mutant allele (adapted 
from FlyBase, Parks et al. (2004) and Thibault et al. (2004). (A) The spz gene of minus 
orientation is located along chromosomal arm 3R in cytogenetic location 97E1 from 
sequence 22,890,712 to 22,895,792. P{XP}spzd00069 and PBac{RB}e04446 were chosen to be 
recombined to delete the genomic region spanning between them, including the start codon 
of the coding sequence (CDS). P{XP}spzd00069 and PBac{RB}e04446 are inserted into the 
intronic region of spz at sequence location 22,893,329 and outside of spz’s gene span at 
22,896,645, respectively. Flybase reports that Spz transcript exists in eight isoforms. Grey 
pentagon=variable length in UTR. Filled grey rectangle=fixed length in UTR. Filled orange 
rectangle=length of exon conserved across the eight isoforms. Unfilled orange rectangle= 
exonic regions which are subjected to alternative splicing.(B) Due to P{XP}spzd00069  and 
PBac{RB}e04446 both being inserted in plus orientations, deletion can be screened by 













step undertaken was to eliminate as many non-hybrid lines as possible, and so the 
homozygous viable lines were tested by PCR first. Internal PCR was possible in homozygous 
flies only, whereby primers deleteGP fwd and deleteGP rev bind to the genomic region in 
between the PBac{RB}dnt2e03444 and P{XP}d05170 insertions (Table 2.2; Figure 4.3A). 
HsFLP-FRT deletion would have been unsuccessful if the genomic region between 
PBac{RB}dnt2e03444 and P{XP}d05170 was still present in the fly line – this would be shown 
by the presence of a 195bp band amplified between primers deleteGP fwd and deleteGP 
(Table 2.2; Figure 4.3A). The 195bp band was detected in all the 14 homozygous viable fly 
lines so these stocks were thrown away (Figure 4.3B).  
 
Internal PCR cannot be used to confirm deletions in the remaining 7 homozygous lethal lines 
because of the presence of the balancer chromosome, so other PCR strategies detailed in 
Figure 2.13 were adopted. Hybrid PCR using primers Tn1 fwd and Tn2 rev under a gradient 
temperature PCR program yielded either absent or spurious bands of unexpected fragment 
sizes (data not shown; Table 2.2). Genomic PCR using primers GP fwd and GP rev gave rise 
to a 5.2kb band across all the 7 remaining fly lines (Figure 4.3C). The 5.2kb bands were 
derived from the balancer chromosome and were expected to be present, but 3.1kb bands, 
which would have been obtained if hsFLP-FRT deletion had been successful, were missing 
(Figure 4.3C; Table 2.2). This suggests that there were no successful hsFLP-FRT deletion to 
generate the hybrid dnt2e03444/d05170. 
 
Despite the results of the genomic PCR on the putative hybrid dnt2e03444/d05170 fly lines, further 
investigation using two-sided and genomic PCR were done on the Exelixis lines 
PBac{RB}dnt2e03444 and P{XP}d05170 (Figure 4.4A; Table 2.2), especially since the hsFLP-   
Figure 4.3 PCR confirmation of putative dnt2e03444/d05170 loss of function alleles. (A) Primer 
sites of deleteGP fwd, deleteGP rev, GP fwd and GP rev (Table 2.2). (B) Internal PCR using 
primers deleteGP fwd and deleteGP rev on homozygous viable lines 1-14. There were 
irrelevant lanes present because of different PCR experiments occupying the same gel. The 
100bp DNA ladder (New England Biolabs) were used throughout gels. (C) Genomic PCR
using primers GP fwd and GP rev on homozygous lethal lines 1-7. There were irrelevant 
lanes due to the DNA template being extracted and used for PCR before the fly lines died 



















































































Figure 4.4 Verification of transposon insertion at the correct location for the Exelixis lines 
that were selected for the purposes of generating a dnt2 FLP-FRT-based deletion allele. (A) 
Primer sites of GP fwd, Tn1 rev and GP rev (Table 2.2). (B) Left-hand side of two-sided PCR 
using primers GP fwd and Tn1 rev on putative dnt2e03444/d05170 homozygous lethal lines 1-7. 
The 100bp DNA ladder (New England Biolabs) was used. (C) Genomic PCR using primers 
GP fwd and GP rev on P{XP}d05170. The 1kb DNA ladder (New England Biolabs) was used.
B homozygous lethal lines
















FRT based deletion strategy has proven to be predictable, precise and efficient (Parks et al., 
2004). As observed by Parks et al. (2004), it was supposedly sufficient to test 5 putative w- 
lines. The PBac{RB}dnt2e03444 flies were shown to carry its piggyBac element in the correct 
location as evidenced by the left-hand side of the two-sided PCR (Figure 4.4B). All the 
homozygous lethal lines carried the piggyBac element too (Figure 4.4B). 
 
Genomic PCR of DNA extracted from P{XP}d05170 flies yielded a 5.2kb band, suggesting 
that the P-element XP was not inserted outside of dnt2’s gene span at sequence 3L: 2,887,453 
(Figure 4.4A; Table 2.2). To confirm the whereabouts of the P-element XP insertion, inverse 
PCR was deployed by directing nested primer pairs against circular fragments of 
P{XP}d05170 DNA (Figure 4.5A; Section 2.2.3). There were two rounds of PCR: the first 
used primers 51A and 51B, and the second 52A and 52B (Figure 4.5A; Table 2.4). The 
resulting single specific PCR band was extracted, purified and sent for sequencing with 
sequencing primer XP-5SEQ (Figure 4.5A and B; Table 2.4). The sequencing output was used 
as a query in BLAST against the D. melanogaster genome (Figure 4.5C). P-element XP of 
Exelixis line P{XP}d05170 was reported in FlyBase to be inserted in cytogenetic location 
63A1 along chromosomal arm 3L. However, BLAST returned significantly matching 
sequence within the Ectoderm-expressed 4 (Ect4) gene at cytogenetic location 66B5 of the 
same chromosomal arm (Figure 4.5D), at least 5 million nucleotides away from dnt2. The 
sequences were found flanking the P{XP}Ect4d04977 transposon element instead. To conclude, 
no new dnt2 allele was generated in this project because the Exelixis P{XP}d05170 fly line 























Figure 4.5 Inverse PCR of the 5’ end of P{XP} elements. (A) Primers used for inverse PCR 
to recover the sequences flanking the 5’ end of P{XP}d05170 (Table 2.4). (B) Preparative gel 
electrophoresis of DNA products after inverse PCR. The 100bp DNA ladder (New England 
Biolabs) was used.(C) Sequencing output used as the query in BLAST. (D) Screenshot of the 
genome browser view from FlyBase for D. melanogaster. BLAST match the sequence 
flanking the 5’ end of P{XP}d05170 to the Ectoderm-expressed 4 (Ect4) gene.  
C
TGA TAA GTG TAT ACT TCG GTA AGC TTC GGC TAT CGA CGG GAC
CAC CTT ATG TTA TTT CAT CAT GCG TGG GAG CTT GGC AGC TCG
AGA GCT TTT TCA TTG CGG TCG CGT CGC TGC CGG CGT CGT TTT
AAA GTG CGA TCT CTG CAG CCC GGG AGG ACC TAA CGC ACA GTC
ACG TTA TTG TTT ACA TAA ATG ATT TTT TTT ACT ATT CAA ACT






4.2.2 Generating a spz Loss of Function Allele  
 
Learning from experience, prior to setting up genetic crosses to generate a new spz allele 
(Figure 2.11), Exelixis flies P{XP}spzd00069 and PBac{RB}e04446 were first verified for 
insertions at correct locations by two-sided PCR (Figure 4.6A). Using primers GP fwd and 
Tn1 rev on DNA template extracted from P{XP}spzd00069, a DNA band of 354bp was expected 
to be amplified (Figure 4.6A, Table 2.3). With primers Tn2 fwd and GP rev on DNA from 
PBac{RB}e04446, a band of 670bp was expected (Figure 4.6A, Table 2.3). The expected band 
sizes were obtained using conventional PCR for both P{XP}spzd00069 and PBac{RB}e04446 
(Figure 4.6B). Subsequently, the conditions for two-sided PCR in amplifying the 354 and 
670bp bands from P{XP}spzd00069 and PBac{RB}e04446 DNA were used as positive controls 
to determine the generation of the hybrid spzd00069/e04446. Out of the 17 putative hybrid 
spzd00069/e04446 fly lines, 15 of these yielded positive bands of the correct sizes for two-sided 
PCR (Figure 4.6C). Therefore, 15 fly lines were confirmed to have the hybrid spzd00069/e04446. 3 
out of the 15 fly lines were kept and maintained as fly stocks and given the following 
genotype labels: w-;;spzMA05/TM6B (stock no. 24, Table 2.1), w-;;spzMA10/TM6B (stock no. 25, 
Table 2.1) and w-;;spzMA12/TM6B (stock no. 26, Table 2.1).  
 
4.2.3 Cuticle Prep to Test for spz Loss of Function Phenotype 
 
In unhatched yw embryos, the normal anterior-posterior and dorsal-ventral axes were 
established (Figure 4.7A). Segmentation of the larval body wall into thoracic and abdominal 
segments was also normal as indicated by the presence of the ventral denticle bands. Females 






































Figure 4.6 Determination of putative spzd00069/e04446 loss of function alleles. (A) Primer sites of 
GP fwd, Tn1 rev, Tn2 fwd and GP rev (Table 2.3). (B) Verification of transposon insertion at 
the correct location using two-sided PCR. The left-hand side was used for P{XP}spzd00069 and 
the right side for PBac{RB}e04446. (C) Two-sided PCR confirmation of 17 fly lines with 























































































Figure 4.7 Cuticle preparations to observe dorsal-ventral phenotype. (A) 5 individuals of 
positive control yw. PS: posterior spiracles. (B) 5 unviable individuals of the F2 
generation originating from F1 spz
2ca1/Df(3R)Exel6205 females crossed to Df(3R)Exel6205/
TM6B males. (C) 5 unviable F2 individuals as a result of F1 spz
MA05/Df(3R)Exel6205 females 
crossed to Df(3R)Exel6205/TM6B males. Scale bar represents 250μm. 
T1 T2 T3 A1 A2 A3 A4 A5 A6A7A8
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ventral view
T1 T2 T3 A1 A2 A3 A4 A5 A6 A7 A8
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lateral view
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spzMA05/Df(3R)Exel6205 were viable and were able to lay eggs, but the eggs never hatch. 
Unhatched offspring of spz2ca1/Df(3R)Exel6205 females exhibited perturbed morphology 
with respect to their DV polarity (Figure 4.7B). There were virtually no clear denticle bands 
because the embryos were dorsalised. Unhatched offspring of  
spzMA05/Df(3R)Exel6205 females also exhibited perturbed polarity lacking denticle bands 
(Figure 4.7C). The embryos differentiated an elongated hollow tube of dorsalised cuticle akin 
to those laid by spz2ca1/Df(3R)Exel6205 females. To conclude, both spz2 and spzMA05 are loss 
of function alleles. 
 
4.2.4 Lethality of spz2 and spzMA05 Allele 
 
The survival index (SI) of spz2ca1 over TM6B was 0.14 (Figure 4.8), indicating that the alleles 
were homozygous semi-lethal (n=1393, χ2(1)=455.088, p<0.001), and that the alleles reduced 
the viability of larval homozygotes surviving. Only 6.4% of larval population survive as 
homozygotes into pupal stages. When heterozygote spz2ca1 females were crossed to 
heterozygote ru1st1ea14spz3ca1 males, the SI of spz2ca1 larvae was 1.06 (n=876, χ2(1)=0.622, 
p=0.430), indicating that the alleles were rescued and corresponded to the Mendelian 
segregation of wild-type chromosome. Heterozygote spz2ca1 crossed to heterozygote 
ru1Diap1st1kniri-1rnroe-1ppe1spz4 improved SI to 1.36, significantly beyond rescued levels 
(n=250, χ2(1)=5.618, p<0.05). The spz2ca1 alleles were again rescued when heterozygote 
spz2ca1 females were crossed to heterozygote spzMA05 males (n=685, χ2(1)=0.292, p=0.589) 




In constrast to spz2ca1, spzMA05 over TM6B was observed to be fully lethal with a SI of 0  
(Figure 4.8). Heterozygote spzMA05 females crossed to heterozygote spz2ca1 males gave a 
rescued SI of 0.88 (n=473, χ2(1)=1.526, p=0.217). This SI of 0.88 replicated the result of an 
earlier SI when heterozygote spz2ca1 females were crossed to heterozygote spzMA05males 
(χ2(1)=1.692, p=0.193). When heterozygote spzMA05 were crossed to heterozygotes 
ru1st1ea14spz3ca1 and ru1Diap1st1kniri-1rnroe-1ppe1spz4, the spzMA05 allele was rescued with SI 
1.24 (n=222, χ2(1)=2.453, p=0.117) and 0.95 (n=375, χ2(1)=0.192, p=0.661), respectively. 
Heterozygote spzMA05 crossed to heterozygote spzMA10 also rescued SI to 0.92 (n=321, 
χ2(1)=0.505, p=0.477), but when crossed to heterozygote spzMA12, SI was 0. The cross 
between heterozygotes spzMA05 and Df(3R)Exel6205 resulted in a SI of 0.74, indicating that the 
allele was not fully rescued (n=719, χ2(1)=12.487, p<0.001). This was also the case when 
heterozygotes Df(3R)Exel6205 were crossed to spzMA10 to yield a SI of 0.55 (n=280, 
χ2(1)=17.857, p<0.001), and when crossed to spzMA12 to give SI 0.53 (n=238, χ2(1)=16.269, 
p<0.001). Crosses between Df(3R)Exel6205 with spzMA05 and spzMA12.gave SI which were not 
statistically different to each other (χ2(1)=3.508, p=0.061). 
 
4.2.5 Lethality of dnt237 Allele 
 
As mentioned in Section 4.2.1, there was no new dnt2 allele generated in this project. Instead, 
new dnt2 alleles were generated by Dr J. Wentzell by hsFLP-FRT deletion using 
PBac{RB}dnt2e03444 and PBac{WH}Shabf05893 (personal communication). Dr J. Wentzell 
generated fly stocks ;;dnt218 (stock no. 36, Table 2.1) and ;;dnt237/(TM6B) (stock no. 37, 
Table 2.1). The dnt218 allele exists in homozygosis but TM6B is required for survival index 










































































































































































































































Figure 4.8 Survival indexes of the spz2 and spzMA05 allele. Expected survival index of wild-type 
chromosome is 1.0. Statistical results on top of each bar in the chart above were results of the
comparisons between test genotypes and expected values according to Mendelian 















Figure 4.9 Survival indexes of the dnt237 allele. Expected survival index of wild-type 
chromosome is 1.0. Statistical results on top of each bar in the chart above were results of the 














































The dnt237 allele is semi-lethal with SI of 0.36 (n=473, χ2(1)=69.819, p<0.001). 15.2% of the 
larval population survive as homozygotes into pupal stages. When heterozygote dnt237 
females were crossed to heterozygote Df(3L)Exel6092, the SI of dnt237 larvae was 0.64 
(n=1254, χ2(1)=47.458, p<0.001). Although this SI value of 0.64 indicates that the allele was 
not rescued, it was significantly higher than the SI of 0.36 from the heterozygote sibling cross 




Before this project, the alleles used for studying the loss of DNT function were dnt141, dnt155, 
dnt2e03444, spz2, spz3 and spz4 (Sutcliffe et al., 2013; Weber et al., 2007; Zhu et al., 2008). 
Dnt141 and dnt155 are null mutant alleles while dnt2e03444 is hypomorphic with a 5.9kb PBac 
insertion (Dos Santos et al., 2015; Zhu et al., 2008). Spz2, spz3 and spz4 are point mutant 
alleles (Tearle and Nusslein-Volhard, 1987; Weber et al., 2007). Due to the generation of spz2, 
spz3 and spz4 by EMS, the point mutant alleles exist with secondary mutations of other genes 
in the same chromosome. Therefore, the work of this chapter aims to generate new loss of 
function alleles for dnt2 and spz.  
 
4.3.1 Generation and Characterisation of dnt237 Allele 
 
Despite the aims of this chapter, no new dnt2 alleles were generated by hsFLP-FRT deletion. 
This was due P{XP}d05170 flies not carrying the P{XP} transposon element at its reported 
insertion site. By using inverse PCR to identify the location of the P{XP} element in DNA 
extracted from P{XP}d05170 flies, the nucleotide sequences were found to flank 
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P{XP}Ect4d04977 instead. P{XP}Ect4d04977 was inserted into the Ect4 gene in plus orientation 
about 5 million nucleotides away from dnt2, and would not be an allowable partner to pair 
with PBac{RB}dnt2e03444 for hsFLP-FRT deletion of the dnt2 locus (Figure 4.1B). So, new 
dnt2 alleles were generated by Dr J. Wentzell using hsFLP-FRT deletion between 
PBac{RB}dnt2e03444 and PBac{WH}Shabf05893, the next allowable partner inserted downstream 
of dnt2, into the 5’ untranslated region (UTR) of the Shaker cognate b (Shab) gene. The new 
dnt2 alleles were called dnt218 and dnt237 (Dr J. Wentzell, personal communication).  
 
The dnt237 fly stock exists in heterozygosis over TM6B with SI of 0.36, indicating that dnt237 
was homozygous semi-lethal, with 15.2% of the larval population surviving as homozygotes 
into pupal stages. When heterozygote dnt237 females were crossed to heterozygote 
Df(3L)Exel6092, the resulting SI value of 0.64 was significantly higher than the SI of 0.36 
from the heterozygote dnt237 sibling cross. The improved viability of the non-tubby larval 
genotype dnt237/Df(3L)Exel6092 over dnt237/dnt237 could be accounted by rescue of the set of 
genes deleted in the Df(3L)Exel6092. Although the viability of dnt237/Df(3L)Exel6092 was 
improved, the improvement was not comparable to SI of 1, and thus the improved viability 
was not a full rescue. This suggests that the dnt237 allele in homozygosis, or in trans with the 
Df(3L)Exel6092 background, reduced the viability of larvae reaching pupal stages. However, 
the dnt218 fly stock exists in homozygosis. The difference in viability between the dnt218 and 
dnt237 allele is not yet understood, and there is a possibility that the dnt237 stock could require 
more time to achieve stable homozygosis.  
 




In this chapter, only new spz alleles were generated by hsFLP-FRT deletion. The new spz 
alleles were called spzMA05, spzMA10 and spzMA12.  
 
The females of spzMA05/Df(3R)Exel6205 laid embryos with dorsalised phenotype. A dorsalised 
phenotype is a well-known loss of function phenotype for the lack of spz activity (Anderson 
and Nusslein-Volhard, 1984; Carroll et al., 1987; DeLotto and DeLotto, 1998). This 
concludes that spzMA05 is a loss of function allele. The spz2 allele is also a loss of function 
allele. Here, spz2ca1/Df(3R)Exel6205 females laid dorsalised embryos, a result matching 
dorsalised embryos laid by spz2/spz2 females (DeLotto and DeLotto, 1998). The cuticles of 
unviable embryos laid by spz2ca1/ru1Diap1st1kniri-1rnroe-1 ppe1spz4 were not prepared because 
spz4 was previously shown to produce embryos with dorsalised cuticle (Morisato and 
Anderson, 1994). 
 
The survival index of spzMA05 over TM6B differs from that of spz2ca1. The spzMA05 allele is 
fully lethal while spz2ca1 alleles together are semi-lethal. The SI of spz2ca1 over TM6B was 
0.14, with 6.4% of the larval population surviving as homozygotes into pupal stages. This 
percentage was comparable to the observed 7.1% of pupal population eclosing as homozygote 
fly adults (Sutcliffe et al., 2013; Zhu et al., 2008).  
 
When heterozygotes spzMA05 and spz2ca1 were crossed with each other in two independent 
crosses, the resulting SI were 1.04 and 0.88. These two SI values were not significantly 
different from each other and they indicate that the non-tubby larval genotype spzMA05/spz2ca1 
was fully viable. Other non-tubby larval genotypes which were fully viable includes: 
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spzMA05/ru1st1ea14spz3ca1, spz2ca1/ru1st1ea14spz3ca1, spzMA05/ru1Diap1st1kniri-1rnroe-1ppe1spz4, 
spz2ca1/Df(3R)Exel6205 and spzMA05/MA10.  
 
The resulting SI of heterozygote spz2ca1 crossed to ru1Diap1st1kniri-1rnroe-1ppe1spz4 was 1.36, 
which is a SI value significantly above 1. This indicates that there were more 
spz2ca1/ru1Diap1st1kniri-1rnroe-1ppe1spz4 larvae surviving into pupal stages than would be 
expected for wild-type rescue. The spz2ca1/ru1Diap1st1kniri-1rnroe-1ppe1spz4 larvae could 
possibly be out-competing the heterozygote population.  
 
While heterozygote spz2ca1 crossed to Df(3R)Exel6205 produce fully viable non-tubby larvae 
with SI of 1.09, this was not the case for when spzMA05 was crossed to Df(3R)Exel6205, in 
which the SI of non-tubby larvae was 0.74. This suggests that the spzMA05 allele in trans over 
Df(3L)Exel6205 reduced the viability of larvae reaching pupal stages. The spzMA10 and spzMA12 
alleles in trans over Df(3L)Exel6205 also reduced larval viability to the same extent as 
spzMA05/Df(3R)Exel6205. It is not clear why heterozygote spzMA05 crossed to spzMA10 produced 
fully viable larvae and yet no spzMA05/spzMA12 larvae reached pupal stages. 
 
Put together, when spz2ca1 was in trans over other spz alleles and Df(3R)Exel6205, the 
viability of the non-tubby larval progeny were rescued, except when the non-tubby larval 
genotype was spz2ca1/ru1Diap1st1kniri-1rnroe-1ppe1spz4. When spzMA05 was in trans over other 
spz alleles, the viability of non-tubby larvae were also rescued, except when the larval 
genotype was spzMA05/spzMA12. Lastly, when all spz alleles generated by hsFLP-FRT were in 










This chapter is about analysing DNT function in the third instar larval stage. Whereas 
Sutcliffe (2011) characterised DNT roles in the larval neuromuscular junction, the author 
investigated the roles of DNTs in organ size and cell numbers in the CNS. 
 
5.1.1 The spz2ca1/TM6B Fly Stock 
 
The spz2ca1/TM6B stock co-exists with ca1, a recessive and eye-colour defective allele of the 
claret gene (Silva and Mensua, 1985; Yamamoto et al., 1989). The claret gene codes for the 
protein Rab32-GEF, that is, a guanine nucleotide exchange factor (GEF) which switches the 
GTPase Rab32 from its inactive to active form (Ma et al., 2004; Wang et al., 2012). In order 
to address whether or not ca1/ca1 interacts with spz2/spz2, the eye-colour defective ca1 allele in 
the fly stock spz2ca1/TM6B was recombined out to generate spz2ca+/TM6B, bearing a ca+ 
wild-type allele. If ca1 is an interacting factor with spz2 that results in a small CNS phenotype, 
the outcome of replacing spz2ca1/spz2ca1 with spz2ca+/spz2ca+ is hypothesised to return the 
CNS phenotype to control size.  
 




Previously, Sutcliffe et al. (2013) and McIlroy et al. (2013) showed that the semi-lethality in 
spz2 animals (SI=0.08 and SI=0.17, respective papers) was rescued by pan-neuronal 
expression of constitutively active Toll, Toll10bB (SI=0.92 and SI=0.60, respectively). The 
rescue was replicated with the overexpression of Toll6CY and Toll7CY in McIlroy et al. (2013) 
(SI=0.39 and SI=0.38, respectively), but with lesser degree of viability. 
 
Here, the viability experiment will be extended by looking into the effect Toll10bB, Toll6CY and 
Toll7CY have on homozygous spz2 CNS size through elav-GAL4 and repo-GAL4, with the idea 
of testing whether or not Toll6 and Toll7 could be potential receptors of Spz. 
 
5.1.3 Overexpression Different Forms of Spz 
 
The spz-GAL4 line crossed to myr-tdTomato reporter revealed complementary patterns with 
anti-Spz-GLR staining in the VNC neuropile. Spz was previously suggested to be secreted 
into the mechanosensory domain. In this chapter, the use of spzGAL4 to overexpress Spz 
presumed increasing base level of Spätzle protein production in cells with active spz 
promoter. 
 
5.1.4 Interaction between DNTs and Notch 
 
In the Drosophila larval CNS, there are mostly neurons and glia. Trophic factors could be 
secreted from neurons or glia or both. Pan-neuronal overexpression of the intracellular 
domain of Notch fragment (NotchICD) affects cell fate decision in embryogenesis (Le Gall et 
al., 2008; Lehmann et al., 1983), and is fully lethal with no single larvae hatching from eggs 
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(personal observation). However, repo-GAL4 overexpression of the intracellular domain 
throughout embryogenesis and up to wandering third instar larval life will result in CNS with 
a long VNC with abdominal glia numbers higher than in yw (Kato et al., 2011). Due to injury-
induced apoptosis being rescued by repo>NotchICD, this suggest the genotype could produce a 
trophic factor that protects cells from apoptosis. This chapter will test for an interaction 
between the DNTs and Notch.  
 
5.1.5 Regulation of Cell Numbers 
 
DNT1, DNT2 and Toll maintain neuronal survival in embryos (Zhu et al., 2008). Whether or 
not they maintain cell survival in the larval VNC remains unknown.  
 
5.1.6 BdnfMet66 and spz2 
 
Hippocampal neurons of bdnfMet66 knock-in mice were analysed by Sholl analysis and were 
shown to display decreased dendritic arbor complexity (Chen et al., 2006). Using FLP 
technique to visualise single cells, it is possible to analyse the dendrites of RP2 neurons for 
the spz2 allele.  
 
5.1.7 Specific Aims 
 
The specific aims of this chapter are: 
∑ To characterise spz2ca1 and spz2ca+ in terms of CNS size. 
∑ To test Toll6 and Toll7 as putative receptors of spz using SI assays. 
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∑ To test Toll6 and Toll7 as putative receptors of spz using CNS size. 
∑ To characterise the CNS size when spz is overexpressed by spz-GAL4. 
∑ To test for an interaction between DNTs and Notch using VNC size phenotype. 
∑ To investigate if Spz, DNT1, DNT2, Toll, Toll6 and Toll7 affect Repo+ cell number. 
∑ To investigate if Spz, DNT1, DNT2, Toll, Toll6 and Toll7 affect pH3+ cell number. 
∑ To investigate if Spz, DNT1, DNT2, Toll, Toll6 and Toll7 affect Dcp1+ cell number. 
∑ To characterise the dendrites of spz2 RP2 neurons according to Sholl analysis. 
 
5.1.8 Methods in Brief 
 
For CNS size experiments, absolute measurements were used and there was no normalising of 
VNC length measurements to body length. This was because only wandering larvae were 
sampled and all test genotypes did not exhibit any obvious differences in body size. There 
was only 1 CNS sample collected for the genotype spzMA05/TM6B because the project ran out 
of time and the data collection was disappointingly left unfinished (Figure 5.1). The sample 
will be used for showing the ROIs of brain area, VNC area and VNC length (Figure 5.1A). 
 
The genetic protocol for recombining ca1 with ca+ was provided in Figure 2.8 (Section 2.1.3). 
Screening details were provided in Figure 2.9. During screening, SI assays on the test 
genotypes were undertaken. Ultimately, 2 out of 15 lines tested positive for the presence of 
spz2 (genotypes: w+;;spz2ca+.33/TM6B, stock no. 20; w+;;spz2ca+.56/ TM6B,LacZ, stock no. 
21, Table 2.1). The two genotypes arose from the same genetic scheme but both could be 
chromosomally different products. The remaining 13 were thrown out after screening because 
the purpose of the genetic protocol was to retrieve genotype spz2ca+/TM6B. During screening, 
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SI was recorded. Observations were made on locomotion and life span defects too. 
Locomotion was classed defective when flies could not stand upright after falling. Shorten life 
spans were detected through flies found dead half-way emerged from their pupal case or via 
young flies with wings remaining folded. 
 
Occasionally, the aberrant chromosomes of fly deficiency lines Df(3R)Exel6205, 
Df(3L)Exel6101 and Df(3L)Exel6092 were abbreviated to Df6205, Df6101 and Df6092. All 
“CK” symbols refer to the activated form of Spz (actSpz(2)), DNT1 (DNT1-CK-3’+) and 
DNT2 (DNT2-CK-6A) fused to UAS construct. All “FL” symbols refer to full length form of 
Spz (spz-FL), DNT1 (DNT1-FL) and DNT2 (DNT2-FL-47C) fused to UAS construct. UAS-
spz2-E1 refers to the UAS construct fused to the full length form of the spz2 allele, a construct 
generated by M. Rai. Toll10b refers to the activated form of Toll fused to UAS. UAS-Toll10bA 
and UAS-Toll10bB refers to the same transgenic construct, but they were inserted into 
chromosome 3 and 2, respectively. To avoid any positional effects, the same insertion (UAS-
Toll10bB) was used every time. The p35 in fly stock UAS-p35,spz2/TM6B,LacZ (stock no. 50, 
Table 2.1) refers to the viral protein highly adapted to inhibit caspase.  
 
To address the effect of ca1 independently of spz2, the fly stock ru1h1th1st1cu1sr1esca1 was used 
(stock no. 42, Table 2.1). This stock was an alternative to “ca1” due to logistic problems with 





Tollr3 is a loss of function allele which is temperature sensitive. For experiments which use 
Tollr3, the permissive temperature for normal embryogenesis was 18°C and the restrictive 
temperature for loss of function study in larval life was 29°C.  
 
To count the number of glia in the VNC, anti-Repo antibodies were used. Cells undergoing 
mitosis were marked by anti-pH3, an antibody targeting phosphorylated histone H3. Cells 
undergoing apoptosis were labelled by anti-Dcp1, an antibody targeting cleaved Drosophila 
Death caspase 1, an effector caspase with determines the rate of cell death (Florentin and 
Arama, 2012). Glial, mitotic and apoptotic cells were automatically counted with DeadEasy 
Larval Glia. Mitotic and apoptotic cell counting using DeadEasy Larval Glia were validated 
the same way as for glial cell counting (Section 2.5.4). Details for ROI selection were covered 
in Section 2.5.4 (Figure 2.15). More consideration towards experiments collecting number of 
mitotic cells included recognising that the abdominal VNC stained with anti-pH3 will produce 
a staining pattern illustrated by Figure 5.26. To account for the possibility that there could be 
genetic effects affecting the mitotic and non-mitotic zone differently, the number of pH3+ 
cells in the non-mitotic zone were independently treated too. The number of pH3+ cells in the 
non-mitotic zone were categorised into number of VNC having less than or equal to 5 cells 
and number of VNC having more than 5 cells undergoing mitosis. Abdominal VNC stained 
with anti-Dcp1 also produced similar zones of dense Dcp1+ (apoptotic zone) and sparse 
Dcp1+ cells (non-apoptotic zone).  
 
All Ebony+ cells were counted using the Cell Counter tool in ImageJ. Z-stack images were 
opened in ImageJ and initialised by the Cell Counter tool. Once initialised, Ebony+ Repo+ 
cells were manually identified throughout the Z-stack and marked by clicking which Cell 
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Counter automatically tallies. Pairings of Ebony+ ventral interface glia (vIG) were manually 
counted and categorised.  
 
All mean values were quoted with standard deviation. For reference to full statistical reports, 
please refer to Appendix (Section 9). Scatter plots were given to provide information on raw 
data in the interest of creating transparency. Box plots were provided to analyse outliers. Bar 




5.2.1 Homozygous spz2ca1 and CNS Size 
 
Homozygous spz2ca1 CNS were significantly smaller than yw in brain and VNC areas (Table 
5.1, Figure 5.1). In addition, the VNC length of spz2ca1 was significantly shorter than yw 
(Table 5.1, Figure 5.1). Meanwhile, the CNS of heterozygous spz2ca1 allele over its 
deficiency Df(3R)Exel6205 were surprisingly akin to those of yw (Table 5.1, Figure 5.1). 
Accordingly, spz2ca1/Df(3R)Exel6205 had CNS significantly larger and longer from the CNS 
of spz2ca1. Data collected from spzMA05/Df(3R)Exel6205 was inconclusive.  
 














yw 25 1.70 ±0.23 25 7.0 ±0.8 25 372 ±25 
spz2ca1 15 0.68 ±0.13 15 5.8 ±0.6 15 333 ±18 
spz2ca1/Df6205 8 1.67 ±0.11 9 7.3 ±0.5 9 378 ±22 
spzMA05/Df6205 1 1.01 - 1 5.5 - 1 355 - 
Table 5.1 Brain and VNC size quantification for genotypes yw, spz2ca1,spz2ca1/Df(3R)Exel 
6205 and spzMA05/Df(3R)Exel6205.  
  
Figure 5.1 Brain and VNC size characteristics for genotypes yw, spz2ca1, spz2ca1/
Df(3R)Exel6205 and spzMA05/Df(3R)Exel6205. (A) Representative mounted CNS images 
acquired with phase contrast using Zeiss Axioplan 2 (for genotypes yw, spz2ca1 and spz2ca1/
Df(3R)Exel6205) and Zeiss LSM710 (spzMA05/Df(3R)Exel6205). ROIs included are those for 
brain area, VNC area and VNC length. Scale bars, 100μm. (B) Markers representing brain 
and VNC areas of individual larvae. Each blue diamond marker represents a yw individual 
(n=25). Red squares, spz2ca1 (n=15). Green triangles, spz2ca1/Df(3R)Exel6205 (n=8). Black 
cross, spzMA05/Df(3R)Exel6205 (n=1). (C) Markers representing VNC areas and lengths of 
individual larvae. Blue diamonds, yw (n=25). Red squares, spz2ca1 (n=15). Green triangles: 
spz2ca1/Df(3R)Exel6205 (n=9). Black cross, spzMA05/Df(3R)Exel6205 (n=1). (D) Boxplots 
showing ranges and outliers for brain area, VNC area and VNC length. Genotypes plotted for 
each size variable: yw, spz2ca1 and spz2ca1/Df(3R)Exel6205. (E) Bar charts showing mean 
brain area, mean VNC area and mean VNC length. Genotypes plotted for each mean size 
variables: yw, spz2ca1 and spz2ca1/Df(3R)Exel6205. Brain area statistics: Levene’s 
statistic=4.0, p<0.05; Welch ANOVA F(2,23.7)=145.4, p<0.001. VNC area: Levene’s 
statistic=3.7, p<0.05; Welch ANOVA F(2,24.8)=17.7, p<0.001. VNC length: Levene’s 







































































































































































5.2.2 Interaction with claret  
 
5.2.2.1 Pecularities with spz+ca+ Stocks 
 
15 lines of balanced fly stocks carried a confirmed allele of ca+ but either spz+ or spz2 (Table 
5.2). Before throwing out stocks which failed the screen for spz2ca+, the author observed two 
peculiarities. Firstly, the stock in line 29 was fully lethal (SI=0) while every other screened 
lines had semi-lethal phenotype (SI range=0.21-0.41). Secondly, there were locomotion and 
life span defects present in fly stocks of genotype spz+ca+ on their backs.  
 
5.2.2.2 Genotype ru1h1th1st1cu1sr1esca1 and CNS Size 
 
Independently of spz2, ru1h1th1st1cu1sr1esca1 was smaller in brain and VNC areas than yw 
(Table 5.3, Figure 5.2). The mean VNC length of ca1 was shorter to that of yw, but not 
signficantly (Games-Howell test, p = 0.438). Having addressed that ru1h1th1st1cu1sr1esca1 
reduced the mean brain and VNC areas compared to yw by ~23% and ~10%, respectively, and 
that spz2ca1 reduced the mean brain and VNC areas compared to yw by ~60% and ~17%, 
respectively, the hypothesis of both genes interacting with each other and affecting CNS size 
development became more compelling. 
 
5.2.2.3 Genotype spz2ca+ and CNS Size 
 








SI of Non-Tubby 
Larvae Reaching 
Pupal Stages 
Observations on Flies Eclosing from Non-
Tubby Pupal Cases 
3 No 0.31 
One was found dead mid-eclosion. 
Some were found dead with wings 
remaining folded. 
Unbalanced flies cannot right themselves 
to stand after falling on their backs. 
20 No 0.33 Some were found dead with wings remaining folded. 
25 No 0.41  
29 No 0.00  
31 No 0.41 Unbalanced flies cannot right themselves to stand after falling on their backs. 
33 Yes 0.26  
44 No 0.30  
45 No 0.21  
48 No 0.22  
51 No 0.29  
52 No 0.24  
56 Yes 0.21 
Unbalanced flies cannot right themselves 
to stand after falling on their backs with 
the exception of one. That fly could stand 
after being pushed over by a paintbrush but 
it could not fly.  
72 No 0.27  
74 No 0.21  
78 No 0.32  
Table 5.2 Fly lines screened for spz2ca+. During screening, SI was recorded. Locomotion and 
life span defects were noted for fly lines 3, 20, 31 and 56.  
 














yw 25 1.70 ±0.23 25 7.0 ±0.8 25 372 ±25 
spz2ca1 15 0.68 ±0.13 15 5.8 ±0.6 15 333 ±18 
ru1h1th1st1cu1sr1
esca1 
19 1.31 ±0.15 16 6.3 ±0.5 16 360 ±22 
spz2ca+.33 13 0.74 ±0.10 16 6.5 ±1.0 16 363 ±38 
spz2ca+.56 21 0.78 ±0.14 22 6.1 ±0.7 22 325 ±23 
Table 5.3 Brain and VNC size quantification for genotypes yw, spz2ca1, ru1h1th1st1cu1sr1es ca1, 
spz2ca+.33 and spz2ca+.56. 
 
  
Figure 5.2 Brain and VNC size characteristics for genotypes yw, spz2ca1, ru1h1Diap1st1cu1sr1
esca1, spz2ca+.33 and spz2ca+.56. (A) Representative mounted CNS images acquired with 
phase contrast using Zeiss Axioplan 2. Scale bars, 100μm. (B) Markers representing brain 
and VNC areas of individual larvae. Each blue diamond marker represents a yw individual 
(n=25). Red squares, spz2ca1 (n=15). Green dashes, ru1h1Diap1st1cu1sr1esca1 (n=19). Purple 
crosses, spz2ca+.33 (n=13). Light blue pluses, spz2ca+.56 (n=21). (C) Markers representing 
VNC areas and lengths of individual larvae. Blue diamonds, yw (n=25). Red squares, spz2ca1 
(n=15). Green dashes, ru1h1Diap1st1cu1sr1esca1 (n=19). Purple crosses, spz2ca+.33 (n=13). 
Light blue pluses, spz2ca+.56 (n=21). (D) Boxplots showing ranges and outliers for brain area,
VNC area and VNC length. Genotypes plotted for each size variables: yw, spz2ca1, ru1h1Diap1
st1cu1sr1esca1, spz2ca+.33 and spz2ca+.56. (E) Bar charts showing mean brain area, mean VNC 
area and mean VNC length. Genotypes plotted for each mean size variables: yw, spz2ca1, ru1
h1Diap1st1cu1sr1esca1, spz2ca+.33 and spz2ca+.56. Brain area statistics: Levene’s statistic=4.0, 
p<0.05; Welch ANOVA F(4,42.4)=125.0, p<0.001. VNC area: Levene’s statistic=3.2, 
p<0.05; Welch ANOVA F(4,42.1)=7.2, p<0.001. VNC length: Levene’s statistic=4.4, p<0.05; 
Welch ANOVA F(4,41.8)=14.7, p<0.001.










































































































































































































































from each other (Table 5.3, Figure 5.2). However, their mean lengths were significantly 
different (Table 5.3, Figure 5.2). Spz2ca+.33 and spz2ca+.56 each were not significantly 
different to spz2ca1 in terms of brain area, VNC area and VNC length (Table 5.3, Figure 5.2). 
 
5.2.2.4 Genotype spz2ca+ and SI  
 
Upon recombining spz2ca1 with spz2ca+, the viability of the latter animals reaching into pupal 
stages improved (Figure 5.3; χ2(2)=24.0, p<0.001). The survival index (SI) for spz2ca1 larvae 
reaching pupation is 0.14, and both spz2ca+.33 (SI=0.21) and spz2ca+.56 (SI=0.26) have 
significantly higher SIs (SI=0.21, χ2(1)=24.2, Bonferroni post hoc p<0.001; SI=0.26, 
χ2(1)=10.6, Bonferroni post hoc p<0.005), although each SI quoted did not reflect rescue to 
wild-type numbers.  
 
5.2.3 Rescue of SI and CNS Size using elavGAL4 
 
Spz2elav-GAL4/TM6B had an SI of 0.25 (Figure 5.4). Overexpressing actSpz increased 
viability (SI=0.43, χ2(1)=14.1, p<0.001), but not to expected wild-type level (χ2(1) = 52.4, 
p<0.001). The overexpression of active Toll receptors, Toll10bB, Toll6CY and Toll7CY, also 
increased viability (SI=0.75, 0.67 and 0.47, respectively). The best of the three receptors in 
improving viability of spz2 animals is Toll10bB (χ2(1)=134.5, p<0.001) although not to the 
extent of wild-type levels (χ2(1)=31.1, p<0.001). Viability improvement from Toll10bB was 
comparable to that from Toll6CY (χ2(1)=2.0, p=0.156) but not from Toll7CY (χ2(1)=21.1, 






























































































































Figure 5.4 Survival index of spz2 larvae when neurons overexpressed activated form of Spz 
(UAS-actSpz(2)), activated Toll (UAS-Toll10bB), activated Toll6 (UAS-Toll6CY), activated Toll7 




to levels as a result of overexpressing actSpz(2) (χ2(1)=0.248, p=0.618) or Toll7CY 
(χ2(1)=0.248, p=0.974). 
 
Whilst viability of spz2 animals could be partially rescued by overexpression of Toll10bB, 
Toll6CY and p35, the brain areas were not (Table 5.4, Figure 5.5). In the case of 
overexpressing Toll7CY, the brain size decreased significantly (Table 5.4, Figure 5.5). When 
there was only a single allele of spz2 in genotype spz2elav-GAL4/+, the mean brain size was 
smaller than in yw (Games Howell post hoc, p<0.005), and was doubled that of spz2ca1 (Table 
5.4, Figure 5.5). However, when comparing VNC, those of spz2elav-GAL4/+ and spz2ca1 were 
similar to each other (Table 5.4, Figure 5.5). Mean VNC area of spz2elav-GAL4/+ was 
smaller than yw (Bonferroni post hoc, p<0.005) but lengths of both genotypes were 
comparable (Bonferroni post hoc, p=0.171). Increasing sampling of spz2elav-GAL4/+ could 
resolve the issue. 
 















yw 25 1.70 ±0.23 25 7.0 ±0.8 25 372 ±25 
spz2ca1 15 0.68 ±0.13 15 5.8 ±0.6 15 333 ±18 
spz2elavGAL4/+ 11 1.39 ±0.16 12 6.0 ±0.6 12 349 ±25 
spz2,elav>spz2,Toll10bB 6 0.72 ±0.07 7 7.0 ±0.7 7 386 ±37 
spz2,elav>spz2,Toll6CY 8 0.67 ±0.07 8 7.0 ±0.6 8 381 ±19 
spz2,elav>spz2,Toll7CY 5 0.54 ±0.04 5 6.0 ±0.5 5 362 ±17 
spz2,elav>spz2,p35 3 0.81 ±0.13 5 7.7 ±0.7 5 450 ±29 
Table 5.4 CNS size rescue of spz2 mutant background using various UAS lines overexpressed 
under elavGAL4 driver. 
 
Even though brain areas were not rescued with pan-neuronal overexpression of Toll10bB, 
Toll6CY and p35, VNC sizes of spz2ca1 were rescued (Table 5.4, Figure 5.5). Rescues by 
Toll10bB and Toll6CY were to the full extent (Table 5.4, Figure 5.5). With p35, mean VNC area 
was higher than yw but not statistically significant. However, the mean VNC length was   
Figure 5.5 CNS size rescue of spz2 mutant background using various UAS lines 
overexpressed under elav-GAL4 driver. (A) Representative mounted CNS images acquired 
with phase contrast using Zeiss Axioplan 2. Scale bars, 100μm. (B) Markers representing 
brain and VNC areas of individual larvae. Each blue diamond marker represents a yw 
individual (n=25). Red squares, spz2 (n=15). Green triangles, spz2elav-GAL4/+ (n=11). 
Purple circles, spz2,elav>spz2,Toll10bB (n=6). Light blue crosses, spz2,elav>spz2,Toll6CY (n=8).
Black dashes, spz2,elav>spz2,Toll7CY (n=5). Orange pluses, spz2,elav>spz2,p35 (n=3) (C) 
Markers representing VNC areas and lengths of individual larvae. Blue diamonds, yw (n= 5).
Red squares, spz2 (n=15). Green triangles, spz2-elav-GAL4/+ (n=12). Purple circles, spz2,elav>
spz2,Toll10bB (n=7). Light blue crosses, spz2,elav>spz2,Toll6CY (n=8). Black dashes, spz2,elav>
spz2,Toll7CY (n=5). Orange pluses, spz2,elav>spz2,p35 (n=5) (D) Boxplots showing ranges and 
outliers for brain area, VNC area and VNC length. (E) Bar charts showing mean brain area, 
mean VNC area and mean VNC length. Brain area statistics: Levene’s statistic=4.4, p<0.001; 
Welch ANOVA F(6,16.253)=102.0, p<0.001. VNC area: Levene’s statistic=1.2, p = 0.307; 
one-way ANOVA F(6,70)=10.7, p<0.001. VNC length, Levene’s statistic=1.4, p=0.233; one-









































































































































































































































































































































































































significantly longer. Undoubtedly, increasing sampling would clear the issue on whether 
VNC size was rescued by p35 to yw level or beyond. Nonetheless, p35 rescues spz2 VNC size. 
The rescue of VNC size to yw levels by pan-neuronal overexpression of Toll10b and Toll6CY 
(Figure 5.5) correlated with the results in which the viability of spz2 animals reaching pupal 
stages were highest with overexpression of these two receptors (Figure 5.4). 
 
The controls spz2elav-GAL4/+ and elav-GAL4/+ were similar to each other in terms of CNS 
size (Table 5.5; Figure 5.6). When Toll10b was overexpressed under elavGAL4, CNS size was 
similar to control elavGAL4/+, indicating no gross whole organ size effect (Table 5.5; Figure 
5.6). The mean VNC sizes in spz2,elav>spz2,Toll10bB and elav>Toll10bB had negligible 
differences, indicating full rescue without perturbation of VNC organ size (Table 5.5; Figure 
5.6). 
 


















yw 25 1.70 ±0.23 25 7.0 ±0.8 25 372 ±25 
spz2ca1 15 0.68 ±0.13 15 5.8 ±0.6 15 333 ±18 
spz2elav-GAL4/+ 11 1.39 ±0.16 12 6.0 ±0.6 12 349 ±25 
spz2,elav>spz2,Toll10bB 6 0.72 ±0.07 7 7.0 ±0.7 7 386 ±37 
elav-GAL4/+ 11 1.25 ±0.21 11 6.0 ±0.7 11 359 ±19 
elav>Toll10bB 10 1.24 ±0.09 15 6.7 ±0.4 15 375 ±23 
Table 5.5 CNS sizes for elav>Toll10bB with and without the background spz2.  
 
5.2.4 Rescue of SI CNS Size using repoGAL4 
 
The stocks spz2ca1/TM6B and spz2repo-GAL4/TM6B were semi- (SI=0.15) and fully lethal 
(SI=0), respectively. With repo-GAL4 overexpression of actSpz(2), Toll10bB, Toll6CY and   
Figure 5.6 Comparing CNS size for elav>Toll10bB with and without the background spz2. (A) 
Representative mounted CNS images acquired with phase contrast using Zeiss Axioplan 2 
except for genotype elav>Toll10bB for which acquisition were from Zeiss LSM710. Scale bars, 
100μm. (B) Markers representing brain and VNC areas of individual larvae. Each blue 
diamond marker represents a yw individual (n=25). Red squares, spz2 (n=15). Green triangles, 
spz2elav-GAL4/+ (n=11). Purple circles, spz2,elav>spz2,Toll10bB (n=6). Black crosses, 
elav-GAL4/+ (n=11). Orange dashes, elav>Toll10b (n=10). (C) Markers representing VNC 
areas and lengths of individual larvae. Blue diamonds, yw (n=25). Red squares, spz2 (n=15). 
Green triangles, spz2elav-GAL4/+ (n=12). Purple circles, spz2,elav>spz2,Toll10bB (n=7). Black 
crosses, elav-GAL4/+ (n = 11). Orange dashes, elav>Toll10b (n=15). (D) Boxplots showing 
ranges and outliers for brain area, VNC area and VNC length. (E) Bar charts showing mean 
brain area (dotted bars), mean VNC area (diagonally-lined bars) and mean VNC length 
(empty white bars). Brain area statistics: Levene’s statistic=3.8, p<0.001; Welch ANOVA 
F(5,28.5)=105.6, p<0.001. VNC area: Levene’s statistic=1.9, p=0.108; one-way ANOVA 







































































































































































































































































Toll7CY, viability of spz2 animals reaching pupal stages across all genotypes improved (Table 
5.6, Figure 5.7; χ2(4)=383.7, p<0.001). Toll6CY being overexpressed was the best at improving 
viability (SI=0.74) and this was comparable with glial overexpression of actSpz(2) (SI=0.64; 
χ2(1)=1.3, p=0.253) but not to wild-type levels (χ2(1)=16.5, p<0.001). Overexpressing Toll10bB 
and Toll7CY improved viability at similar levels (Table 5.6; χ2(1) = 0.2, p = 0.641). While the 
overexpression of Toll6CY and Toll7CY under both elav- and repo-GAL4 provided similar 
viability to spz2 mutants, this was not the case for actSpz(2) and Toll10bB. It was better for spz2 




SI of spz2 




actSpz(2) 0.43 0.64 5.8 0.016 
Toll10bB 0.75 0.46 14.0 0.000 
Toll6CY 0.67 0.74 1.0 0.309 
Toll7CY 0.47 0.43 0.8 0.381 
Table 5.6 Comparing SI rescues of spz2 using neuronal and glial drivers.  
 


















yw 25 1.70 ±0.23 25 7.0 ±0.8 25 372 ±25 
spz2ca1 15 0.68 ±0.13 15 5.8 ±0.6 15 333 ±18 
spz2repoGAL4/+ 11 1.63 ±0.18 12 6.9 ±0.6 12 382 ±20 
spz2,repo>spz2,Toll10bB 10 0.70 ±0.09 11 8.4 ±0.7 11 583 ±49 
spz2,repo>spz2,Toll6CY 1 0.45 - 1 5.6 - 1 377 - 
spz2,repo>spz2,Toll7CY 2 0.63 ±0.04 3 6.6 ±0.5 3 397 ±19 
Table 5.7 CNS size rescue of spz2 mutant background using various UAS lines overexpressed 
under repo-GAL4 driver.  
 
The repo-GAL4 overexpression of Toll10bB, Toll6CY and Toll7CY was insufficient to rescue 
brain areas of spz2 mutant backgrounds (Figure 5.8). When there was only a single dose of 
spz2 in genotype spz2repo-GAL4/+, unlike in spz2elav-GAL4/+, mean CNS sizes were alike to 
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yw’s (Table 5.7). With respect to the VNC, due to low sampling numbers of 
spz2,repo>spz2,Toll6CY (n=1) and spz2,repo>spz2,Toll7CY (n=3), whether or not VNC sizes 
were rescued remained inconclusive. With the overexpression of Toll10bB, mean VNC area and 
length were higher than rescued levels (Table 5.7, Figure 5.8).  
 
As with the control elav-GAL4/+, the control yw differs from the control repo-GAL4/+ in 
brain and VNC areas (Table 5.8, Figure 5.9). When compared to the more appropriate control, 
that is repo-GAL4/+, repo>Toll10bB did not change brain area (Table 5.8, Figure 5.9). 
However, an increase in gross size was seen in the VNC (Table 5.8, Figure 5.9). Additionally, 
while overexpressing Toll10bB constitutively in spz2 resulted in mean VNC area larger than yw, 
this mean was comparable to that in repo>Toll10bB (Table 5.8, Figure 5.9). However, the mean 
VNC length in spz2,repo>spz2,Toll10bB still surpassed the mean length in repo>Toll10bB 
significantly (Table 5.8, Figure 5.9), suggesting an interaction between spz2 and repo>Toll10bB 
to deform gross morphology further.  
 


















yw 25 1.70 ±0.23 25 7.0 ±8 25 372 ±25 
spz2ca1 15 0.68 ±0.13 15 5.8 ±6 15 333 ±18 
spz2repoGAL4/+ 11 1.63 ±0.18 12 6.9 ±6 12 382 ±20 
spz2,repo>spz2,Toll10bB 10 0.70 ±0.09 11 8.4 ±7 11 583 ±49 
repoGAL4/+ 12 0.45 ±0.12 12 5.9 ±2 12 364 ±21 
repo>Toll10bB 12 0.63 ±0.11 12 7.8 ±5 12 516 ±33 













































































Figure 5.7 Survival index of spz2 larvae when their glia overexpressed activated
form of Spz (UAS-actSpz(2)), activated Toll (UAS-Toll10bB), activated Toll6 (UAS-Toll6CY), 
and activated Toll7 (UAS-Toll7CY).
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Figure 5.8 CNS size rescue of spz2 mutant background using various UAS lines 
overexpressed under repo-GAL4 driver. (A) Representative mounted CNS images acquired 
with phase contrast using Zeiss Axioplan 2. Scale bars, 100μm. (B) Markers representing 
brain and VNC areas of individual larvae. Each blue diamond marker represents a yw 
individual (n=25). Red squares, spz2 (n=15). Green triangles, spz2repo-GAL4/+ (n=11). Purple
circles, spz2,repo>spz2,Toll10bB (n=10). Light blue crosses, spz2,repo>spz2,Toll6CY (n=1). Black 
dashes, spz2,repo>spz2,Toll7CY (n=2). (C) Markers representing VNC areas and lengths of 
individual larvae. Blue diamonds, yw (n=25). Red squares, spz2 (n=15). Green triangles, 
spz2repo-GAL4/+ (n=12). Purple circles, spz2,repo>spz2,Toll10bB (n=11). Light blue crosses, 
spz2,repo>spz2,Toll6CY (n=1). Black dashes, spz2,repo>spz2,Toll7CY (n=3). (D) Boxplots 
showing ranges and outliers for brain area, VNC area and VNC length. (E) Bar charts 
showing mean brain area, mean VNC area and mean VNC length. Brain area statistics: 
Levene’s statistic=3.9, p<0.05; Welch ANOVA F(3,27.8)=173.8, p<0.001. VNC area: 
Levene’s statistic=2.0, p=0.120; one-way ANOVA F(3,59)=29.0, p<0.001. VNC length, 






































































































































































































































Figure 5.9 Comparing CNS size for repo>Toll10bB with and without the background spz2. (A)
Representative mounted CNS images acquired with phase contrast using Zeiss Axioplan 2 
except for genotypes repo-GAL4/+ and repo>Toll10bB for which acquisition were from Zeiss 
LSM710. Scale bars, 100μm. (B) Markers representing brain and VNC areas of individual 
larvae. Each blue diamond marker represents a yw individual (n=25). Red squares, spz2 
(n=15). Green triangles, spz2repo-GAL4/+ (n=11). Purple circles, spz2,repo>spz2,Toll10bB 
(n=10). Black crosses, repo-GAL4/+ (n=12). Orange dashes, repo>Toll10bB (n=12). (C) 
Markers representing VNC areas and lengths of individual larvae. Blue diamonds, yw (n=25). 
Red squares, spz2 (n=15). Green triangles, spz2repo-GAL4/+ (n=12). Purple circles, 
spz2,repo>spz2,Toll10bB (n=11). Black crosses, repo-GAL4/+ (n= 12). Orange dashes, repo>
Toll10bB (n=12). (D) Boxplots showing ranges and outliers for brain area, VNC area and VNC 
length. (E) Bar charts showing mean brain area (dotted bars), mean VNC area (diagonally-
lined bars) and mean VNC length (empty white bars). Brain area statistics: Levene’s statistic
=4.1, p<0.005; Welch ANOVA F(5,33.7)=115.8, p<0.001. VNC area: Levene’s statistic=4.2, 
p<0.005; Welch ANOVA F(5,33.8)=51.0, p<0.001. VNC length, Levene’s statistic=3.6, p=












































































































































































































































































5.2.5 Overexpressing Different Forms of Spz under spzGAL4 
 
Neither Spz-CK nor Spz-FL had an effect on brain and VNC areas through spzGAL4 (Table 
5.9; Figure 5.10). VNC of spz>Spz-FL had the same mean length as the control while the 
mean VNC length amongst spz>Spz-CK was higher than those of the control spz-GAL4/+ and 
spz>Spz-FL (Table 5.9; Figure 5.10).  
 


















spz-GAL4 12 1.31 ±0.19 12 6.0 ±0.4 12 361 ±18 
spz>actSpz(2) 8 1.20 ±0.18 9 6.2 ±0.7 9 389 ±29 
spz>Spz-FL 6 1.21 ±0.16 6 5.7 ±0.4 6 359 ±9 
Table 5.9 Overexpressing two different forms of Spätzle using spz-GAL4. 
 




n Mean (µm) SD (µm) 
repo>NotchICD 11 702 ±54 
repo>NotchICD,actSpz(2) 19 622 ±59 
repo>NotchICD,spz-FL 12 598 ±52 
repo>NotchICD,spz-E1 12 645 ±64 
spz2,repo>spz2,NotchICD 11 993 ±164 
Table 5.10 Effects on VNC length by overexpressing repo>NotchICD with different Spätzle 
forms or with spz2 mutant background.  
 
Against the background repo>NotchICD, the overexpression of actSpz(2), spz-FL and spz2-E1 
resulted in similar mean VNC lengths among each other (Table 5.10, Figure 5.11). However, 
the mean length of the VNC in larvae overexpressing actSpz(2) and spz-FL were significantly 
shorter than that of the control repo>NotchICD. In spz2,repo>spz2,NotchICD, the CNS size was   
Figure 5.10 Effect of active and full-length Spätzle protein through spz-GAL4 on CNS size. 
(A) Representative mounted CNS images acquired with phase contrast using Zeiss Axioplan 
2. Scale bars, 100μm. (B) Markers representing brain and VNC areas of individual larvae. 
Each blue diamond marker represents a control spz-GAL4/+ individual (n=12). Red squares, 
spz>actSpz(2) (n=8). Green triangles, spz>Spz-FL (n=6). (C) Markers representing VNC 
areas and lengths of individual larvae. Blue diamonds, spz-GAL4/+ (n=12). Red squares, 
spz>actSpz(2) (n=9). Green triangles, spz>Spz-FL (n=6). (D) Boxplots showing ranges and 
outliers for brain area, VNC area and VNC length. (E) Bar charts showing mean brain area, 
mean VNC area and mean VNC length. Brain area statistics: Levene’s statistic=0.0, p=0.979; 
one-way ANOVA F(2,23)=1.2, p=0.321. VNC area: Levene’s statistic=0.6, p=0.568; one-way 
ANOVA F(2,24)=1.8, p=0.195. VNC length, Levene’s statistic=1.8, p=0.183; one-way 
ANOVA F(2,24)=5.6, p<0.05. 
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Figure 5.11 Effect on VNC length by repo>NotchICD with Spätzle in different protein forms. 
(A) Representative mounted CNS images acquired with phase contrast using Zeiss Axioplan 
2. Scale bars, 100μm. (B) Scatter plot with each dot representing an individual larvae’s VNC
length. (C) Boxplots showing ranges and outliers for VNC length in each genotype. (D) Bar 
charts showing mean VNC length in each genotype. VNC length, Levene’s statistic=10.6, 




not rescued. Brain area looked as small as those of spz2ca2 (Figure 5.1). VNC morphology 
was perturbed to a large extent – an absolute length of approximately 1mm (Figure 5.11). The 
viability of spz2,repo>spz2,NotchICD larvae reaching pupal stages was very poor, with SI lower than 
that spz2ca1(SI=0.04 and 0.15, respectively; χ2(1)=37.5, p<0.001; Figure 5.12). 
 
In 4 different experimental groups, overexpression of activated and full length forms of both 
DNT1 and DNT2 in the background of repo>NotchICD neither shorten nor lengthen the mean 
VNC length in control genotype repo>NotchICD (Figure 5.13; one-way ANOVA, p=0.278). 
 
5.2.7  Loss of Function Morphology and Cell Numbers 
 
5.2.7.1 Optic Lobe Morphology 
 
The medulla neuropile in the larval optic lobe is normally stained by anti-BP102 (Figure 
5.14A; G9 as control genotype). In homozygous spz2ca1 mutants, anti-BP102 staining 
revealed that the medulla neuropile were almost non-existent (Figure 5.14B). The medulla 
neuropile structures were retained in spz2ca1/ru1st1ea14spz3ca1, ru1h1th1st1cu1sr1esca1, 
spz2ca1/Df(3R)Exel6205, spzMA05/Df(3R)Exel6205 and dnt141/dnt155 mutants (Figure 5.14C-
G). Loss of medulla neuropile structure in spz2ca1 accounted for the small brain areas of all 
spz2 animals (Figure 5.1, Figure 5.2, Figure 5.5, Figure 5.8).  
 
Adult eyes of spz2ca1/ru1st1ea14spz3ca1, spz2ca1/ru1Diap1st1kniri-1rnroe-1ppe1spz4, and 
spz2ca1/Df(3R)Exel6205 were largely normal in structure in comparison to wild-type eyes of 
Oregon-R. Although spz2ca1 lost the medulla neuropile during third instar larvae, the adult   
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Figure 5.12 Survival index as a measure of animal viability for genotypes spz2ca1/TM6B and 



























































































































































































































Figure 5.13 Effect on VNC length by repo>NotchICD with DNT1 and DNT2 in different 
protein forms. (A) Representative mounted CNS images acquired with phase contrast 
using Zeiss Axioplan 2. Scale bars, 100μm. (B) Scatter plot with each dot representing an 
individual larvae’s VNC length. (C) Boxplots showing ranges and outliers for VNC length in 
each genotype. (D) Bar charts showing mean VNC length in each genotype. VNC length, 
Levene’s statistic=2.2, p=0.088; one-way ANOVA F(4,47)=1.3, p=0.278. 
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E spz2ca1/Df6205 spzMA05/Df6205F DNT41/DNT55G
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H I J K L
Figure 5.14 Optic lobe and eye development of spz and dnt1 mutants. (A to G) Horizontal 
views of anti-BP102 staining in larval third instar CNS. (H to L) Eyes of adult flies with w+ 
background. Red arrows and asterisk refer to medulla neuropile. Yellow arrows and 
asterisk refer to thoracic processes. Scale bars, (A to G) 50 µm; (H to L) 100 μm.
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eyes retained normal gross morphology (Figure 5.14). 
 
5.2.7.2 VNC Cortex Organisation 
 
Anti-Elav staining in yw and spz2ca1 showed no obvious morphological differences between 
the two genotypes (Figure 5.15). The same applied between yw and spzMA05/Df(3R)Exel6205 
(Figure 5.16).  
 
Double staining of anti-GS2 and anti-Elav stainings, however, revealed a subtle difference 
between yw and spz2ca1 (Figure 5.15), not pertaining to glial cell shape but to cell 
organisation instead. In the dorsal maximum projections, the neuropile-associated glia 
labelled by anti-GS2 in spz2ca1 appeared to be more compactly packed than in yw. The subtle 
cell disorganisation was reflected in double anti-Ebony and anti-Repo staining, in which the 
organisation of the ventral interface glia (vIG) looked affected (Figure 5.17). The organisation 
looked affected but the categorisation of the vIG pairing showed that the differences were not 
signficant (Table 5.6). The number of Ebony+ cells in the abdomen was not affected in 
spz2ca1 (Figure 5.18).  
 
Genotype No. of VNC with ≤ 5 pairings 
No. of VNC with > 5 
pairings but not all cell 
are in pairs 
No. of VNC with all cells 
in pairs  
(either 7/7 or 8/8 pairs in 
full) 
yw 2 7 1 
spz2ca1 1 7 5 













Figure 5.15 Anti-Elav and anti-GS2 staining in yw (n=7) and spz2ca1 (n=11). Maximum 
projections were used throughout. White arrows: corresponding thoracic spaces. Yellow 
arrows: corresponding abdominal areas. Scale bars, 50µm. 
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anti-Elav staining in yw VNC (n=12)
dorsal ventral
anti-Elav staining in spzMA05/Df(3R)Exel6205 VNC (n=4)
dorsal ventral
Figure 5.16 Anti-Elav staining in yw (n=12) and spzMA05/Df(3R)Exel6205 (n=4). Maximum






















Figure 5.17 Anti-Ebony and anti-Repo staining in yw (n=13) and spz2ca1 (n=10).  White 
























Figure 5.18 Counting abdominal Ebony+ Repo+ cells in larval third instar VNC. Genotypes: 





5.2.7.3 Repo+ Glia Numbers 
 
The mean numbers of thoracic and abdominal Repo+ cells in spz2ca1 mutants were not 
significantly different from those in yw (Figure 5.19). The genotypes spz2ca1/Df(3R)Exel6205 
and spzMA05/ Df(3R)Exel6205 had increased mean Repo+ cells than yw (Figure 5.19). 
 
Results in Figure 5.20 show that glial numbers in the VNC of dnt141/Df(3L)Exel6101 and 
dnt237/Df(3L)Exel6101 were unaffected. Double Toll7 and Toll6 mutants had more abdominal 
Repo+ glia than yw, but their thoracic glial numbers were not affected (Figure 5.21).  
 
5.2.7.4 Survival Index of Tollr3 
 
When Tollr3ca1/TM6B flies were crossed to Df(3R)ro80b,st1e1/TM6B flies, the resulting SI of 
their non-tubby progeny (with normal embryogenesis at 18°C but loss of function larval life at 
29°C) was 0.13 (Figure 5.22).  
 
5.2.7.5 pH3+ Mitotic Cells 
 
The number of pH3+ cells in loss of function spz mutants were not significantly affected 
(Figure 5.23). Neither were proliferative levels in dnt1 and dnt2 mutants (Figure 5.24). In 
double Toll7 and Toll6 mutants, there was an increase in mitotic events in the thorax (Figure 
5.25) while mitosis was unaffected in the abdomen (Figure 5.25).  
 
  
Figure 5.19 Counting Repo+ cells in genotypes yw, spz2ca1, spz2ca1/Df(3R)Exel6205 and 
spzMA05/Df(3R)Exel6205. (A) Horizontal views of anti-Repo staining in thoracic VNC. (B) 
Profile of Repo+ in each genotype’s thoracic VNC, accounting all values from larvae (scatter 
plot), value distributions (box plot) and means as average (bar chart). Levene’s statistic=0.2, 
p=0.910; one-way ANOVA F(3,48)=2.4, p=0.076. (C) Horizontal views of anti-Repo staining 
in abdominal VNC. (D) Profile of Repo+ cells in each genotype’s abdominal VNC, 
accounting all values from larvae (scatter plot), value distributions (box plot) and means as 
average (bar chart). Levene’s statistic=1.6, p=0.204; one-way ANOVA F(3,72)=6.9, p<0.001. 
Scale bars, 25µm. 
A
yw spz2ca1 spz2ca1/Df6205 spzMA05/Df6205
anti-Repo staining in THORAX
yw spz2ca1 spz2ca1/Df6205 spzMA05/Df6205





































































































































































Figure 5.20 Counting Repo+ cells in genotypes yw, dnt141/Df(3L)Exel6101 and dnt237/
Df(3L)Exel6092. (A) Horizontal views of anti-Repo staining in thoracic VNC. (B) Profile of 
Repo+ cells in each genotype’s thoracic VNC, accounting all values from larvae (scatter 
plot), value distributions (box plot) and means as average (bar chart). Levene’s statistic=0.3, 
p=0.726; one-way ANOVA F(2,37)=0.1, p=0.929. (C) Horizontal views of anti-Repo staining 
in abdominal VNC. (D) Profile of Repo+ cells in each genotype’s abdominal VNC, 
accounting all values from larvae (scatter plot), value distributions (box plot) and means as 
average (bar chart). Levene’s statistic=0.2, p=0.803; one-way ANOVA F(2,45)=0.4, p=0.685.
Scale bars, 25µm. 
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Figure 5.21 Counting Repo+ cells in genotypes yw and Toll7P114/Toll7P8;Toll631/Toll626. (A) 
Horizontal views of anti-Repo staining in thoracic VNC. (B) Profile of Repo+ cells in each 
genotype’s thoracic VNC, accounting all values from larvae (scatter plot), value distributions 
(box plot) and means as average (bar chart). Levene’s statistic=0.1, p=0.790; t-test t(26)=-1.3, 
p = 0.193. (C) Horizontal views of anti-Repo staining in abdominal VNC. (D) Profile of 
Repo+ cells in each genotype’s abdominal VNC, accounting all values from larvae (scatter 
plot), value distributions (box plot) and means as average (bar chart). Levene’s statistic=0.1, 
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Figure 5.22 Survival index as a measure of animal viability for Tollr3ca1/Df(3R)ro80b,st1e1. In 
this experiment, embryogenesis was at permissive temperature 18°C and larval life stages at 
restrictive temperature 29°C. The statistical result in the chart above was a result of the 













Figure 5.23 Counting pH3+ cells in genotypes yw, spz2ca1, spz2ca1/Df(3R)Exel6205 and 
spzMA05/Df(3R)Exel6205. (A) Horizontal views of anti-pH3 staining in thoracic VNC. (B) 
Profile of pH3+ cells in each genotype’s thoracic VNC, accounting all values from larvae 
(scatter plot), value distributions (box plot) and means as average (bar chart). Levene’s 
statistic=1.8, p=0.173; one-way ANOVA F(3,28)=1.9, p=0.160. (C) Horizontal views of anti-
pH3 staining in abdominal VNC. (D) Profile of pH3+ cells in each genotype’s abdominal 
VNC, accounting all values from larvae (scatter plot), value distributions (box plot) and 
means as average (bar chart). Levene’s statistic=1.1, p=0.340; one-way ANOVA F(3,47)=1.9, 
p=0.139. Scale bars, 25µm. 
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Figure 5.24 Counting pH3+ cells in genotypes yw, dnt141/Df(3L)Exel6101 and dnt237/
Df(3L)Exel6092. (A) Horizontal views of anti-pH3 staining in thoracic VNC. (B) Profile of 
pH3+ cells in each genotype’s thoracic VNC, accounting all values from larvae (scatter plot), 
value distributions (box plot) and means as average (bar chart). Levene’s statistic=2.6, p=0.105; 
one-way ANOVA F(2,18)=1.8, p=0.187. (C) Horizontal views of anti-pH3 staining in 
abdominal VNC. (D) Profile of pH3+ cells in each genotype’s abdominal VNC, accounting 
all values from larvae (scatter plot), value distributions (box plot) and means as average (bar 
chart). Levene’s statistic=1.6, p=0.206; one-way ANOVA F(2,38)=1.6, p=0.207. Error bars 
represent standard deviations. Scale bars, 25µm. 
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Figure 5.25 Counting pH3+ cells in genotypes yw and Toll7P114/Toll7P8;Toll631/Toll626. (A) 
Horizontal views of anti-pH3 staining in thoracic VNC. (B) Profile of pH3+ cells in each 
genotype’s thoracic VNC, accounting all values from larvae (scatter plot), value distributions 
(box plot) and means as average (bar chart). Levene’s statistic=0.6, p=0.444; t-test t(13)=-2.6, 
p=0.023. (C) Horizontal views of anti-pH3 staining in abdominal VNC. (D) Profile of pH3+ 
cells in each genotype’s abdominal VNC, accounting all values from larvae (scatter plot), 
value distributions (box plot) and means as average (bar chart). Levene’s statistic=0.3, 
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Within the ‘non-mitotic’ zone of the abdomen (Figure 5.26), the number of pH3+ could go up 
to 12 and the collective mean across all genotypes was 5 cells (Table 5.12). Across all 
genotypes, the number of pH3+ cells did not differ significantly from each other.  
 
Genotype 
No. of VNC 
with pH3+ 
cells ≤ 5 
No. of VNC 
with pH3+ 
cells > 5 
% of VNC 
with pH3+ 
cells ≤ 5 
% of VNC 
with pH3+ 
cells > 5 
yw 18 12 60.0 40.0 
spz2ca1 3 2 60.0 40.0 
spz2/Df6205 1 7 12.5 87.5 
spzMA05/Df6205 2 6 25.0 75.0 
dnt141/Df6101 4 2 66.7 33.3 
dnt237/Df6092 3 1 75.0 25.0 
Toll7P114/Toll7P8;Toll631/Toll626 2 2 50.0 50.0 
Table 5.12 Proliferative levels in the ‘non-mitotic’ zone.  
χ2(6)=9.6, p=0.145.  
 
5.2.7.6 Dcp1+ Apoptotic Cells 
 
Abdominal apoptotic levels of loss of function spz were lowered than in yw (Figure 5.27). 
Among the loss of function groups, only the spz2ca1 group had apoptosis at levels significantly 
below yw. When considering only the ‘non-apoptotic’ zone, the levels of apoptosis were 
correlated with global levels in the abdominal region (Table 5.13). 
 
Genotype N No. of Abdominal Dcp1+ Cells 
No. of Dcp1+ Cells in ‘Non-
Apoptotic’ Zone 
Mean No. SD Mean No. SD 
yw 17 101 ±12 27 ±8 
spz2ca1 5 69 ±25 12 ±6 
spz2/Df6205 5 94 ±4 21 ±4 
spzMA05/Df6205 5 92 ±16 24 ±6 
Table 5.13 Apoptotic levels in spz loss of function genotypes.  
  
214
Figure 5.26 Illustration of the areas within the abdomen which contained either dense pH3+ 
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Figure 5.27 Counting Dcp1+ cells in genotypes yw, spz2ca1, spz2ca1/Df(3R)Exel6205 and 
spzMA05/Df(3R)Exel6205. (A) Horizontal views of anti-Dcp1 staining in thoracic VNC. (C) 
Profile of Dcp1+ in each genotype’s thoracic VNC, accounting all values from larvae (scatter 
plot), value distributions (box plot) and means as average (bar chart). Levene’s statistic=2.7, 




5.2.7.7 Sholl Analysis of spz2 Loss of Function 
 
In the thorax, RP2 neurons of spz2 (Figure 5.28B) appeared to occupy smaller volumes than 
the control (Figure 5.28A) in terms of space occupied by dendrites. RP2 cell bodies looked 
similar in size (Figure 5.28A, B). The furthest dendrite intersection recorded at 50 µm away 
from the spz2 soma in comparison to 95 µm from the control soma (Figure 5.28C). RP2 of 
spz2 had denser branching than control at 10 microns away from the cell body (Figure 5.28D). 
At 40 microns distance from the control soma, the highest mean number of intersection was 
within 10 microns of the edge of the spz2 RP2 dendrite branches (Figure 5.28D). Independent 
of the distance from soma variable, the linear Sholl plots for control and spz2 looked similar in 
terms of fitting peak and trough curves (Figure 5.28D). All together, these results indicate that 
RP2 neurons of spz2 occupied smaller volumes than wild-type in VNC but branching 
complexity between the two might not be different. 
 
Within the first three abdominal segments, RP2 neurons from control, spz2 and 
spz2/Df(3R)Exel6205 genotypes were sampled and cross-compared (Figure 5.29). The linear 
Sholl plots for each genotype show somewhat bell-shaped curves (Figure 5.30). Fitted curve 
for spz2 in A1-3 was similar to that in the thorax (Figure 5.29D) for the highest mean number 
of intersection occurring at 15 microns away from the peripheral. For the control and 
spz2/Df(3R)Exel6205, their peaks were approximately half-way of their respective furthest 
distance from the soma. RP2 neurons of spz2 and spz2/Df6205 showed smaller volume 
occupancy than those of yw (Figure 5.30A, B).   
Figure 5.28 Sholl analysis comparing between control and spz2 thoracic RFP+ RP2 neurons.
(A, B) Raw images in maximum projection and in horizontal view. (A’, B’) Corresponding 
segmented images. (A’’, B’’) Sholl profiles. (C) Profile of number of intersection points at 
distances in 5µm increments from the soma. Each blue diamond marker represents an 
intersection for the control genotype (n=5). Red squares, spz2 (n=3). (D) Corresponding
mean profile with curve fitted to polynomial function. Red arrows emphasises the yellow 
dots marking the point at which the main axon leaves the soma. Scale bar, 25µm. 
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Figure 5.29 Sholl analysis comparing control, spz2 and spz2/Df(3R)Exel6205 abdominal 1-3 
RFP+ RP2 neurons. (A, B, C) Raw images in maximum projection and in horizontal view. 
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Figure 5.30 Sholl profile corresponding to Figure 5.29. (A) Profile of number of intersection 
points at distances in 5µm increments from the soma. Each blue diamond marker represents 
an intersection for the control genotype (n=2). Red squares, spz2 (n=2). Green triangles, spz2/
Df(3R)Exel6205 (n=4). (B) Corresponding mean profile with curve fitted to polynomial 
function. Red arrows emphasises the yellow dots marking the point at which the main axon 




Volume occupancy of RP2 neurons between control and spz2/Df(3R)Exel6205 overlapped in 




5.3.1 CNS Size Experiments 
 
The brains of spz2ca1/Df6205 did not phenocopy those of spz2ca1 in size. Given that the allele 
spz2 arose through chemical mutagenesis, it is conceivable that there are other possible 
mutated genes, in the form of recessive alleles, elsewhere of Df(3R)Exel6205, which interact 
with spz2 in homozygosis to result in the small brain phenotype. However, the suggestion of 
ca1 interacting with spz2 to reduce CNS size has been tested to be incorrect because spz2ca1, 
spz2ca+.33 and spz2ca+.56 brains were similar to each other. Therefore, the interacting factor 
of spz2 to affect CNS size remains unknown. This unknown interaction would have disrupted 
the development of the medulla neuropile in spz2ca1 as shown in Figure 5.14.  
 
While the spz2ca1 VNC was smaller than yw, the Ebony+ neuropile associated glia numbers 
were unaffected and the Ebony+ glia were more tightly packed into the VNC. Repo+ glial 
numbers were also not affected in spz2ca1. Therefore, the small VNC size of spz2ca1 could not 
be a result of deficient glia numbers packing in the VNC. While there was no obvious 
qualitative difference between anti-Elav stainings of yw and spz2ca1, whether or not the small 
VNC could be attributed to neuronal numbers, the current combination of staining with anti-
Elav followed by automatic counting with DeadEasy would not be an accurate means to 
measure neuronal abundance in the VNC cortex.  
Figure 5.31 Sholl analysis comparing between control and spz2/Df(3R)Exel6205 abdominal 
6-7 RFP+ RP2 neurons. (A, B) Raw images in maximum projection and in horizontal view. 
(A’, B’) Corresponding segmented images. (A’’, B’’) Sholl profiles. (C) Profile of number of
intersection points at distances in 5 µm increments from the soma. Each blue diamond 
marker represents an intersection for the control genotype (n=2). Green triangles, spz2/
Df(3R)Exel6205 (n=3). (D) Corresponding mean profile with curve fitted to polynomial 
function. Red arrows emphasises the yellow dots marking the point at which the main axon 
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VNC size of spz2 could be rescued with spz2,elav> spz2,Toll10b and spz2,elav> spz2,Toll6CY. 
VNC size were extended longer than yw in spz2,elav>spz2,p35, spz2,repo>spz2,Toll10bB and 
spz2,repo> spz2,NotchICD. Accordingly, there was a positive association between rescued 
VNC size with higher SI values and extended VNC size with lower SI values. The extended 
VNC in genotypes spz2,repo> spz2,Toll10bB and spz2,repo> spz2,NotchICD could be due to 
genetic interactions affecting a combination of the extracellular matrix and glia that result in 
an elongated VNC phenotype. Toll is known to mediate cell-cell interactions to orient cell 
arrangements (Pare et al., 2014). Notch signalling in glia has been reported to cause 
neighbouring differentiating enruons to extrude a mesh of filopodia into the extracellular 
space (Kuzina et al., 2011). Also, glycosyltransferase Fringe has been reported to induce 
longitudinal glia to activation of Notch signalling (Thomas and van Meyel, 2007).  
 
It was observed that spz2 viability was better in spz2,repo>spz2,actSpz(2) than 
spz2,elav>spz2,actSpz(2), and vice versa for Toll10bB. An explanation was provided in the 
above paragraph for Toll10bB, but more data is required in the form of CNS sizes from 
genotypes spz2,repo>spz2,actSpz(2) and  spz2,elav>spz2,actSpz(2) to formulate an explanation. 
 
The overexpression of different forms of Spz protein, CysKnot or full-length form, using spz-
GAL4 could have differential effect in VNC length whereby the CK-form gave a longer VNC 
than the FL-form. However, this conclusion could be marred by the presence of an outlier to 
skew the mean. Increasing biological samples would resolve the issue. With the combined 
used of UAS-myr-Tomato, spz-GAL4 was shown to be active in the surface glia and in the 
neurons. Thus, spz-GAL4 and repo-GAL4 would overlap in promoter activity in the surface 
glia. When CK- and FL-forms were overexpressed in the background of repo>NotchICD, their 
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effect on VNC length did not differ from each other. Therefore, it is unlikely for the CK-form 
to give a longer VNC than the FL-form unless there were penetrance issues from 
overexpressing the CK-form. Overexpression of different forms of DNT1 and DNT2 did not 
affect VNC length.  
 
5.3.2 Mitosis and Apoptosis Experiments 
 
Within the non-mitotic zone across all genotypes, the numbers of pH3+ cells did not differ 
significantly from each other. It was difficult to draw conclusions from these data given the 
large variance in control group and the low sampling numbers in test groups. 
 
Up to the point of the wandering larvae, the spz2ca1 CNS did not grow to wild-type size. 
Abdominal apoptotic levels were about half that of wild-type in the VNC while abdominal 
proliferative levels were unchanged. The average absolute numbers of Dcp+ cells in yw 
wandering stage was not instructed in the small CNS of spz2ca1. However, whether or not this 
is biological meaningful at wandering larval stage would require more data analysis to take 
into account the ratio of dying cells per unit VNC area or volume for control and test 
genotypes. The VNC of wandering spz2,elav>spz2,p35 was larger than the VNC of spz2ca1. 
Given that p35 is an apoptotic inhibitor, this would suggest that the wandering spz2ca1 is small 
due to earlier events of apoptosis.  
 
In the embryos, there were increase cell death in loss of function dnt1 and dnt2 loss of 
function mutants. Although apoptosis was not investigated here for DNT1 and DNT2, 
proliferation and glial numbers were. These numbers were maintained. If the aim of the larval 
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life stage is to grow and to do so with organ size adjusted properly to each other before 
entering pupal stages, perhaps redundancy is employed to achieve this. When the dnt1 and 
dnt2 receptors were affected, that is, Toll7 and Toll6, the double Toll7 Toll6 mutants have 
higher proliferative levels, in particular, in the thorax. The number of glial in the thorax is 
higher but not significant (possibly due to low sample numbers) while the number is 
significantly higher in the abdomen, therefore the VNC of double mutants Toll7 Toll6 had 
more glia, and this might be due to slight qualitative lengthening of the nerve cord. While 
smaller CNS may compact basal number of glia, longer CNS would require more surface 
materials and glial support. Perhaps more proliferative signal were instructed too.   
 
5.3.3 Sholl Analysis  
 
Sholl analysis gave surprising results. It is not unexpected to expect small RP2 neurons with 
smaller coverage of dendrites in tightly packed neuropile of spz2. However, 
spz2/Df(3R)Exel6205 had no CNS gross size effect but the coverage of A1-3 RP2 neurons in 
the abdomen was smaller than spz2 and the control. Therefore, at the single cell resolution 
level, spz2/Df(3R)Exel6205 were affected. Increasing sample sizes would strengthen the 
results of this analysis. Whether or not the dendrites were cell-autonomously or non-cell-
automously affected would require MARCM clones or the use of dominant negative Spz 
receptors in the RP2 cells.  
 




The spz2ca1 flies have been reported to barely walk (Zhu et al., 2008). During the screen for 
spz2ca+ flies, some spz+ lines were observed to have locomotion defects (Table 5.2). 
Therefore, locomotion defects in spz2ca+ might be due to a yet identified gene. Given the lack 
of rescue of spz2 brain area (and thereby, the medulla neuropile structure), the unidentified 
gene is very likely one related to both optic lobe structures and to locomotion. Mutants such 
as lobula plateless (lop), minibrain (mnb), optomotor blind (omb), sine oculis (so) and small 
optic lobes (sol), as well as double mutants mnb with so, and so with sol, exhibit reduction in 
optic lobe structures as a result of cell date, and the mutants were correlated with locomotor 
activity rhythm and behaviour changes (Delaney et al., 1991; Helfrich, 1986).  
 
It is important to bear in mind when making future fly stocks to incorporate spz loss of 
function alleles that the locomotion or lethality phenotype is not the criteria used to determine 
the presence of spz loss of function alleles. Instead, the protocol in Figure 2.9 should be used.  
 
5.3.5 Limitations of Chapter 5 
 
Males and females were not considered. In hindsight, such a lack of consideration was a 
limitation to the experiments which involved measuring CNS size experiments, counting cell 
death number and profiling A6-7 abdominal neurons. This is because there is plenty of 
evidence in the CNS for prevalent sexual dimorphism (Cachero et al., 2010; Goto et al., 2011; 
Kimura, 2011; Kimura et al., 2005; Sanders and Arbeitman, 2008; Taylor, 1989). To improve 
the experiments in this chapter would require repeating the experiments and increasing the 










With neuropile axon bundles visualised by G9 and glia with repo>DsRed (genotype: UAS-
DsRed/+;G9/+;repo-GAL4/+), Kato et al. (2011) observed in injured VNC that the wound 
initially expanded, but after 6 hours of culture, the neuropile wound would shrink, and by 22 
hours in culture, the wound could closed in completely. The overexpression of the 
intracellular domain of Notch in glia (genotype: UAS-DsRed/+;G9/+;repo-GAL4/UAS-
NotchICD-myc) prevented injury-induced apoptosis and there was no observation of wound 
expansion (Kato et al., 2011). Only wound reduction was observed, and by 13 hours in 
culture, the neuropile restored in its gross appearance neatly-arranged axon bundles. The 
above findings suggested that NotchICD (or the overproduction of glia upon the 
overexpression of NotchICD) could lead to the production of a trophic factor that promotes 
wound closure. Here, this chapter is about investigating if Spz, DNT1 or DNT1 could be the 
factor to promote gross CNS repair.  
 
6.1.1 Technical Aspects of the Injury Model 
 
In the stabbing injury model, dissected larval CNS is pierced through the abdomen from the 
dorsal side with a fine needle. This is technically very difficult because the model is prone to 
degradation problems. Degradation is common as a result of dissection and tissue piercing. 
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Degraded CNS has a rough cauliflower-like surface appearance, which is visible under a 
dissecting stereomicroscope. Within the tissue of non-stabbed samples, degradation can be 
recognised by cortex or neuropile vacuoles seen with the background signal of 
immunostained samples (Kato and Hidalgo, 2013). The vacuoles in the degrading larval CNS 
are reminiscent of inflammation- and injury-induced cavitation in the brain and spinal cord of 
Sprague Dawley rats, respectively (Ahmed et al., 2014; Fitch et al., 1999).  
 
To avoid degradation, CNS needs to be extracted gently from the larval body without forceful 
pulling and tugging of surrounding tissue (Kato and Hidalgo, 2013). The damage of the CNS 
as a consequence of forceful extraction is naked to the visible eye but damaged CNS will 
disintegrate in culture (Kato and Hidalgo, 2013). During dissection, it is possible to spill the 
contents of the larval gut – there would be a sudden appearance of food suspensions in the 
dissecting medium upon breaking the larval body. At this point, the dissecting medium must 
be replaced so that the food suspensions are not carried over into sterile culture environment. 
Microbial growth in culture can cause dissected CNS to disintegrate. When piercing the VNC, 
the needle goes through the abdomen from the dorsal side until the needle hits the bottom of 
the dissecting dish. It is easy to blunt the tip of the needle, but a larger than necessary wound 
will inevitably cause the CNS to disintegrate. The wound made by the needle is naked to the 
visible eye under a dissecting stereomicroscope, so it is important to maintain a sharp needle 
tip and to ensure that the needle only pierced through the abdomen once without being 
forceful (Kato and Hidalgo, 2013).  
 
Regular upkeeping of a sharp needle also contributes to achieving consistency in the stabbing 
injury model. Another way to reach consistency is to use the posterior half of the VNC as the 
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reference point for the needle to pierce through. CNS samples with cauliflower-like 
appearance or with extensive vacuolisations are not considered for analysis. Due to the 
inherent problems in using the stabbing injury model, before investigating whether or not the 
DNTs and Tolls could affect CNS repair, it was first necessary to observe wound closure in 
time-lapse.  
 
6.1.2 Technical Aspects of Time-Lapse Imaging 
 
The protein-trap line G9 drives GFP expression from the locus of the reticulon gene, whose 
protein products are associated with the secretory pathway including the endoplasmic 
reticulum organelle (Morin et al., 2001; Wakefield and Tear, 2006). Effectively, G9 3rd instar 
larvae have high expression of GFP in their VNC neuropile (Morin et al., 2001; O'Sullivan et 
al., 2012; Wakefield and Tear, 2006). This effectiveness of G9’s fluorescing VNC neuropile 
was therefore utilised to carry out stabbing injury and time-lapse imaging.  
 
It was difficult to book an imaging session of more than 3 hours during the day for time-lapse 
recordings due to high demand for the Leica confocal system. Therefore, imaging sessions 10 
to 15 hours long were done during the evenings. As the computer hardware operating the 
Leica is old and limited on processing memory, there is a tendency for the image acquisition 
software to stop operating and close on itself during the overnight imaging. Whenever this 
happens, the acquired image is lost without being saved. One way to overcome this problem 
is to use the newer Zeiss confocal system which has a bigger memory and processing capacity. 
However, the Zeiss system was found to be less effective in maintaining a stable temperature 
at 25°C in comparison to the Leica. After a session of 12 hours overnight imaging on the 
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Zeiss, the heated stage recorded a temperature of 28°C. So, time-lapse imaging was 
preferentially recorded on the Leica despite the risk of losing data. Given that Kato et al. 
(2011) observed wound closure between 6 to 22 hours after stabbing, and that it was 
necessary to observe for wound closure in this chapter, the time-lapse recording was set up 
with overnight recording beginning at 6 hours post-stabbing. 
 
6.1.3 Specific Aims 
 
The specific aims of this chapter are: 
∑ To reproduce the wound closure in the stabbing injury model as published in papers 
by Kato et al. (2011) and Kato and Hidalgo (2013). 
∑ To assess the effect of spzMA05 on the ability of the nerve cord to close nervous system 
wound. 
∑ To also assess the effect of Toll6 and Toll7 loss of function alleles on nervous system 
wound closure.  
∑ To examine the effects on wound closure by an activated form of Spz, a CysKnot with 
3’tail form of DNT1, and a CysKnot-only form of DNT2.  
 
6.1.4 Methods in Brief 
 
3 G9 VNC were stabbed using a needle and subsequently their wound progression was 
recorded by Z-stack time-lapse imaging. Throughout each Z-stack of images, at each time 
point, the largest outline of the neuropile wound was set as the ROI area and measured in 
square microns in ImageJ. Paired t-test were used to compare mean wound areas from two 
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time points because of related sampling, as opposed to independent sampling, at hourly time 
points (Section 9.3.1). Bonferroni post hoc corrections were applied to paired t-test p-values 
(Section 9.3.1).  
 
Using time-lapse imaging to investigate the effect of various genes on VNC wound would be 
too laborious and would require generating stocks in a G9 background. Instead, the VNC of 
test and control (yw) genotypes were stabbed using a needle and cultured for 20 to 24 hours 
before fixing and staining with anti-GS2 antibody. After confocal imaging, ROI was again 
defined by the largest outline of the neuropile wound throughout each Z-stack, and measured 
in µm2. The data sampled for each genotype were normally distributed with equal variances, 
so one-way ANOVA and Dunnett post hoc correction were applied to compare mean wound 
areas of test genotypes to the mean wound area of yw (Section 9.3.2 and 9.3.3).  
 




6.2.1 Assessment of Wound Progression in G9 VNC Neuropile 
 
In the first recording of an injured G9 VNC, imaging took place 6 to 21 hours after applying 
injury (Table 6.1). There was a wound epicentre observed at 6 hours after stabbing injury in 
the posterior medial of the neuropile (Figure 6.1A). There were also vacuoles surrounding the 
wound epicentre at the posterior lateral (Figure 6.1A). The vacuoles were considered to be 
lesion resulting from stabbing injury and were included into the wound ROI. From 6 to 21   
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nth G9 sample 1st 2nd 3rd Mean wound 
area, Wmean  
(±SD μm2) Hours after stabbing (hr) Wound area, W (μm
2) 
3   2547  
4   3303  
5   3683  
6 7387 3614 4359 5120±1988 
7 7605 3428 4327 5120±2199 
8 7948 3578 4611 5379±2284 
9 7837 3506 4401 5248±2286 
10 6776 3072 4683 4844±1857 
11 7475 2838 5029 5114±2320 
12 6292 2682 4561 4512±1806 
13 5883 2614 4644 4380±1650 
14 5745 2487 4223 4152±1630 
15 5907 1490 3751 3716±2209 
16 5420 1645  3533±2669 
17 5468 1241  3355±2989 
18 5541    
19 5366    
20 5661    























Table 6.1 Hourly measurements of neuropile wound areas corresponding to the 3 time-lapse 
imaging events of stabbed G9 VNC depicted in Figure 6.1.  
ΔW/ΔT (to 1 d.p.) is the rate of change in wound area from the initial to final time points. 
δW/δT (to 1 d.p.) is the rate of change in wound area over smaller defined time periods. 
  
Figure 6.1 Wound progression among stabbed G9 larval VNC neuropile (n=3). The yellow 
asterisk indicates the lesion epicentre in the (A) 1st, (B) 2nd and (C) 3rd G9 sample. (D) 
Wound area profile of 3 individual G9 samples from (A) to (C), each represented by solid 
coloured lines. The mean wound area profile is represented by a dotted black line. 
Statistics: paired t-test. (E) Corresponding profile of relative change in wound area. The 
reference time is the initial time point common to all the time-lapse recordings, that is, 6 
hours after applying injury. Scale bars in (A) to (C) represent 10μm.  
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hours after injury, the wound area decreased from 7387μm2 to 5493μm2 (Table 6.1, Figure 
6.1D), a decrease of approximately a quarter of its initial size (relative change in wound 
area=0.744, Table 6.2, Figure 6.1E,). 
 
The second injured G9 VNC was imaged from 6 to 17 hours after stabbing injury (Table 6.1, 
Figure 6.1B). Wound area was at its largest (3614μm2) and smallest (1241μm2) at the start 
and end of time-lapse imaging, respectively (Table 6.1, Figure 6.1D). By 17 hours after 
applying injury, the wound area decreased by approximately two-thirds of its initial size 
(relative change in wound area=0.343, Table 6.2, Figure 6.1E). 
 
For the third time-lapse recording, stabbed G9 VNC was imaged beginning at 3 hours after 
applying stabbing injury (Table 6.1, Figure 6.1C). Between 3 to 6 hours post-injury, the 
wound area steadily increased (δW/δT3-6h=+604.0μm2h-1, Table 6.1, Figure 6.1D). From 6 
hours onwards after injury, the wound area continued to increase, until at 11 hours post-
stabbing, the wound area began to decrease, and by 15 hours after stabbing, the wound area 
decreased by approximately one- tenth of the size at 6 hours post-injury (relative change in 
wound area=0.861, Table 6.2, Figure 6.1E). 
 
The wound kinetics in each of the three stabbed G9 VNC were different to each other in terms 
of when the wound area stopped expanding upon injury (1st G9: 8 hours after injury; 2nd G9: 
11 hours after injury; 3rd G9: wound expansion not observed). There was also a difference in 
the degree of wound area change. For example, from 6 to 15 hours post-injury, the relative 
changes in wound area for the 1st, 2nd and 3rd G9 sample were 0.800, 0.412 and 0.861, 
respectively (Table 6.2). The corresponding rates of change in wound area (δW/δT6-15h)   
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Nth G9 sample 2nd 3rd 4th Mean relative change 
in wound area Hours after 
stabbing (hr) Relative change in wound area 
3   0.584  
4   0.758  
5   0.845  
6* 1.000 1.000 1.000 1.000 
7 1.030 0.949 0.993 0.990 
8 1.076 0.990 1.058 1.041 
9 1.061 0.970 1.010 1.014 
10 0.917 0.850 1.074 0.947 
11 1.012 0.785 1.154 0.984 
12 0.852 0.742 1.046 0.880 
13 0.796 0.723 1.065 0.862 
14 0.778 0.688 0.969 0.812 
15 0.800 0.412 0.861 0.691 
16 0.734 0.455  0.594 
17 0.740 0.343  0.542 
18 0.750    
19 0.726    
20 0.766    
21 0.744    
 
Table 6.2 Relative changes in neuropile wound areas for the corresponding 3 time-lapse 
imaging events of stabbed G9 VNC depicted in Figure 6.1. 
The relative change in wound area is the ratio of wound area at any given time point over the 
reference wound area at 6 hours (*) after applying injury. The reference wound area is the 




were -164.4μm2h-1, -236.0μm2h-1 and -67.6μm2h-1, respectively (Table 6.1). There could be an 
association between the smaller wound in the 2nd G9 sample (Figure 6.1B) with faster wound 
shrinkage (δW/δT6-15h =-236.0μm2h-1), and the larger wounds in the 1st and 3rd samples 
(Figure 6.1A and C) with slower wound closure (1st G9: δW/δT6-15h =-164.4μm2h-1; 3rd G9: 
δW/δT6-15h=-67.6μm2h-1) (Dr A. Hidalgo and Dr K. Kato, personal communication). The 
differences in wound kinetics in terms of when wound stopped enlarging, and in terms of how 
fast the rate of shrinkage occurred, reflect the challenges in using the current injury model. 
Nonetheless, the wound at 6 hours post-injury could shrink to approximately half of its size 
by 17 hours after stabbing (mean relative change in wound area=0.542, Table 6.2, Figure 
6.1E). Wound enlargements were no longer observed among stabbed G9 samples at 11 hours 
after injury. So, while the mean wound areas between 6 and 15 hours post-stabbing were not 
statistically different to each other (paired t-test t(2)=3.196, p=0.086), the mean wound areas 
between 6 and 15 hours post-injury were statistically different (paired t-test t(2)=16.001, 
p<0.01, Bonferroni post hoc p<0.05). The significant reduction in mean wound area indicates 
that wound closure using the stabbing injury model was reproducible in this project.  
 
6.2.2 Effect of Spz on Wound Size  
 
Stabbing yw VNC (n=24) resulted in a mean neuropile wound area of 4575±1858μm2 
between 20 to 24 hours later (Figure 6.2). In loss of function genotype spzMA05/ 
Df(3R)Exel6205 (n=6), stabbing resulted in a mean wound of 6674±1935μm2 at 20 hours after 
injury. The mean wound area as a result of stabbing injury in spzMA05/Df(3R)Exel6205 was 
statistically larger than the mean in yw (one-way ANOVA F(3)=4.087, p<0.05, Dunnett post-



















































































Figure 6.2 Effect of Spz on neuropile wound. (A) Single optical slice examples of wound in 
genotypes yw, spzMA05/Df(3R)Exel6205, elav>actSpz(2) and repo>actSpz(2). (B) Values of 
neuropile wound area between 20 to 24 hours after applying stabbing injury. (C) 




neuronal driver elavGAL4 (n=7) lowered the mean wound area from control to 3411± 
1373μm2 at 24 hours after injury, albeit not significantly (one-way ANOVA F(3)=4.087, 
p=0.314). When activated Spz was overexpressed under glial driver repoGAL4 (n=7), the 
mean neuropile wound area increased to control to 5097±1231μm2 at 21 hours after injury, 
but not significantly (one-way ANOVA F(3)=4.087, p=0.853). 
 
6.2.3 Effect of Toll6, Toll7, DNT1 and DNT2 on Wound Size 
 
The mean neuropile wound area at 20 to 21 hours after injury in Toll7P114/Toll7P8;Toll631/ 
Toll626 double loss of function mutant was 4516±1562μm2 (Figure 6.3). This mean value was 
virtually not different to control whose mean was 4575±1858μm2 at 20 to 24 hours post 
injury. When elav-GAL4 was used to overexpress an activated DNT1 in the form of CysKnot 
with 3’ tail (genotype: UAS-DNT1-CK3’+), the mean wound area (4399±1352μm2) at 22 
hours post stabbing was also virtually not different to control. The lack of difference in 
comparing to control mean wound area was also observed when elav-GAL4 overexpressed 
activated DNT2 CysKnot (genotype: UAS-DNT2-CK-6A) and the resulting mean wound area 
after 21hours of applying injury was 4666±1869μm2. In contrast, when repo-GAL4 was 
crossed to UAS-DNT1-CK3’+, the mean neuropile wound area at 22 hours after injury was 
lowered from control to 3893±149μm2. This was also the case in repo>DNT2-CK-6A, in 
which the mean wound area at 21 hours post-injury was 3172±908μm2. However, the 
reduction in mean neuropile wound areas were not statistically different in the data set of 
Figure 6.3 (one-way ANOVA F(5)=0.708, p=0.621). 
  
Figure 6.3 Effect of Toll6, Toll7, DNT1 and DNT2 on neuropile wound. (A) Single optical 
slice examples of wound in genotypes yw, Toll7P114/Toll7P8;Toll631/Toll626, elav>DNT1-CK3’+,
repo>DNT1-CK3’+, elav>DNT2-CK-6A and repo>DNT2-CK-6A. (B) Values of neuropile 
wound area between 20 to 24 hours after applying stabbing injury. (C) Corresponding mean 




































































































































6.3.1 Importance of Replicating Injury Model  
 
One of the main characteristics of the stabbing injury model described in the papers by Kato 
et al. (2011) and (Kato and Hidalgo, 2013) is a natural wound area shrinkage over time in the 
VNC. A similar shrinking in wound area over time was demonstrated in this project too, 
particularly between 11 and 15 hours after applying stabbing injury to G9 VNC (Figure 
6.1D). However, Kato et al. (2011) observed that wound closure began at 6 hours after 
stabbing injury. The 5-hour difference in the start of wound closure reflects the technical 
difficulties in using the stabbing injury model, which is sensitive to degradation. Also, the 
exact size of the starting lesion cannot be fully controlled in the stabbing injury model. 
Nonetheless, technical care, such as gentle dissection and frequent maintenance of a sharp 
needle tip, were taken to achieve consistency in applying stabbing injury. Due to the 
challenges in carrying out the stabbing injury model, before investigating the effects of genes 
on the ability of the CNS to close a wound as a result of piercing the nerve cord, it was 
important to have demonstrated wound shrinking first in Figure 6.1.  
 
6.3.2 Effects on Wound Closure 
 
In this project, almost all cases of test genotypes did not have an effect on the nerve cord to 
close a stabbing injury wound. The test genotypes which were not significant different from 
control yw are: Toll7P114/Toll7P8;Toll631/ Toll626, elav>DNT1-CK3’+, repo>DNT1-CK3’+, 
elav>DNT2-CK-6A, repo>DNT2-CK-6A, elav>actSpz(2), repo>actSpz(2). The only 
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genotype which resulted in a statistically significant increase in mean VNC neuropile wound 
area was spzMA05/Df(3R)Exel6205. The loss of spz function could have exacerbated wound 








7.1 Summary of Findings 
 
7.1.1 Major Findings in Chapter 3 
 
The specific aims of this chapter were: 
∑ To characterise reporter patterns of dnt1-, dnt2- and spz-GAL4 in the larval VNC. 
∑ To characterise larval VNC EGFP patterns of Mi{MIC} insertions into the spz and 
Toll6 gene. 
∑ To characterise immunostaining patterns of anti-DNT1, anti-DNT2 and anti-Spz 
antibodies in the larval VNC. 
∑ To characterise immunostaining patterns on anti-Toll and anti-Toll7 antibodies in the 
larval VNC. 
 
The author characterised the reporter patterns of dnt1-, dnt2- and spz-GAL4 successfully. The 
Mi{MIC}-GFP patterns in the larval VNC were also successfully characterised. While there 
was extensive work done for the characterisation of anti-DNT1, anti-DNT2 and anti-Spz, 
these antibodies were not specific. Despite this limitation, anti-DNT1-VRY and anti-DNT2-
KRLwere able to detect the epitopes of activated DNT1 and DNT2 in genotypes elav>DNT1-




Anti-Spz-GLR did not detect activated Spz in genotype repo>actSpz(2). However, anti-Spz-
GLR and the EGFP pattern in spzMi08633 matched spatially in the larval VNC. The axon 
bundles in the mechanosensory domain were revealed with both anti-Spz-GLR and anti-
EGFP stainings. In addition, spz>myr-tdTomato reporter signal was complementary to the 
anti-Spz-GLR and EGFP patterns. Given that myr-tdTomato is targeted to the membrane, Spz 
could be inferred to be a secreted protein that is deposited into synaptic rich areas of the 
mechanosensensory domain with the third instar larval VNC neuropile. 
 
The patterns of anti-Toll-d300 and anti-Toll7-AAQ were characterised successfully in G9 and 
yw control genotypes, respectively. Although the aim of characterising anti-Toll-d300 and 
anti-Toll7-AAQ was achieved, future work would benefit from immunostaining third instar 
larval VNC in loss of function genotypes for Toll and Toll7.  
 
7.1.2 Major Findings in Chapter 4 
 
The specific aims of this chapter were: 
∑ To generate a loss of function allele of dnt2 and spz by hsFLP-FRT deletion. 
∑ To classify any newly generated spz allele. 
∑ To characterise the viability of any newly generated dnt2 and spz allele.  
 
The author did not generate a loss of function allele of dnt2. The fly stock carrying the allele 
dnt237 was a gift of Dr. J. Wentzell, and this allele was shown to be semi-lethal, reducing 




Only new alleles of spz were established. The new allele spzMA05 has been shown to have a 
loss of function nature through the lack of ventralising signal when patterning the DV axis in 
offspring of spzMA05/Df(3R)Exel6205 mothers. The larvae of genotype spzMA05/Df(3R)Exel 
6205 are semi-lethal.  
 
7.1.3 Major Findings in Chapter 5 
 
The specific aims of this chapter are: 
∑ To characterise spz2ca1 and spz2ca+ in terms of CNS size. 
∑ To test Toll6 and Toll7 as putative receptors of spz using SI assays. 
∑ To test Toll6 and Toll7 as putative receptors of spz using CNS size. 
∑ To characterise the CNS size when spz is overexpressed by spz-GAL4. 
∑ To test for an interaction between DNTs and Notch using VNC size phenotype. 
∑ To investigate if Spz, DNT1, DNT2, Toll, Toll6 and Toll7 affect Repo+ cell number. 
∑ To investigate if Spz, DNT1, DNT2, Toll, Toll6 and Toll7 affect pH3+ cell number. 
∑ To investigate if Spz, DNT1, DNT2, Toll, Toll6 and Toll7 affect Dcp1+ cell number. 
∑ To characterise the dendrites of spz2 RP2 neurons according to Sholl analysis. 
 
The genotypes spz2ca1 and spz2ca+ were characterised in terms of CNS size, and it has been 
concluded that ca1 is not the contributing factor leading to loss of medulla neuropile. The 
locomotion defect in genotype spz2ca1 is very likely not attributed to spz2.  
 
According to SI assays, there is a stronger genetic interaction between Toll and Toll6 with spz 
from overexpression using elav-GAL4. More CNS data is required for Toll6 and Toll7 from 
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overexpression using repo-GAL4, although SI assays from spz2,elav>spz2,Toll6CY suggest 
Toll6 is a good candidate for Spz as a receptor.  
 
VNC lengths were characterised from overexpression spz-GAL4 lines. No conclusion can be 
derived from this experiment due to negative results.  
 
Repo>NotchICD together with either mature Spz (actSpz) or full-length Spz (spz-FL) 
significantly reduced the extended VNC length exhibited by repo>NotchICD alone. When 
repo>NotchICD took place in homozygous spz2 mutant background, the VNC significantly 
lengthen when compared to the control background, repo>NotchICD alone. Repo>NotchICD 
with mature or full-length DNT1 and DNT2 did not have an effect on the extended VNC 
length exhibited by repo>NotchICD alone. Rather than assessing whether the DNTs interacted 
with Notch, these VNC length assay instead informed Spz was different from DNT1 and 
DNT2 in exerting effects on VNC length in the background repo>NotchICD. 
 
The following genotypes were assessed for counting glia: spz2ca1/spz2ca1, 
spz2ca1/Df(3R)Exel6205, spzMA05/Df(3R)Exel6205, dnt141/Df(3L)Exel6101, 
dnt237/Df(3L)Exel6092 and Toll7P114/Toll7P8;Toll631/Toll626. The mean number of thoracic 
Repo-positive cells from each genotype did not significantly differ from yw. The genotypes 
with a significantly increased mean number of abdominal Repo-positive cells than yw were 
spz2ca1/Df(3R)Exel6205, spzMA05/Df(3R)Exel6205 and Toll7P114/Toll7P8;Toll631/Toll626. Due 




Again, due to the lack of time, no gain of function studies was done with anti-pH3 stainings. 
The only genotype with a mean number of thoracic pH3-positive cells to significantly 
increase from yw was Toll7P114/Toll7P8;Toll-631/Toll-626. The mean number of abdominal 
pH3-positive cells from each genotype did not significantly differ from yw.  
 
The mean numbers of abdominal Dcp1-positive cells in spz2ca1/Df(3R)Exel6205 and 
spzMA05/Df(3R)Exel6205 were not significantly different from yw, while there was 
significantly less Dcp1-positive cells in homozygous spz2ca1 mutants. Given time constraints, 
thoracic regions and gain of function studies were left out.  
 
The RP2 dendrites in thoracic segments 1-3 of homozygous spz2 occupied a smaller field than 
the RP2 dendrites of control genotype. So did the RP2 neurons of both homozygous spz2 and 
heterozygous spz2/Df6205 in the abdominal segments 1-3.  
 
The major limitation of this chapter is the general low sampling number throughout 
experiments coupled with neglecting sexual dimorphism in the larval CNS. A minor 
limitation is the lack of normalised data between cell counts and VNC area or volume.  
 
7.1.4 Major Findings in Chapter 6 and Future Work 
 
The specific aims of this chapter were: 
∑ To reproduce the wound closure in the stabbing injury model as published in papers 
by Kato et al. (2011) and Kato and Hidalgo (2013). 
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∑ To assess the effect of spzMA05 on the ability of the nerve cord to close nervous system 
wound. 
∑ To also assess the effect of Toll6 and Toll7 loss of function alleles on nervous system 
wound closure.  
∑ To examine the effects on wound closure by an activated form of Spz, a CysKnot with 
3’tail form of DNT1, and a CysKnot-only form of DNT2.  
 
Wound closure in stabbed G9 samples was reproduced in this project. However, the kinetics 
of the wound closure in this project was slower in comparison to the kinetic measured by 
Kato et al. (2011). This reflects the technical difficulty for the author to master application of 
the stabing injury model. Therefore, all assessments of genetic effects on the ability of the 
nerve cord to close a wound must be treated with pessimism, in particular when concluding an 
association between loss of spz and lack of wound closure. For this association to strengthen, 
the sample size of stabbed spzMA05/Df(3R)Exel6205 VNC must increase to at least match the 
sampled size of control genotype. With respect to meeting the aims of this chapter and 
contributing to scientific knowledge, the author acknowledged that the results of this chapter 
require replication.  
 
The author avoided describing a closure in wound area as wound repair because only gross 
neuropile structures were observed through the use of G9 and anti-GS2 antibodies. There 
were no attempts in this work to label single axons to observe any fine structural changes 
upon stabbing injury. Due to the lack of definition for structural ‘repair’ in this project, the 
author found it challenging to apply the results of this chapter to mammalian studies of CNS 
development and regeneration. In addition, there was no time to experiment on how lack of 
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spz contributed to increasing wound area. While losing spz function was found weakly 
associated to a negative effect on wound closure, overexpressing Spz either under neuronal or 
glial driver had no impact on the rate of wound closure. In order to explain this, future work 
would have to include overexpressing activated Spz in the background of spzMA05/Df(3R)Exel 
6205. If the overexpression of functional Spz should lower the wound area in spzMA05/Df(3R) 
Exel6205, it would indicate that Spz is one of the factors required in repair but that an excess 
amount of Spz is unnecessary and insufficient to further close in wound area, thus explaining 
the neutral effect on wound closure when neurons overexpressed activated Spz. 
 
7.2 Conclusions on the DNTs and Tolls in the Larval VNC 
 
During the course of this thesis, and together with the author’s data, the Hidalgo lab published 
that Toll-6 and Toll-7 are neurotrophic receptors (McIlroy et al., 2013). DNT1 is found to 
bind Toll7, while DNT2 binds both Toll-6 and Toll-7 (McIlroy et al., 2013). There are no 
good antibodies for labelling Toll-6, but there is an available Mi{MIC}-GFP for Toll-6. Toll-
6 is expressed in many cell bodies, dorsally and ventrally. The Mi{MIC}-GFP pattern do not 
match to the in situs pattern clearly (McIlroy, 2012; McIlroy et al., 2013). However, the 
combine use of Toll-6 Mi{MIC}-GFP and D42(Toll-6)-GAL4 motoneuron reporter show that 
Toll-6 is expressed in the the aCC motoneurons, but not the RP2s. Motoneurons underlie 
larval locomotion behaviour and Toll-6 mutants exhibit locomotion defects (McIlroy et al., 
2013). Anti-Toll7-AAQ reveals Toll-7 in the neuropile of the VNC, central brain and optic 
lobes. The staining pattern matches the in situ pattern of Toll-7 transcripts, especially in the 
neuropile of the central brain and optic lobes (McIlroy, 2012; McIlroy et al., 2013). Toll-6 in 
aCC motoneurons and Toll-7 in the neuropile are in VNC areas relevant to DNT2 in the 
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dorsal neuropile. DNT1 in the neuropile also is in the relevant VNC region to Toll-7. Given 
that the Toll protein family is collectively known for innate immunity functions (Leulier and 
Lemaitre, 2008; Ooi et al., 2002; Tauszig et al., 2000), the discovery of Toll-6 and Toll-7 as 
neurotrophic factors provides an insight into understanding how receptors in the same protein 
family can signal and function in different systems. This is relevant for studies of vertebrate 
Toll-like receptors in neurobiology and of neurotrophic factors in immunity (Barak et al., 
2014; Hepburn et al., 2014; Larsen et al., 2007; Okun et al., 2011).  
 
Spz is restricted to the mechanosensory domain while DNT2 are distributed along DM and 
DL neurons. Neurites of sensory projections project into the ventral region while neurites of 
motoneurons project into the dorsal region (Landgraf et al., 2003). There are few, if any, 
direct monosynaptic connections between sensory and motoneurons (Landgraf et al., 2003). 
This suggests Spz and DNT2 are very likely expressed by different neurons in the VNC. 
Because specific neuronal classes project to different medio-lateral domains and to different 
dorso-ventral layers of the neuropile (Zlatic et al., 2009), Spz and DNT2 can be thought to 
serve different modalities. This situation is reflected in embryonic motoneuron targeting and 
at the larval NMJ whereby DNT function with neuron-type specificity (Sutcliffe et al., 2013; 
Zhu et al., 2008). Spz mutation affects embryonic SNa motor axons and larval muscle 4 NMJ; 
dnt1 mutation affects embryonic ISNb/d motor axons; and double dnt1 dnt2 mutations affect 
muscle 6-7 NMJ (Sutcliffe et al., 2013; Zhu et al., 2008). Therefore, DNT in the larval VNC 
lends more semblances to vertebrate NTs in displaying function which depends on neuronal 




Toll is the receptor for Spz, and commercial anti-Toll-d300 reveals Toll signal in the larval 
CNS too. However, the larval atterns of Spz and Toll distribution do not match. In stage 15 
embryos, spz transcripts are expressed in the midline while Toll is detected the in CNS axons 
and in some midline cells (Zhu et al., 2008). Spz’s larval distribution is along the entire 
mechanosensory domain of the VNC while Toll is restricted to simple neuronal processes in 
the thorax. In the optic lobe, Spz is missing while Toll is in the neuroepithelia, inner 
proliferative centre (IPC) and OPC. This suggests Toll’s expression in the VNC is temporally 
regulated from embryonic to larval stages. The neuronal processes in the thorax revealed by 
anti-Toll-d300 are indicative of  immature neuronal cells in arrest, acting as functional 
stockpile for future use in the adult (Li et al., 2014). This may even suggests that Toll’s 
expression is spatially regulated to prevent signalling with Spz and any resulting inappropriate 
neuronal function such as misspecification of normal VNC length.  
 
Biochemical studies are required to follow up from SI assays and CNS size experiments to 
confirm that Toll6 and Spz bind to each other. Spz has already been proposed to bind Toll2, 
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9.1 Statistical Tests in Chapter 4 
 
9.1.1 Figure 4.8 Survival Index 
 










 No. of pupae All together χ
2 n/a n/a categorical data χ
2=707.723, df=13 p<0.001 Bonferroni: 𝑝 × 14 
spz2ca1/TM6B 1393 To expected wild-type χ2=455.088, df=1 p<0.001  
spz2ca1/TM6B x ru1st1ea14spz3ca1/TM6B  876 To expected wild-type χ
2=0.622, df=1 0.430  
To spz2ca1/TM6B χ2=299.251 p<0.001 p<0.001 
spz2ca1/TM6B x ru1Diap1st1kniri-1rnroe-1ppe1spz4/TM6B 250 To expected wild-type χ
2=5.618, df=1 p<0.05  
To spz2ca1/TM6B χ2=239.743 p<0.001 p<0.001 
spz2ca1/TM6B x spzMA05/TM6B 685 To expected wild-type χ
2=0.292, df=1 0.589  
To spz2ca1/TM6B χ2=271.935, df=1 p<0.001 p<0.001 
spz2ca1/TM6B x Df(3R)Exel6205/TM6B 662 To expected wild-type χ
2=1.208, df=1 0.272  
To spz2ca1/TM6B χ2=284.065, df=1 p<0.001 p<0.001 
spzMA05/TM6B 382 To expected wild-type  n/a   
spzMA05/TM6B x spz2ca1/TM6B 473 
To expected wild-type χ2=1.526, df=1 0.217  
To spzMA05/TM6B χ2=141.012, df=1 p<0.001 p<0.001 
To spz2ca1/TM6B x spzMA05/TM6B χ2=1.692, df=1 0.193 2.707 
spzMA05/TM6B x ru1st1ea14spz3ca1/TM6B 222 To expected wild-type χ
2=2.453, df=1 0.117  
To spzMA05/TM6B χ2=170.215, df=1 p<0.001 p<0.001 
spz MA05/TM6B x ru1Diap1st1kniri-1rnroe-1ppe1spz4/TM6B 375 To expected wild-type χ
2=0.192, df=1 0.661  
To spzMA05/TM6B χ2=146.709, df=1 p<0.001 p<0.001 
spzMA05/TM6B x spzMA10/TM6B  321 To expected wild-type χ
2=0.505, df=1 0.477  
To spzMA05/TM6B χ2=140.359, df=1 p<0.001 p<0.001 
spzMA05/TM6B x spzMA12/TM6B  329 To expected wild-type n/a   
spzMA05/TM6B x Df(3R)Exel6205/TM6B  719 To expected wild-type χ
2=12.487, df=1 p<0.001  
To spzMA05/TM6B χ2=125.901, df=1 p<0.001 p<0.001 
Df(3R)Exel6205/TM6B x spzMA10/TM6B 280 
To expected wild-type χ2=17.857, df=1 p<0.001  
To spzMA05/TM6B χ2=125.901, df=1 p<0.001 p<0.001 
To spzMA05/TM6B x Df(3R)Exel6205/TM6B χ2=3.435, df=1 0.064 0.894 
Df(3R)Exel6205/TM6B x spzMA12/TM6B  238 
To expected wild-type χ2=16.269, df=1 p<0.001  
To spzMA05/TM6B χ2=87.292, df=1 p<0.001 p<0.001 
To spzMA05/TM6B x Df(3R)Exel6205/TM6B χ2=3.508, df=1 0.061 0.855 
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9.1.2 Figure 4.9 Survival Index 
 






Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of pupae SI χ
2 n/a n/a categorical data  
 n/a 
dnt237/TM6B 473 To expected wild-type χ2=69.819, df=1 p<0.001  
dnt237/TM6B x Df(3L)Exel6092/TM6B 1254 To expected wild-type χ
2=47.458, df=1 p<0.001  
To dnt237/TM6B χ2=16.150, df=1 p<0.001  
 
9.2 Statistical Tests in Chapter 5 
 
9.2.1 Figure 5.1 CNS Size Characteristics 
 
Genotype 
Brain Area VNC Area VNC Length 











yw 25 1.70 ±0.23 25 7.0 ±0.8 25 372 ±25 
spz2ca1 15 0.68 ±0.13 15 5.8 ±0.6 15 333 ±18 
spz2ca1/Df(3R)Exel6205 8 1.67 ±0.11 9 7.3 ±0.5 9 378 ±22 
spzMA05/Df(3R)Exel6205 1 1.01 - 1 5.5 - 1 355 - 
 








Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of brain 
Brain area Welch 
ANOVA 




Levene’s Test Mean±SD 
(x105μm2) 
F=145.425, 
df=2,23.696 p<0.001 Games-Howell All together 4.030, p<0.05 
yw 25  k=-0.214; s=0.250; p(KS)=0.200; p(SW)=0.894 (all normal) 1.70±0.23   
 
spz2ca1 15 To yw k=-1.135; s=0.559; p(KS)<0.05; p(SW)=0.067 (treat as normal) 0.68±0.13   p<0.001 
spz2ca1/Df(3R)Exel6205 8 To yw k=-0.583, s=-0.079; p(KS)=0.200; p(SW)=0.683 (all normal) 1.67±0.11 
  p=0.805 
To spz2ca1   p<0.001 
 No. of VNC 
VNC area Welch 
ANOVA 




Levene’s Test Mean±SD 
(x104μm2) 
F=17.692, 
df=2,24.797 p<0.001 Games-Howell All together 3.748, p<0.05 
yw 25  k=-1.167, s=-0.204, p(KS)=0.200, p(SW)=0.209 (all normal) 7.0±0.8    
spz2ca1 15 To yw k=2.055, s=-0.320, p(KS)=0.200, p(SW=0.398 (treat as normal) 5.8±0.6   p<0.001 
spz2ca1/Df(3R)Exel6205 9 To yw k=4.367, s=-1.888, p(KS)=0.156, p(SW)<0.05 (treat as normal) 7.3±0.5 
  p=0.387 
To spz2ca1   p<0.001 
 No. of VNC 
VNC length one-way 
ANOVA 




Levene’s Test Mean±SD 
(μm) 
F=17.069, 
df=2,46 p<0.001 Bonferroni All together 2.733, p=0.076 
yw 25  k=-1.344, s=0.301, p(KS)=0.200, p(SW)=0.051 (all normal) 372±25    
spz2ca1 15 To yw k=1.357, s=-0.488, p(KS)=0.200, p(SW)=0.614 (all normal) 333±18   p<0.001 
spz2ca1/Df(3R)Exel6205 9 To yw k=2.658, s=-1.421, p(KS)=0.200, p(SW)=0.161 (treat as normal) 378±22 
  p=1.000 




9.2.2 Figure 5.2 CNS Size Characteristics 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of brain 




Levene’s Test Mean±SD 
(x105μm2) 
F=124.983, 
df=4,42.419 p<0.001 Bonferroni All together 3.966, p<0.05 
yw 25  p(KS)=0.200; p(SW)=0.894 (all normal) 1.70±0.23    
spz2ca1 15 To yw p(KS)<0.05; p(SW)=0.067 (treat as normal) 0.68±0.13   p<0.001 
ru1h1Diap1st1cu1sr1esca1 19 To spz2ca1 p(KS)=0.200; p(SW)=0.608 (all normal) 1.31±0.15   p<0.001 
spz2ca+.33 13 To spz2ca1 p(KS)=0.200; p(SW)=0.558 (all normal) 0.74±0.10   p=0.714 
spz2ca+.56 21 To spz2ca1 p(KS)=0.200; p(SW)=0.540 (all normal) 0.78±0.14   p=0.190 
 No. of VNC 




Levene’s Test Mean±SD 
(x104μm2) 
F=7.212, 
df=4,42.065 p<0.001 Games-Howell All together 3.232, p<0.05 
yw 25  p(KS)=0.200; p(SW)=0.209 (all normal) 7.0±0.8    
spz2ca1 15 To yw p(KS)=0.200; p(SW)=0.398 (all normal) 5.8±0.6   p<0.001 
ru1h1Diap1st1cu1sr1esca1 16 To spz2ca1 p(KS)=0.200; p(SW)=0.140 (all normal) 6.3±0.5   p=0.130 
spz2ca+.33 16 To spz2ca1 p(KS)=0.200; p(SW)=0.428 (all normal) 6.5±1.0   p=0.174 
spz2ca+.56 22 To spz2ca1 p(KS)=0.200; p(SW)=0.595 (all normal) 6.1±0.7   p=0.534 
 No. of VNC 




Levene’s Test Mean±SD 
(μm) 
F=14.653, 
df=4,41.781 p<0.001 Games-Howell All together 4.359, p<0.05 
yw 25  p(KS)=0.200; p(SW)=0.051 (all normal) 372±25    
spz2ca1 15 To yw p(KS)=0.200; p(SW)=0.614 (all normal) 333±18   p<0.001 
ru1h1Diap1st1cu1sr1esca1 16 To spz2ca1 p(KS)=0.200; p(SW)=0.030 (treat as normal) 360±22   p<0.005 
spz2ca+.33 16 To spz2ca1 p(KS)=0.200; p(SW)=0.248 (all normal) 363±38   p=0.063 




9.2.3 Figure 5.3 Survival Index 
 






Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of pupae All together χ
2 n/a n/a categorical data χ
2=24.062, df=2 p<0.001 Bonferroni: 𝑝 × 3 
spz2ca1/TM6B 1393 To expected wild-type χ2=455.088, df=1 p<0.001  
spz2ca+.33/TM6B 2061 To expected wild-type χ
2=448.055, df=1 p<0.001  
To spz2ca1/TM6B χ2=24.168, df=1 p<0.001 p<0.001 
spz2ca+.56/TM6B 1862 
To expected wild-type χ2=473.573, df=1 p<0.001  
To spz2ca1/TM6B χ2=10.638, df=1 p<0.005 p<0.005 
To spz2ca+.33/TM6B χ2=3.350, df=1 0.067 0.201 
 
9.2.4 Figure 5.4 Survival Index 
 






Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of pupae All together χ
2 n/a n/a categorical data χ
2=154.672, df=5 p<0.001 Bonferroni: 𝑝 × 6 
spz2,elav-GAL4/TM6B 1553 To expected wild-type χ2=340.240, df=1 p<0.001  
spz2,elav>spz2,actSpz(2) 483 To expected wild-type χ
2=52.407, df=1 p<0.001  
To spz2,elav-GAL4/TM6B χ2=14.086, df=1 p<0.001 (p=0.000175) p<0.01 (p= 0.00105) 
spz2,elav>spz2,Toll10bB 1848 To expected wild-type χ
2=31.093, df=1 p<0.001  
To spz2,elav-GAL4/TM6B χ2=134.502, df=1 p<0.001 p<0.001 
spz2,elav>spz2,Toll6CY 1653 
To expected wild-type χ2=50.352, df=1 p<0.001  
To spz2,elav-GAL4/TM6B χ2=102.100, df=1 p<0.001 p<0.001 
To spz2,elav>spz2,Toll10bB χ2=2.013, df=1 0.156 0.936 
spz2,elav>spz2,Toll7CY 865 
To expected wild-type χ2=79.133, df=1 p<0.001  
To spz2,elav-GAL4/TM6B χ2=28.019, df=1 p<0.001 p<0.001 
To spz2,elav>spz2,Toll10bB χ2=21.053, df=1 p<0.001 (p=0.000004) p<0.001 (p=0.000024) 
To spz2,elav>spz2,Toll6CY χ2=11.649, df=1 p<0.001 (p=0.000642) p<0.05 (p=0.003852) 
spz2,elav>spz2,p35 355 
To expected wild-type χ2=32.114, df=1 p<0.001  
To spz2,elav-GAL4/TM6B χ2=16.170, df=1 p<0.001 (p=0.000058) p<0.001 (p=0.000348) 
To spz2,elav>spz2,actSpz(2) χ2=0.248, df=1 0.618 3.708 
To spz2,elav>spz2,Toll7CY χ2= 0.001, df=1 0.974 5.844 
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9.2.5 Figure 5.5 Rescue of CNS Size 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of brain 
Brain area Welch 
ANOVA 




Levene’s Test Mean±SD 
(x105μm2) 
F=102.025, 
df=6,16.253 p<0.001 Games-Howell All together 4.376, p<0.001 
yw 25  k=-0.214; s=0.250; p(KS)=0.200; p(SW)=0.894 (all normal) 1.70±0.23   
 
spz2ca1 15  k=-1.135; s=0.559; p(KS)<0.05; p(SW)=0.067 (treat as normal) 0.68±0.13    
spz2elavGAL4/+ 11 To spz2ca1 k=0.154; s=0.548; p(KS)=0.200; p(SW)=0.902 (all normal) 1.39±0.16   p<0.001 
spz2,elav>spz2,Toll10bB 6 To spz2ca1 k=0.219; s=0.933; p(KS)=0.200; p(SW)=0.350 (all normal) 0.72±0.07   p=0.977 
spz2,elav>spz2,Toll6CY 8 To spz2ca1 k=-0.569; s=0.028; p(KS)=0.200; p(SW)=0.915 (all normal) 0.67±0.07   p=1.000 
spz2,elav>spz2,Toll7CY 5 To spz
2ca1 k=0.221; s=-0.640; p(KS)=0.200; 
p(SW)=0.923 (all normal) 0.54±0.04   p<0.05 
spz2,elav>spz2,p35 3 To spz
2ca1 k=n/a; s=-1.470; p(KS)=n/a; p(SW)=0.355 
(treat as normal) 0.81±0.13   p=0.679 
 No. of VNC 
VNC area one-way 
ANOVA 




Levene’s Test Mean±SD 
(x104μm2) 
F=10.652, 
df=6,70 p<0.001 Bonferroni All together 1.218, p=0.307 
yw 25  k=-1.167, s=-0.204, p(KS)=0.200, p(SW)=0.209 (all normal) 7.0±0.8    
spz2ca1 15  k=2.055, s=-0.320, p(KS)=0.200, p(SW=0.398 (treat as normal) 5.8±0.6    
spz2elavGAL4/+ 12 To spz2ca1 k=4.394; s=1.170; p(KS)=0.200; p(SW)<0.05 (treat as normal) 6.0±0.6   p=1.000 
spz2,elav>spz2,Toll10bB 7 To spz2ca1 k=1.178; s=1.004; p(KS)=0.200; p(SW)=0.443 (all normal) 7.0±0.7   p<0.05 
spz2,elav>spz2,Toll6CY 8 To spz2ca1 k=4.664; s=-1.941; p(KS)<0.05; p(SW)<0.05 (treat as normal) 7.0±0.6   p<0.05 
spz2,elav>spz2,Toll7CY 5 To spz
2ca1 k=0.855; s=0.152; p(KS)=0.200; 
p(SW)=0.985 (all normal) 6.0±0.5   p=1.000 
spz2,elav>spz2,p35 5 To spz
2ca1 k=-2.312; s=-0.092; p(KS)=0.200; 
p(SW)=0.606 (all normal) 7.7±0.7   p<0.001 
Please turn over 
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Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of VNC 





Levene’s Test Mean±SD 
(μm) 
F=16.873, 
df=6,70 p<0.001 Bonferroni All together 1.384, p=0.233 
yw 25  k=-1.344, s=0.301, p(KS)=0.200, p(SW)=0.051 (all normal) 372±25    
spz2ca1 15  k=1.357, s=-0.488, p(KS)=0.200, p(SW)=0.614 (all normal) 333±18    
spz2elavGAL4/+ 12 To spz2ca1 k=2.223; s=1.387; p(KS)=0.162; p(SW)=0.098 (all normal) 349±25   p=1.000 
spz2,elav>spz2,Toll10bB 7 To spz2ca1 k=0.436; s=0.729; p(KS)=0.200; p(SW)=0.838 (all normal) 386±37   p<0.001 
spz2,elav>spz2,Toll6CY 8 To spz2ca1 k=-0.938; s=-0.276; p(KS)=0.200; p(SW)=0.581 (all normal) 381±19   p<0.001 
spz2,elav>spz2,Toll7CY 5 To spz
2ca1 k=-1.435; s=-0.216; p(KS)=0.200; 
p(SW)=0.299 (all normal) 362±17   p=0.455 
spz2,elav>spz2,p35 5 To spz
2ca1 k=1.077; s=0.913; p(KS)=0.200; 




9.2.6 Figure 5.6 CNS Size Characteristics 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of brain 
Brain area Welch 
ANOVA 




Levene’s Test Mean±SD 
(x105μm2) 
F=105.547, 
df=5,28.450 p<0.001 Games-Howell All together 3.728, p<0.001 
yw 25  k=-0.214; s=0.250; p(KS)=0.200; p(SW)=0.894 (all normal) 1.70±0.23   
 
spz2ca1 15  k=-1.135; s=0.559; p(KS)<0.05; p(SW)=0.067 (treat as normal) 0.68±0.13    
spz2elavGAL4/+ 11  k=0.154; s=0.548; p(KS)=0.200; p(SW)=0.902 (all normal) 1.39±0.16    
spz2,elav>spz2,Toll10bB 6 To elav>Toll10bB k=0.219; s=0.933; p(KS)=0.200; p(SW)=0.350 (all normal) 0.72±0.07   p<0.001 
elavGAL4/+ 11 To elav>Toll10bB k=-1.396; s=0.057; p(KS)=0.200; p(SW)=0.482 (all normal) 1.25±0.21   p=1.000 
elav>Toll10bB 10  k=-1.613; s=-0.456; p(KS)=0.200; p(SW)=0.093 (all normal) 1.24±0.09    
 No. of VNC 
VNC area one-way 
ANOVA 




Levene’s Test Mean±SD 
(x104μm2) F=9.846, df=5,79 p<0.001 Bonferroni All together 1.878, p=0.108 
yw 25  k=-1.167, s=-0.204, p(KS)=0.200, p(SW)=0.209 (all normal) 7.0±0.8    
spz2ca1 15  k=2.055, s=-0.320, p(KS)=0.200, p(SW=0.398 (treat as normal) 5.8±0.6    
spz2elavGAL4/+ 12  k=4.394; s=1.170; p(KS)=0.200; p(SW)<0.05 (treat as normal) 6.0±0.6    
spz2,elav>spz2,Toll10bB 7 To elav>Toll10bB k=1.178; s=1.004; p(KS)=0.200; p(SW)=0.443 (all normal) 7.0±0.7   p=1.000 
elavGAL4/+ 11 To elav>Toll10bB k=0.401; s=0.369; p(KS)=0.200; p(SW)=0.779 (treat as normal) 6.0±0.7   p=0.060 
elav>Toll10bB 15  k=0.368; s=0.207; p(KS)=0.200; p(SW)=0.861 (all normal) 6.7±0.4    








Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of VNC 





Levene’s Test Mean±SD 
(μm) F=8.240, df=5,79 p<0.001 Bonferroni All together 1.570, p=0.178 
yw 25  k=-1.344, s=0.301, p(KS)=0.200, p(SW)=0.051 (all normal) 372±25    
spz2ca1 15  k=1.357, s=-0.488, p(KS)=0.200, p(SW)=0.614 (all normal) 333±18    
spz2elavGAL4/+ 12  k=2.223; s=1.387; p(KS)=0.162; p(SW)=0.098 (all normal) 349±25    
spz2,elav>spz2,Toll10bB 7 To elav>Toll10bB k=0.436; s=0.729; p(KS)=0.200; p(SW)=0.838 (all normal) 386±37   p=1.000 
elavGAL4/+ 11 To elav>Toll10bB k=1.551; s=0.838; p(KS)=0.200; p(SW)=0.671 (all normal) 359±19   p=1.000 
elav>Toll10bB 15  k=-0.417; s=0.258; p(KS)=0.200; p(SW)=0.390 (all normal) 375±23    
 
9.2.7 Figure 5.7 Survival Index 
 






Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of pupae All together χ
2 n/a n/a categorical data χ
2=383.717, df=4 p<0.001 Bonferroni: 𝑝 × 5 
spz2,repo-GAL4/TM6B 1365 To expected wild-type n/a   
spz2,repo>spz2,actSpz(2) 477 To spz2,repo-GAL4/TM6B χ2=351.002, df=1 p<0.001 p<0.001 
spz2,repo>spz2,Toll10bB 446 To spz
2,repo-GAL4/TM6B χ2=266.226, df=1 p<0.001 p<0.001 
To spz2,repo>spz2,actSpz χ2=4.137, df=1 p<0.05 (p=0.0420) 0.21 
spz2,repo>spz2,Toll6CY 898 
To expected wild-type χ2=16.472, df=1 p<0.001 (p=0.000049)  
To spz2,repo-GAL4/TM6B χ2=411.898, df=1 p<0.001 p<0.001 
To spz2,repo>spz2,actSpz χ2=1.307, df=1 0.253 1.265 
To spz2,repo>spz2,Toll10bB χ2=11.302, df=1 p<0.001 (p=0.000774) p<0.05 (p=0.00387) 
spz2,repo>spz2,Toll7CY 1620 To spz
2,repo-GAL4/TM6B χ2=266.517, df=1 p<0.001 p<0.001 




9.2.8 Table 5.6 Comparison of Survival Index between Neuronal and Glial Overexpression of Activated Spz, Toll, Toll6 and Toll7 
 






Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of pupae SI χ
2 n/a n/a categorical data  
 Bonferroni: 𝑝 × 8 
spz2,elav>spz2,actSpz(2) 483     
spz2,repo>spz2,actSpz(2) 477 To spz2,elav>spz2,actSpz(2) χ2=5.761, df=1 p<0.05 (p=0.0164) 0.1312 
spz2,elav>spz2,Toll10bB 1848     
spz2,repo>spz2,Toll10bB 446 To spz2,elav>spz2,Toll10bB χ2=14.000, df=1 p<0.001 (p=0.000183) p<0.01 (p=0.001464) 
spz2,elav>spz2,Toll6CY 1653     
spz2,repo>spz2,Toll6CY 898 To spz2,repo>spz2,Toll6CY χ2=1.034, df=1 0.309 2.472 
spz2,elav>spz2,Toll7CY 865     
spz2,repo>spz2,Toll7CY 1620 To spz2,repo>spz2,Toll7CY χ2=0.766, df=1 0.381 3.048 
 
9.2.9 Figure 5.8 Rescue of CNS Size 
 
 Brain Area VNC Area VNC Length 











yw 25 1.70 ±0.23 25 7.0 ±0.8 25 372 ±25 
spz2ca1 15 0.68 ±0.13 15 5.8 ±0.6 15 333 ±18 
spz2repoGAL4/+ 11 1.63 ±0.18 12 6.9 ±0.6 12 382 ±20 
spz2,repo>spz2,Toll10bB 10 0.70 ±0.09 11 8.4 ±0.7 11 583 ±49 
spz2,repo>spz2,Toll6CY 1 0.45 - 1 5.6 - 1 377 - 
spz2,repo>spz2,Toll7CY 2 0.63 ±0.04 3 6.6 ±0.5 3 397 ±19 
 
Table 9.2 CNS size rescue of spz2/spz2 background using various UAS lines overexpressed under repoGAL4 driver.  
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Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of brain 
Brain area Welch 
ANOVA 




Levene’s Test Mean±SD 
(x105μm2) 
F=173.862, 
df=3,27.754 p<0.001 Games-Howell All together 3.882, p<0.05 
yw 25  k=-0.214; s=0.250; p(KS)=0.200; p(SW)=0.894 (all normal) 1.70±0.23   
 
spz2ca1 15  k=-1.135; s=0.559; p(KS)<0.05; p(SW)=0.067 (treat as normal) 0.68±0.13    
spz2repoGAL4/+ 11 To spz2ca1 k=-0.257; s=0.124; p(KS)=0.200; p(SW)=1.000 (all normal) 1.63±0.18   p<0.001 
spz2,repo>spz2,Toll10bB 10 To spz2ca1 k=0.018; s=-0.184; p(KS)=0.200; p(SW)=0.688 (all normal) 0.70±0.09   p=0.988 
 No. of VNC 
VNC area one-way 
ANOVA 




Levene’s Test Mean±SD 
(x104μm2) 
F=29.028, 
df=3,59 p<0.001 Bonferroni All together 2.024, p=0.120 
yw 25  k=-1.167, s=-0.204, p(KS)=0.200, p(SW)=0.209 (all normal) 7.0±0.8    
spz2ca1 15  k=2.055, s=-0.320, p(KS)=0.200, p(SW=0.398 (treat as normal) 5.8±0.6    
spz2repoGAL4/+ 12 To spz2ca1 k=-1.215; s=0.427; p(KS)=0.139; p(SW)=0.231 (all normal) 6.9±0.6   p<0.005 
spz2,repo>spz2,Toll10bB 11 To spz2ca1 k=-1.267; s=0.151; p(KS)=0.200; p(SW)=0.571 (all normal) 8.4±0.7   p<0.001 
 No. of VNC 
VNC length Welch 
ANOVA 




Levene’s Test Mean±SD 
(μm) 
F=88.598, 
df=3,26.424 p<0.001 Bonferroni All together 5.559, p<0.005 
yw 25  k=-1.344, s=0.301, p(KS)=0.200, p(SW)=0.051 (all normal) 372±25    
spz2ca1 15  k=1.357, s=-0.488, p(KS)=0.200, p(SW)=0.614 (all normal) 333±18    
spz2repoGAL4/+ 12 To spz2ca1 k=0.301; s=0.140; p(KS)=0.200; p(SW)=0.832 (all normal) 382±20   p<0.001 




9.2.10 Figure 5.9 CNS Size Characteristics 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of brain 
Brain area Welch 
ANOVA 




Levene’s Test Mean±SD 
(x105μm2) 
F=115.809, 
df=5,33.6 p<0.001 Games-Howell All together 4.143, p<0.005 
yw 25  k=-0.214; s=0.250; p(KS)=0.200; p(SW)=0.894 (all normal) 1.70±0.23   
 
spz2ca1 15  k=-1.135; s=0.559; p(KS)<0.05; p(SW)=0.067 (treat as normal) 0.68±0.13    
spz2repoGAL4/+ 11  k=-0.257; s=0.124; p(KS)=0.200; p(SW)=1.000 (all normal) 1.63±0.18    
spz2,repo>spz2,Toll10bB 10 To repo>Toll10bB k=0.018; s=-0.184; p(KS)=0.200; p(SW)=0.688 (all normal) 0.70±0.09   p<0.001 
repoGAL4/+ 12 To repo>Toll10bB k=3.263; s=-1.007; p(KS)=0.050; p(SW)=0.113 (all normal) 1.22±0.12   p=0.999 
repo>Toll10bB 12  k=3.292; s=-1.568; p(KS)=0.031; p(SW)=0.024 (treat as normal) 1.23±0.11    
 No. of VNC 
VNC area Welch 
ANOVA 




Levene’s Test Mean±SD 
(x104μm2) 
F=51.033, 
df=5,33.793 p<0.001 Bonferroni All together 4.219, p<0.005 
yw 25  k=-1.167, s=-0.204, p(KS)=0.200, p(SW)=0.209 (all normal) 7.0±0.8    
spz2ca1 15  k=2.055, s=-0.320, p(KS)=0.200, p(SW=0.398 (treat as normal) 5.8±0.6    
spz2repoGAL4/+ 12  k=-1.215; s=0.427; p(KS)=0.139; p(SW)=0.231 (all normal) 6.9±0.6    
spz2,repo>spz2,Toll10bB 11 To repo>Toll10bB k=-1.267; s=0.151; p(KS)=0.200; p(SW)=0.571 (all normal) 8.4±0.7   p=0.186 
repoGAL4/+ 12 To repo>Toll10bB k=-0.019; s=0.352; p(KS)=0.200; p(SW)=0.954 (treat as normal) 5.9±0.2   p<0.001 
repo>Toll10bB 12  k=-0.111; s=-0.779; p(KS)=0.200; p(SW)=0.266 (all normal) 7.8±0.5    








Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of VNC 
VNC length one-way 
ANOVA 




Levene’s Test Mean±SD 
(μm) 
F=155.344, 
df=5,81 p<0.001 Bonferroni All together 3.619, p=0.00526 
yw 25  k=-1.344, s=0.301, p(KS)=0.200, p(SW)=0.051 (all normal) 372±25    
spz2ca1 15  k=1.357, s=-0.488, p(KS)=0.200, p(SW)=0.614 (all normal) 333±18    
spz2repoGAL4/+ 12  k=0.301; s=0.140; p(KS)=0.200; p(SW)=0.832 (all normal) 382±20    
spz2,repo>spz2,Toll10bB 11 To repo>Toll10bB k=2.132; s=1.363; p(KS)=0.200; p(SW)=0.065 (all normal) 583±49   p<0.001 
repoGAL4/+ 12 To repo>Toll10bB k=-1.097; s=0.248; p(KS)=0.200; p(SW)=0.556 (all normal) 364±21   p<0.001 






9.2.11 Figure 5.10 CNS Size Characteristics 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of brain 
Brain area one-way 
ANOVA 




Levene’s Test Mean±SD 
(x105μm2) F=1.194, df=2,23 
p=0.321 
Bonferroni 
All together 0.021, p=0.979 
spzGAL4/+ 12  k=0.988; s=1.336; p(KS)=0.095; p(SW)<0.05 (treat as normal) 1.31±0.19   
 
spz>actSpz(2) 8 To spzGAL4/+ k=0.281; s=0.229; p(KS)=0.200; p(SW)=0.769 (all normal) 1.20±0.18   p=0.539 
spz>spz-FL 6 To spzGAL4/+ k=-1.830, s=0.547; p(KS)=0.200; p(SW)=0.187 (all normal) 1.21±0.16   p=0.792 
 No. of VNC 
VNC area one-way 
ANOVA 




Levene’s Test Mean±SD 
(x104μm2) F=1.750, df=2,24 p=0.195 Bonferroni All together 0.580, p=0.568 
spzGAL4/+ 12  k=0.905, s=0.667, p(KS)=0.190, p(SW)=0.685 (all normal) 6.0±0.4    
spz>actSpz(2) 9 To spzGAL4/+ k=1.701, s=0.732, p(KS)=0.181, p(SW=0.399 (all normal) 6.2±0.7   p=1.000 
spz>spz-FL 6 To spzGAL4/+ k=-1.541, s=-0.679, p(KS)=0.200, p(SW)=0.308 (all normal) 5.7±0.4   p=0.692 
 No. of VNC 
VNC length one-way 
ANOVA 




Levene’s Test Mean±SD 
(μm) F=5.599, df=2,24 p<0.05 Bonferroni All together 1.826, p=0.183 
spzGAL4/+ 12  k=-0.365, s=-0.401, p(KS)=0.200, p(SW)=0.829 (all normal) 361±18    
spz>actSpz(2) 9 To spzGAL4/+ k=2.199, s=1.306, p(KS)=0.200, p(SW)=0.244 (all normal) 389±29   p<0.05 





9.2.12 Figure 5.11 CNS Size Characteristics 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of VNC 
VNC length Welch 
ANOVA 




Levene’s Test Mean±SD 
(μm) 
F=17.261, 
df=4,27.254 p<0.001 Games-Howell All together 10.615, p<0.001 
repo>NotchICD 11  k=-0.427, s=-0.098, p(KS)=0.200, p(SW)=0.983 (all normal) 702±54    
repo>NotchICD,actSpz(2) 19 To repo>NotchICD k=1.978, s=1.386, p(KS)=0.076, p(SW)<0.05 (treat as normal) 622±59   p<0.05 
repo>NotchICD,spz-FL 12 To repo>NotchICD k=-0.961; s=-0.017; p(KS)=0.200; p(SW)=0.730 (all normal) 598±52   p<0.05 
repo>NotchICD,spz2-FL 12 To repo>NotchICD k=-0.366; s=0.608; p(KS)=0.200; p(SW)=0.556 (all normal) 645±64   p=0.175 
spz2,repo>spz2,NotchICD 11 To repo>NotchICD k=-1.548; s=0.316; p(KS)=0.200; p(SW)=0.117 (all normal) 993±164   p<0.001 
 
9.2.13 Figure 5.12 Survival Index 
 






Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of pupae SI χ
2 n/a n/a categorical data  
 n/a 
spz2ca1/TM6B 1393     





9.2.14 Figure 5.13 CNS Size Characteristics 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of VNC 
VNC length one-way 
ANOVA 




Levene’s Test Mean±SD 
(μm) F=1.316, df=4,47 p=0.278 Games-Howell All together 2.160, p<0.05 
repo>NotchICD 11  k=-0.427, s=-0.098, p(KS)=0.200, p(SW)=0.983 (all normal) 702±54    
repo>NotchICD,DNT1-CK3’+ 10 To repo>NotchICD k=1.684, s=1.081, p(KS)=0.200, p(SW)=0.314 (treat as normal) 681±35   p=1.000 
repo>NotchICD,DNT1-FL 12 To repo>NotchICD k=3.342; s=1.664; p(KS)=0.117; p(SW)<0.05 (treat as normal) 718±107   p=1.000 
repo>NotchICD,DNT2-CK-6A 11 To repo>NotchICD k=-1.167; s=0.463; p(KS)=0.200; p(SW)=0.418 (all normal) 659±55   p=1.000 
repo>NotchICD,DNT2-FL-47C 8 To repo>NotchICD k=0.450; s=-0.035; p(KS)=0.200; p(SW)=0.998 (all normal) 669±66   p=1.000 
 
9.2.15 Figure 5.17 Characterising Ebony+ Repo+ Cells in the Ventral VNC 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 








χ2 n/a n/a categorical data   n/a 
yw 13     





9.2.16 Figure 5.18 Counting Ebony+ Repo+ Cells 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 









Mean±SD t=0.418, df=21 p=0.680 n/a 0.054, 
p=0.819 
yw 13  p(KS)=0.200; p(SW)=0.485 (all normal) 88.62±5.45    
spz2ca1 10 To yw p(KS)=0.200; p(SW)=0.989 (all normal) 87.60±6.19    
 
9.2.17 Figure 5.19 Counting Thoracic Repo+ Cells Using DeadEasy 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 









Mean±SD F=2.436, df=3,48 p=0.076 Dunnett 
All together 0.179, p=0.910 
yw 25  k=1.279; s=-0.644; p(KS)=0.200; p(SW)=0.377 (all normal) 375±62   
 
spz2ca1 11 To yw k=0.889; s=0.138; p(KS)=0.200; p(SW)=0.597 (all normal) 321±65   p=0.837 
spz2ca1/Df(3R)Exel6205 11 To yw k=-0.769; s=-0.186; p(KS)=0.200; p(SW)=0.729 (all normal) 350±69   p=0.055 





9.2.18 Figure 5.19 Counting Abdominal Repo+ Cells Using DeadEasy 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 









Mean±SD F=6.893, df=3,72 p<0.001 Dunnett 
All together 1.570, p=0.204 
yw 29  k=0.047; s=-0.126; p(KS)=0.200; p(SW)=0.836 (all normal) 375±26   
 
spz2ca1 12 To yw k=3.494; s=-1.378; p(KS)=0.200; p(SW)=0.126 (treat as normal) 369±48   p=0.934 
spz2ca1/Df(3R)Exel6205 20 To yw k=-0.935; s=-0.519; p(KS)=0.130; p(SW)=0.069 (all normal) 409±39   p<0.05 
spzMA05/Df(3R)Exel6205 15 To yw k=0.091; s=0.130; p(KS)=0.200; p(SW)=0.755 (all normal) 414±41   p<0.05 
 
9.2.19 Figure 5.20 Counting Thoracic Repo+ Cells Using DeadEasy 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 









Mean±SD F=0.074, df=2,37 p=0.929 Dunnett 
All together 0.323, p=0.726 
yw 22  k=1.279; s=-0.644; p(KS)=0.200; p(SW)=0.377 (all normal) 375±62   
 
dnt141/Df(3L)Exel6101 8 To yw k=1.083; s=-0.042; p(KS)=0.200; p(SW)=0.874 (all normal) 384±46   p=0.916 




9.2.20 Figure 5.20 Counting Abdominal Repo+ Cells Using DeadEasy 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 









Mean±SD F=0.382, df=2,45 p=0.685 Dunnett 
All together 0.221, p=0.803 
yw 29  k=0.047; s=-0.126; p(KS)=0.200; p(SW)=0.836 (all normal) 375±26   
 
dnt141/Df(3L)Exel6101 8 To yw k=-0.281; s=0.750; p(KS)=0.200; p(SW)=0.350 (all normal) 384±23   p=0.617 
dnt237/Df(3L)Exel6092 11 To yw k=0.783; s=0.755; p(KS)=0.200; p(SW)=0.671 (all normal) 378±21   p=0.950 
 
9.2.21 Figure 5.21 Counting Thoracic Repo+ Cells Using DeadEasy 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of VNC 
Repo+ cell 
number t-test 





Mean±SD t=-1.336, df=26 p=0.193 n/a 0.073, 
p=0.790 
yw 22  k=1.279; s=-0.644; p(KS)=0.200; p(SW)=0.377 (all normal) 375±62   
 





9.2.22 Figure 5.21 Counting Abdominal Repo+ Cells Using DeadEasy 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of VNC 
Repo+ cell 
number t-test 





Mean±SD t=-6.334, df=37 p<0.001 n/a 0.104, 
p=0.748 
yw 29  k=0.047; s=-0.126; p(KS)=0.200; p(SW)=0.836 (all normal) 375±26   
 
Toll7P114/Toll7P8;Toll631/Toll726 10 To yw k=0.465; s=-0.284; p(KS)=0.200; p(SW)=0.960 (all normal) 434±24    
 
9.2.23 Figure 5.22 Survival Index 
 






Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of pupae SI χ
2 n/a n/a categorical data  
 n/a 





9.2.24 Figure 5.23 Counting Thoracic pH3+ Cells Using DeadEasy 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 









Mean±SD F=1.854, df=3,28 p=0.160 Dunnett 
All together 1.783, p=0.173 
yw 11  k=0.630; s=-0.762; p(KS)=0.200; p(SW)=0.578 (all normal) 52±13   
 
spz2ca1 5 To yw k=-0.597; s=0.842; p(KS)=0.200; p(SW)=0.428 (all normal) 63±16   p=0.225 
spz2ca1/Df(3R)Exel6205 8 To yw k=0.398; s=-0.567; p(KS)=0.200; p(SW)=0.729 (all normal) 58±6   p=0.616 
spzMA05/Df(3R)Exel6205 8 To yw k=-0.053; s=0.865; p(KS)=0.200; p(SW)=0.377 (all normal) 49±11   p=0.912 
 
9.2.25 Figure 5.23 Counting Abdominal pH3+ Cells Using DeadEasy 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 









Mean±SD F=1.920, df=3,47 p=0.139 Dunnett 
All together 1.148, p=0.340 
yw 30  k=-0.392; s=-0.035; p(KS)=0.200; p(SW)=0.950 (all normal) 38±8   
 
spz2ca1 5 To yw k=0.160; s=-0.985; p(KS)=0.200; p(SW)=0.576 (all normal) 35±9   p=0.785 
spz2ca1/Df(3R)Exel6205 8 To yw k=2.008; s=1.350; p(KS)=0.200; p(SW)=0.251 (all normal) 41±5   p=0.656 




9.2.26 Figure 5.24 Counting Thoracic pH3+ Cells Using DeadEasy 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 









Mean±SD F=1.843, df=2,18 p=0.929 Dunnett 
All together 2.565, p=0.105 
yw 11  k=0.630; s=-0.762; p(KS)=0.200; p(SW)=0.578 (all normal) 52±13   
 
dnt141/Df(3L)Exel6101 6 To yw k=-1.644; s=-0.055; p(KS)=0.200; p(SW)=0.677 (all normal) 62±16   p=0.267 
dnt237/Df(3L)Exel6092 4 To yw k=-0.002; s=1.055; p(KS)=n/a; p(SW)=0.457 (all normal) 64±5   p=0.227 
 
9.2.27 Figure 5.24 Counting Abdominal pH3+ Cells Using DeadEasy 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 









Mean±SD F=1.641, df=2,38 p=0.207 Dunnett 
All together 1.646, p=0.206 
yw 30  k=-0.392; s=-0.035; p(KS)=0.200; p(SW)=0.950 (all normal) 38±8   
 
dnt141/Df(3L)Exel6101 6 To yw k=0.098; s=-0.781; p(KS)=0.200; p(SW)=0.703 (all normal) 38±5   p=0.998 





9.2.28 Figure 5.25 Counting Thoracic pH3+ Cells Using DeadEasy 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of VNC 
pH3+ cell 
number t-test 





Mean±SD t=-2.568, df=13 p<0.05 n/a 0.623, 
p=0.444 
yw 11  k=0.630; s=-0.762; p(KS)=0.200; p(SW)=0.578 (all normal) 52±13   
 
Toll7P114/Toll7P8;Toll631/Toll726 4 To yw k=2.820; s=1.576; p(KS)=n/a; p(SW)=0.252 (treat as normal) 74±19    
 
9.2.29 Figure 5.25 Counting Abdominal pH3+ Cells Using DeadEasy 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of VNC 
pH3+ cell 
number t-test 




Levene’s Test Mean±SD   n/a 
0.309, 
p=0.582  t=-1.682, df=32 p=0.102 
 
yw 30  k=-0.392; s=-0.035; p(KS)=0.200; p(SW)=0.950 (all normal) 38±8   
 





9.2.30 Figure 5.26 Characterising Proliferative Levels in the ‘Non-Mitotic’ Zone 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of VNC 
≤5 or >5 
proliferating 
cells χ
2 n/a n/a categorical data χ
2=9.554, df=6 p=0.145 not necessary to test 
All together 
yw 30     
spz2ca1 5     
spz2ca1/Df(3R)Exel6205 8     
spzMA05/Df(3R)Exel6205 8     
dnt141/Df(3L)Exel6101 6     
dnt237/Df(3L)Exel6092 5     
Toll7P114/Toll7P8;Toll631/Toll726 4     
 
9.2.31 Figure 5.27 Counting Abdominal cDcp1+ Cells Using DeadEasy 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 









Mean±SD F=6.484, df=3,28 p<0.005 Dunnett 
All together 2.675, p=0.066 
yw 17  k=1.6514; s=-0.474; p(KS)=0.200; p(SW)=0.730 (all normal) 101±12   
 
spz2ca1 5 To yw k=4.638; s=-2.137; p(KS)<0.05; p(SW)<0.05 (treat as normal) 69±25   p<0.001 
spz2ca1/Df(3R)Exel6205 5 To yw k=-1.913; s=-0.379; p(KS)=0.200; p(SW)=0.677 (all normal) 94±3   p=0.717 





9.2.32 Figure 5.28 Sholl Analysis of Thoracic RP2 Neurons 
 




Statistics Test Value & df p-Value 
Multiple Comparisons 
& Correction 
 No. of neurons 
no. of intersection at 




Mean±SD t=0.200, df=4 p=0.851 n/a 3.226, 
p=0.147 
control 3  p(KS)=n/a; p(SW)=0.363 (treat as normal) 4.0±2.6    
spz2 3 To control p(KS)=n/a; p(SW)<0.001(treat as not normal) 3.7±1.2    
 No. of neurons 
no. of intersection at 




Mean±SD t=-2.607, df=5 p<0.05 n/a 2.400, 
p=0.182 
control 4  p(KS)=n/a; p(SW)=0.850 (treat as normal) 2.8±1.7    
spz2 3 To control p(KS)=n/a; p(SW)=0.537 (treat as normal) 8.0±3.6    
 No. of neurons 
no. of intersection at 




Mean±SD t=-2.214, df=6 p=0.069 n/a 0.800, 
p=0.405 
control 5  p(KS)=0.200; p(SW)=0.421 (all normal) 4.4±2.6    
spz2 3 To control p(KS)=n/a; p(SW)=0.253 (treat as normal) 9.3±3.8    
 No. of neurons 
no. of intersection at 




Mean±SD t=-0.431, df=6 p=0.682 n/a 2.385, 
p=0.173 
control 5  p(KS)<0.05; p(SW)<0.05 (not normal) 6.2±1.8    
spz2 3 To control p(KS)=n/a; p(SW)=0.537 (treat as normal) 7.0±3.6    
 No. of neurons 
no. of intersection at 




Mean±SD t=-1.204, df=6 p=0.274 n/a 2.076, 
p=0.200 
control 5  p(KS)<0.05; p(SW)=0.065 (treat as normal) 8.4±3.1    
spz2 3 To control p(KS)=n/a; p(SW)<0.001 (treat as not normal) 10.7±0.6    
 No. of neurons 
no. of intersection at 




Mean±SD t=-0.961, df=6 p=0.374 n/a 0.842, 
p=0.394 
control 5  p(KS)=0.200; p(SW)=0.501 (all normal) 8.2±2.6    
spz2 3 To control p(KS)=n/a; p(SW)=0.253 (treat as normal) 10.3±3.8    
 No. of neurons 
no. of intersection at 




Mean±SD t=0.044, df=6 p=0.966 n/a 2.867, 
p=0.141 
control 5  p(KS)=0.200; p(SW)=0.253 (all normal) 12.8±4.8    
spz2 3 To control p(KS)=n/a; p(SW)=0.463 (treat as normal) 12.7±2.1    
Please turn over 
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Statistics Test Value & df p-Value 
Multiple Comparisons 
& Correction 
 No. of neurons 
no. of intersection at 




Mean±SD t=8.301, df=6 p<0.001 n/a 5.250, 
p=0.062 
control 5  p(KS)=0.161; p(SW)=0.325 (all normal) 13.0±0.7    
spz2 3 To control p(KS)=n/a; p(SW)<0.001 (treat as not normal) 6.0±1.7    
 No. of neurons 
no. of intersection at 




Mean±SD t=2.337, df=6 p=0.058 n/a 0.869, 
p=0.387 
control 5  p(KS)=0.200; p(SW)=0.738 (all normal) 12.2±3.6    
spz2 3 To control p(KS)=n/a; p(SW)=0.097 (treat as normal) 5.0±5.3    
 No. of neurons 
no. of intersection at 
50μm distance n/a 
Kolmogorov-Smirnov (KS); 
Shapiro-Wilk (SW) n/a Mean±SD   n/a 
control 5  p(KS)=0.200; p(SW)=0.097 (all normal) 11.2±5.4    
spz2 1 To control p(KS)=n/a; p(SW)=n/a 8    
 No. of neurons 
no. of intersection at 
55μm distance n/a not necessary to test 
n/a Mean±SD   n/a  
control 5   8.6±4.9    
 No. of neurons 
no. of intersection at 
60μm distance n/a not necessary to test 
n/a Mean±SD   n/a  
control 5   6.2±4.4    
 No. of neurons 
no. of intersection at 
65μm distance n/a not necessary to test 
n/a Mean±SD   n/a  
control 4   6.8±8.9    
 No. of neurons 
no. of intersection at 
70μm distance n/a not necessary to test 
n/a Mean±SD   n/a  
control 2   7.5±6.4    
 No. of neurons 
no. of intersection at 
75μm distance n/a not necessary to test 
n/a Mean±SD   n/a  
control 2   6.5±7.8    
 No. of neurons 
no. of intersection at 
80μm distance n/a not necessary to test 
n/a Mean±SD   n/a  
control 1   18    
 No. of neurons 
no. of intersection at 
85μm distance n/a not necessary to test 
n/a Mean±SD   n/a  
control 1   12    
 No. of neurons 
no. of intersection at 
90μm distance n/a not necessary to test 
n/a Mean±SD   n/a  
control 1   6    
 No. of neurons 
no. of intersection at 
95μm distance n/a not necessary to test 
n/a Mean±SD   n/a  
control 1   1    
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9.2.33 Figure 5.29 and Figure 5.30 Sholl Analysis of Abdominal A1-A3 RP2 Neurons 
 




Statistics Test Value & df p-Value 
Multiple Comparisons 
& Correction 
 No. of neurons 






(KS); Shapiro-Wilk (SW) n/a Mean±SD χ
2=4.000, df=2 p=0.135 not necessary to test 
All together 
control 1  p(KS)=n/a; p(SW)=n/a 2    
spz2 2  p(KS)=n/a; p(SW)=n/a 1.0±0.0    
spz2/Df(3R)Exel6205 2  p(KS)=n/a; p(SW)=n/a 2.0±0.0    
 No. of neurons 






(KS); Shapiro-Wilk (SW) n/a Mean±SD χ
2=0.368, df=2 p=0.832 not necessary to test 
All together 
control 1  p(KS)=n/a; p(SW)=n/a 6    
spz2 2  p(KS)=n/a; p(SW)=n/a 4.5±3.5    
spz2/Df(3R)Exel6205 4  p(KS)=n/a; p(SW)=0.894 (treat as normal) 6.3±3.5    
 No. of neurons 






(KS); Shapiro-Wilk (SW) n/a Mean±SD χ
2=4.500, df=2 p=0.105 not necessary to test 
All together 
control 1  p(KS)=n/a; p(SW)=n/a 4    
spz2 2  p(KS)=n/a; p(SW)=n/a 4.0±4.2    
spz2/Df(3R)Exel6205 4  p(KS)=n/a; p(SW)=0.275 (treat as normal) 15.3±5.0    
 No. of neurons 






(KS); Shapiro-Wilk (SW) n/a Mean±SD χ
2=5.187, df=2 p=0.075 not necessary to test 
All together 
control 2  p(KS)=n/a; p(SW)=n/a 2.0±1.4    
spz2 2  p(KS)=n/a; p(SW)=n/a 8.0±4.2    
spz2/Df(3R)Exel6205 4  p(KS)=n/a; p(SW)=0.262 (treat as normal) 16.0±7.3    
 No. of neurons 






(KS); Shapiro-Wilk (SW) n/a Mean±SD χ
2=5.187, df=2 p=0.075 not necessary to test 
All together 
control 2  p(KS)=n/a; p(SW)=n/a 2.5±0.7    
spz2 2  p(KS)=n/a; p(SW)=n/a 9.5±4.9    
spz2/Df(3R)Exel6205 4  p(KS)=n/a; p(SW)=0.275 (treat as normal) 16.8±5.3    









Statistics Test Value & df p-Value 
Multiple Comparisons 
& Correction 
 No. of neurons 






(KS); Shapiro-Wilk (SW) n/a Mean±SD χ
2=5.449, df=2 p=0.066 not necessary to test 
All together 
control 2  p(KS)=n/a; p(SW)=n/a 3.5±0.7    
spz2 2  p(KS)=n/a; p(SW)=n/a 7.0±0.0    
spz2/Df(3R)Exel6205 4  p(KS)=n/a; p(SW)=0.041 (treat as normal) 11.8±3.2    
 No. of neurons 






(KS); Shapiro-Wilk (SW) n/a Mean±SD χ
2=2.983, df=2 p=0.225 not necessary to test 
All together 
control 2  p(KS)=n/a; p(SW)=n/a 4.5±0.7    
spz2 2  p(KS)=n/a; p(SW)=n/a 9.5±4.9    
spz2/Df(3R)Exel6205 4  p(KS)=n/a; p(SW)=0.304 (treat as normal) 4.3±4.0    
 No. of neurons 






(KS); Shapiro-Wilk (SW) n/a Mean±SD χ
2=5.046, df=2 p=0.080 not necessary to test 
All together 
control 2  p(KS)=n/a; p(SW)=n/a 6.0±1.4    
spz2 2  p(KS)=n/a; p(SW)=n/a 11.0±2.8    
spz2/Df(3R)Exel6205 3  p(KS)=n/a; p(SW)<0.001 (treat as not normal) 2.3±2.3    
 No. of neurons 






(KS); Shapiro-Wilk (SW) n/a Mean±SD χ
2=0.000, df=2 p=1.000 not necessary to test 
control 2  p(KS)=n/a; p(SW)=n/a 8.0±0.0    
spz2 2  p(KS)=n/a; p(SW)=n/a 8.5±6.4    
 No. of neurons 
no. of intersection at 
50μm distance n/a not necessary to test n/a Mean±SD   n/a 
control 2  p(KS)=n/a; p(SW)=n/a 10.0±0.0    
spz2 1  p(KS)=n/a; p(SW)=n/a 8    
 No. of neurons 
no. of intersection at 
55μm distance n/a not necessary to test n/a Mean±SD   n/a 
control 2  p(KS)=n/a; p(SW)=n/a 9.5±2.1    
spz2 1  p(KS)=n/a; p(SW)=n/a 6    
 No. of neurons 
no. of intersection at 
60μm distance n/a not necessary to test n/a Mean±SD   n/a 
control 2    13.5±0.7    
 No. of neurons 
no. of intersection at 
65μm distance n/a not necessary to test n/a Mean±SD   n/a 
control 2    13.0±8.5    
 No. of neurons 
no. of intersection at 
70μm distance n/a not necessary to test n/a Mean±SD   n/a 
control 2    16.0±7.1    
Please turn over 
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Statistics Test Value & df p-Value 
Multiple Comparisons 
& Correction 
 No. of neurons 
no. of intersection at 
75μm distance n/a not necessary to test n/a Mean±SD   n/a 
control 2    12.0±4.2    
 No. of neurons 
no. of intersection at 
80μm distance n/a not necessary to test n/a Mean±SD   n/a 
control 2    10.0±5.7    
 No. of neurons 
no. of intersection at 
85μm distance n/a not necessary to test n/a Mean±SD   n/a 
control 2    12.5±0.7    
 No. of neurons 
no. of intersection at 
90μm distance n/a not necessary to test n/a Mean±SD   n/a 
control 2    13.0±0.0    
 No. of neurons 
no. of intersection at 
95μm distance n/a not necessary to test n/a Mean±SD   n/a 
control 2    8.5±0.7    
 No. of neurons 
no. of intersection at 
100μm distance n/a not necessary to test n/a Mean±SD   n/a 
control 2    8.0±2.8    
 No. of neurons 
no. of intersection at 
105μm distance n/a not necessary to test n/a Mean±SD   n/a 
control 2    7.0±2.8    
 No. of neurons 
no. of intersection at 
110μm distance n/a not necessary to test n/a Mean±SD  
 n/a 
control 2    5.0±2.8    
 No. of neurons 
no. of intersection at 
115μm distance n/a not necessary to test n/a Mean±SD  
 n/a 
control 2    2.0±1.4    
 No. of neurons 
no. of intersection at 
120μm distance n/a not necessary to test n/a Mean±SD  
 n/a 





9.2.34 Figure 5.31 Sholl Analysis of Abdominal A6-A7 RP2 Neurons 
 




Statistics Test Value & df p-Value 
Multiple Comparisons 
& Correction 
 No. of neurons 
no. of intersection at 
2.5μm distance  not necessary to test n/a Mean±SD  p=0.135 not necessary to test 
control 0       
spz2/Df(3R)Exel6205 1   1    
 No. of neurons 
no. of intersection at 
5.0μm distance  not necessary to test n/a Mean±SD  p=0.832 not necessary to test 
control 0       
spz2/Df(3R)Exel6205 2   2.5±2.1    
 No. of neurons 
no. of intersection at 
7.5μm distance  not necessary to test n/a Mean±SD   not necessary to test 
control 2   4.0±1.4    
spz2/Df(3R)Exel6205 1   3    
 No. of neurons 
no. of intersection at 
10.0μm distance t-test 
Kolmogorov-Smirnov 
(KS); Shapiro-Wilk (SW) 
Levene’s Test 




control 2  p(KS)=n/a; p(SW)=n/a 4.0±2.8    
spz2/Df(3R)Exel6205 2  p(KS)=n/a; p(SW)=n/a 7.0±4.2    
 No. of neurons 
no. of intersection at 
12.5μm distance t-test 
Kolmogorov-Smirnov 
(KS); Shapiro-Wilk (SW) 
Levene’s Test 




control 2  p(KS)=n/a; p(SW)=n/a 8.0±5.7    
spz2/Df(3R)Exel6205 2  p(KS)=n/a; p(SW)=n/a 8.5±2.1    
 No. of neurons 
no. of intersection at 
15.0μm distance t-test 
Kolmogorov-Smirnov 
(KS); Shapiro-Wilk (SW) 
Levene’s Test 
Mean±SD t=-0.509, df=3 p=0.646 not necessary to test 1.286, 
p=0.339 
control 2  p(KS)=n/a; p(SW)=n/a 7.5±4.9    
spz2/Df(3R)Exel6205 3  p(KS)=n/a; p(SW)=0.253 (treat as normal) 10.7±7.6    
 No. of neurons 
no. of intersection at 
17.5μm distance t-test 
Kolmogorov-Smirnov 
(KS); Shapiro-Wilk (SW) 
Levene’s Test 
Mean±SD t=0.764, df=3 p=0.500 not necessary to test 0.021, 
p=0.893 
control 2  p(KS)=n/a; p(SW)=n/a 9.5±3.5    
spz2/Df(3R)Exel6205 3  p(KS)=n/a; p(SW)=0.537 (treat as normal) 7.0±3.6    








Statistics Test Value & df p-Value 
Multiple Comparisons 
& Correction 
 No. of neurons 
no. of intersection at 
20.0μm distance t-test 
Kolmogorov-Smirnov 
(KS); Shapiro-Wilk (SW) 
Levene’s Test 
Mean±SD t=-1.142, df=3 p=0.283 not necessary to test 2.282, 
p=0.228 
control 2  p(KS)=n/a; p(SW)=n/a 7.5±3.5    
spz2/Df(3R)Exel6205 3  p(KS)=n/a; p(SW)=0.463 (treat as normal) 10.7±2.1    
 No. of neurons 
no. of intersection at 
22.5μm distance t-test 
Kolmogorov-Smirnov 
(KS); Shapiro-Wilk (SW) 
Levene’s Test 
Mean±SD t=-0.055, df=3 p=0.960 not necessary to test 1.584, 
p=0.297 
control 2  p(KS)=n/a; p(SW)=n/a 12.0±8.5    
spz2/Df(3R)Exel6205 3  p(KS)=n/a; p(SW)=0.174 (treat as normal) 12.3±5.5    
 No. of neurons 
no. of intersection at 
25.0μm distance t-test 
Kolmogorov-Smirnov 
(KS); Shapiro-Wilk (SW) 
Levene’s Test 
Mean±SD t=-0.832, df=3 p=0.466 not necessary to test 1.584, 
p=0.297 
control 2  p(KS)=n/a; p(SW)=n/a 8.5±0.7    
spz2/Df(3R)Exel6205 3  p(KS)=n/a; p(SW)=1.000 (treat as normal) 11.0±4.0    
 No. of neurons 
no. of intersection at 
27.5μm distance t-test 
Kolmogorov-Smirnov 
(KS); Shapiro-Wilk (SW) 
Levene’s Test 
Mean±SD t=-0.666, df=3 p=0.553 not necessary to test 7.736, 
p=0.069 
control 2  p(KS)=n/a; p(SW)=n/a 6.5±0.7    
spz2/Df(3R)Exel6205 3  p(KS)=n/a; p(SW)=0.220 (treat as normal) 13.0±13.1    
 No. of neurons 
no. of intersection at 
30.0μm distance t-test 
Kolmogorov-Smirnov 
(KS); Shapiro-Wilk (SW) 
Levene’s Test 
Mean±SD t=-0.525, df=3 p=0.636 not necessary to test 1.142, 
p=0.364 
control 2  p(KS)=n/a; p(SW)=n/a  8.0±5.7    
spz2/Df(3R)Exel6205 3  p(KS)=n/a; p(SW)=0.726 (treat as normal)  13.0±12.1    
 No. of neurons 
no. of intersection at 
32.5μm distance t-test 
Kolmogorov-Smirnov 
(KS); Shapiro-Wilk (SW) 
Levene’s Test 
Mean±SD t=-0.351, df=3 p=0.749 not necessary to test 4.860, 
p=0.115 
control 2  p(KS)=n/a; p(SW)=n/a  8.0±4.2    
spz2/Df(3R)Exel6205 3  p(KS)=n/a; p(SW)=0.235 (treat as normal)  12.3±16.3    
 No. of neurons 
no. of intersection at 
35.0μm distance t-test 
Kolmogorov-Smirnov 
(KS); Shapiro-Wilk (SW) 
Levene’s Test 




control 2  p(KS)=n/a; p(SW)=n/a  6.5±6.4    
spz2/Df(3R)Exel6205 2  p(KS)=n/a; p(SW)=n/a  13.5±6.4    








Statistics Test Value & df p-Value 
Multiple Comparisons 
& Correction 
 No. of neurons 
no. of intersection at 
37.5μm distance t-test 
Kolmogorov-Smirnov 
(KS); Shapiro-Wilk (SW) 
Levene’s Test 
Mean±SD t=-0.293, df=3 p=0.789 not necessary to test 0.595, 
p=0.497 
control 2  p(KS)=n/a; p(SW)=n/a  3.5±3.5    
spz2/Df(3R)Exel6205 3  p(KS)=n/a; p(SW)=0.407 (treat as normal)  4.7±4.7    
 No. of neurons 
no. of intersection at 
40.0μm distance t-test 
Kolmogorov-Smirnov 
(KS); Shapiro-Wilk (SW) 
Levene’s Test 
Mean±SD t=0.243, df=1.125 p=0.845 not necessary to test n/a, equal variances not 
assumed 
control 2  p(KS)=n/a; p(SW)=n/a  3.0±2.8    
spz2/Df(3R)Exel6205 2  p(KS)=n/a; p(SW)=n/a  2.5±0.7    
 No. of neurons 
no. of intersection at 
42.5μm distance n/a not necessary to test n/a Mean±SD   n/a 
control 1    1    
spz2/Df(3R)Exel6205 2    1.0±0.0    
 No. of neurons 
no. of intersection at 
45.0μm distance n/a not necessary to test n/a Mean±SD   n/a 





9.3 Statistical Tests in Chapter 6 
 
9.3.1 Figure 6.1 Time-Lapse Analysis 
 





Test Value & 
df p-Value 
Multiple Comparisons & 
Correction 






n/a Mean±SD (μm2)  
 
Bonferroni: 𝑝 × 10 
G9 at 6 hours after injury 3 
To G9 at 8 hours after 
injury 
p(KS)=n/a; p(SW)=0.358 (treat as normal) 5120±1998 
t=-1.503, df=2 p=0.272  
To G9 at 11 hours after 
injury t=0.014, df=2 p=0.990  
To G9 at 15 hours after 
injury t=3.196, df=2 p=0.086  
G9 at 7 hours after injury 3  p(KS)=n/a; p(SW)=0.393 (treat as normal) 5120±2199    
G9 at 8 hours after injury 3 
To G9 at 11 hours after 
injury p(KS)=n/a; p(SW)=0.436 (treat as normal) 5379±2284 
t=0.757, df=2 p=0.528  
To G9 at 15 hours after 
injury t=4.140, df=2 p=0.054  
G9 at 9 hours after injury 3  p(KS)=n/a; p(SW)=0.376 (treat as normal) 5248±2286    
G9 at 10 hours after injury 3  p(KS)=n/a; p(SW)=0.857 (treat as normal) 4844±1857    




(p=0.003883) p<0.05 (0.03883) 
G9 at 12 hours after injury 3  p(KS)=n/a; p(SW)=0.955 (treat as normal) 4512±1806    
G9 at 13 hours after injury 3  p(KS)=n/a; p(SW)=0.735 (treat as normal) 4380±1650    
G9 at 14 hours after injury 3  p(KS)=n/a; p(SW)=0.928 (treat as normal) 4152±1630    




9.3.2 Figure 6.2 Wound Area 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of VNC 





Levene’s Test Mean±SD 
(μm2) F=4.087, df=3 p<0.05 Dunnett All together 0.547, p=0.653 
yw 24  k=0.565; s=0.610; p(KS)=0.200; p(SW)=0.488 (all normal) 4575±1858   
 
spzMA05/Df(3R)Exel6205 6 To yw k=1.897; s=1.209; p(KS)=0.200; p(SW)=0.229 (all normal) 6674±1935   p=0.031 
elav>actSpz(2) 7 To yw k=-0.214; s=0.446; p(KS)=0.200; p(SW)=0.904 (all normal) 3411±1373   p=0.314 




9.3.3 Figure 6.3 Wound Area 
 




Statistics Test Value & df p-Value 
Multiple Comparisons & 
Correction 
 No. of VNC 





Levene’s Test Mean±SD 
(μm2) F=0.708, df=5 p=0.621 not necessary to test All together 1.130, p=0.357 
yw 24  k=0.565; s=0.610; p(KS)=0.200; p(SW)=0.488 (all normal) 4575±1858   
 
Toll7P114/Toll7P8;Toll631/Toll726 11  k=0.244; s=0.121; p(KS)=0.200; p(SW)=0.925 (all normal) 4516±1562    
elav>DNT1-CK3’+ 7  k=-1.577; s=-0.017; p(KS)=0.200; p(SW)=0.753 (all normal) 4399±1352    
repo> DNT1-CK3’+ 3  k=n/a; s=-1.593; p(KS)=n/a; p(SW)=0.257 (treat as normal) 3893±149    
elav>DNT2-CK-6A 5  k=0.706; s=0.897; p(KS)=0.200; p(SW)=0.629 (all normal) 4666±1868    
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